
<html lang="en"     class="pb-page"  data-request-id="4e14e4df-6fa8-4dbc-abc5-92f5a3c70eda"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm9012642;issue:issue:10.1021/jmcmar.2009.52.issue-22;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Potent and Selective Inhibitors of the Mammalian Target of Rapamycin (mTOR) Kinase" /></meta><meta name="dc.Creator" content="Pawel  Nowak" /></meta><meta name="dc.Creator" content="Derek C.  Cole" /></meta><meta name="dc.Creator" content="Natasja  Brooijmans" /></meta><meta name="dc.Creator" content="Matthew G.  Bursavich" /></meta><meta name="dc.Creator" content="Kevin J.  Curran" /></meta><meta name="dc.Creator" content="John W.  Ellingboe" /></meta><meta name="dc.Creator" content="James J.  Gibbons" /></meta><meta name="dc.Creator" content="Irwin  Hollander" /></meta><meta name="dc.Creator" content="YongBo  Hu" /></meta><meta name="dc.Creator" content="Joshua  Kaplan" /></meta><meta name="dc.Creator" content="David J.  Malwitz" /></meta><meta name="dc.Creator" content="Lourdes  Toral-Barza" /></meta><meta name="dc.Creator" content="Jeroen C.  Verheijen" /></meta><meta name="dc.Creator" content="Arie  Zask" /></meta><meta name="dc.Creator" content="Wei-Guo  Zhang" /></meta><meta name="dc.Creator" content="Ker  Yu" /></meta><meta name="dc.Description" content="The mammalian target of rapamycin (mTOR) is a central regulator of cell growth, metabolism, and angiogenesis and an emerging target in cancer research. High throughput screening (HTS) of our compou..." /></meta><meta name="Description" content="The mammalian target of rapamycin (mTOR) is a central regulator of cell growth, metabolism, and angiogenesis and an emerging target in cancer research. High throughput screening (HTS) of our compou..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 19, 2009" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm9012642" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2009 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm9012642" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm9012642" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm9012642" /></link>
        
    
    

<title>Discovery of Potent and Selective Inhibitors of the Mammalian Target of Rapamycin (mTOR) Kinase | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm9012642" /></meta><meta property="og:title" content="Discovery of Potent and Selective Inhibitors of the Mammalian Target of Rapamycin (mTOR) Kinase" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0012.jpeg" /></meta><meta property="og:description" content="The mammalian target of rapamycin (mTOR) is a central regulator of cell growth, metabolism, and angiogenesis and an emerging target in cancer research. High throughput screening (HTS) of our compound collection led to the identification of 3-(4-morpholin-4-yl-1-piperidin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenol (5a), a modestly potent and nonselective inhibitor of mTOR and phosphoinositide 3-kinase (PI3K). Optimization of compound 5a, employing an mTOR homology model based on an X-ray crystal structure of closely related PI3Kγ led to the discovery of 6-(1H-indol-5-yl)-4-morpholin-4-yl-1-[1-(pyridin-3-ylmethyl)piperidin-4-yl]-1H-pyrazolo[3,4-d]pyrimidine (5u), a potent and selective mTOR inhibitor (mTOR IC50 = 9 nM; PI3Kα IC50 = 1962 nM). Compound 5u selectively inhibited cellular biomarker of mTORC1 (P-S6K, P-4EBP1) and mTORC2 (P-AKT S473) over the biomarker of PI3K/PDK1 (P-AKT T308) and did not inhibit PI3K-related kinases (PIKKs) in cellular assays. These pyrazolopyrimidines represent an exciting new series of mTOR-selective inhibitors with potential for development for cancer therapy." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm9012642"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm9012642">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm9012642&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm9012642&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm9012642&amp;href=/doi/10.1021/jm9012642" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2009</span><span class="cit-fg-volume">, 52</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 7081-7089</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/52/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm900969p" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm900871v" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Potent and Selective Inhibitors of the Mammalian Target of Rapamycin (mTOR) Kinase</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pawel++Nowak">Pawel Nowak</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Derek+C.++Cole">Derek C. Cole</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Natasja++Brooijmans">Natasja Brooijmans</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+G.++Bursavich">Matthew G. Bursavich</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+J.++Curran">Kevin J. Curran</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+W.++Ellingboe">John W. Ellingboe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+J.++Gibbons">James J. Gibbons</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Irwin++Hollander">Irwin Hollander</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=YongBo++Hu">YongBo Hu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joshua++Kaplan">Joshua Kaplan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+J.++Malwitz">David J. Malwitz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lourdes++Toral-Barza">Lourdes Toral-Barza</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeroen+C.++Verheijen">Jeroen C. Verheijen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arie++Zask">Arie Zask</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei-Guo++Zhang">Wei-Guo Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ker++Yu">Ker Yu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Chemical Sciences</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Discovery Oncology</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Structural Biology</span></div><div class="aff-info" id="wr"><span class="aff-text">Wyeth Research, 401 N. Middletown Road, Pearl River, New York 10965</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: 845 602-4303. Fax: 845 602-5561. E-mail: <a href="/cdn-cgi/l/email-protection#06686971676d7646717f63726e2865696b"><span class="__cf_email__" data-cfemail="5b35342c3a302b1b2c223e2f3375383436">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm9012642&amp;href=/doi/10.1021%2Fjm9012642" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2009</span></span><span class="cit-volume">, 52</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 7081–7089</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 19, 2009</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 June 2009</li><li><span class="item_label"><b>Published</b> online</span>19 October 2009</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 November 2009</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm9012642" title="DOI URL">https://doi.org/10.1021/jm9012642</a></div><div class="article_header-article-copyright"><strong>Copyright © 2009 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7081%26pageCount%3D9%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DPawel%2BNowak%252C%2BDerek%2BC.%2BCole%252C%2BNatasja%2BBrooijmans%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D52%26issueNum%3D22%26contentID%3Djm9012642%26title%3DDiscovery%2Bof%2BPotent%2Band%2BSelective%2BInhibitors%2Bof%2Bthe%2BMammalian%2BTarget%2Bof%2BRapamycin%2B%2528mTOR%2529%2BKinase%26numPages%3D9%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7089%26publicationDate%3DNovember%2B2009">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm9012642"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4230</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">42</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm9012642" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Potent and Selective Inhibitors of the Mammalian Target of Rapamycin (mTOR) Kinase&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Pawel&quot;,&quot;last_name&quot;:&quot;Nowak&quot;},{&quot;first_name&quot;:&quot;Derek&quot;,&quot;last_name&quot;:&quot;C. Cole&quot;},{&quot;first_name&quot;:&quot;Natasja&quot;,&quot;last_name&quot;:&quot;Brooijmans&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;G. Bursavich&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;J. Curran&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;W. Ellingboe&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;J. Gibbons&quot;},{&quot;first_name&quot;:&quot;Irwin&quot;,&quot;last_name&quot;:&quot;Hollander&quot;},{&quot;first_name&quot;:&quot;YongBo&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Joshua&quot;,&quot;last_name&quot;:&quot;Kaplan&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;J. Malwitz&quot;},{&quot;first_name&quot;:&quot;Lourdes&quot;,&quot;last_name&quot;:&quot;Toral-Barza&quot;},{&quot;first_name&quot;:&quot;Jeroen&quot;,&quot;last_name&quot;:&quot;C. Verheijen&quot;},{&quot;first_name&quot;:&quot;Arie&quot;,&quot;last_name&quot;:&quot;Zask&quot;},{&quot;first_name&quot;:&quot;Wei-Guo&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Ker&quot;,&quot;last_name&quot;:&quot;Yu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2009&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;19&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;52&quot;,&quot;pages&quot;:&quot;7081-7089&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm9012642&quot;},&quot;abstract&quot;:&quot;The mammalian target of rapamycin (mTOR) is a central regulator of cell growth, metabolism, and angiogenesis and an emerging target in cancer research. High throughput screening (HTS) of our compound collection led to the identification of 3-(4-morpholin-4-yl-1-piperidin-4-yl-1H-pyrazolo[3,4-d]pyrimidin-6-yl)phenol (5a), a modestly potent and nonselective inhibitor of mTOR and phosphoinositide 3-kinase (PI3K). Optimization of compound 5a, employing an mTOR homology model based on an X-ray crystal structure of closely related PI3Kγ led to the discovery of 6-(1H-indol-5-yl)-4-morpholin-4-yl-1-[1-(pyridin-3-ylmethyl)piperidin-4-yl]-1H-pyrazolo[3,4-d]pyrimidine (5u), a potent and selective mTOR inhibitor (mTOR IC50 = 9 nM; PI3Kα IC50 = 1962 nM). Compound 5u selectively inhibited cellular biomarker of mTORC1 (P-S6K, P-4EBP1) and mTORC2 (P-AKT S473) over the biomarker of PI3K/PDK1 (P-AKT T308) and did not inhibit PI3K-related kinases (PIKKs) in cellular assays. These pyrazolopyrimidines represent an exciting new se&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9012642&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9012642" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9012642&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9012642" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9012642&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9012642" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm9012642&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9012642&amp;href=/doi/10.1021/jm9012642" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm9012642" /></input><a href="/doi/pdf/10.1021/jm9012642" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm9012642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm9012642%26sid%3Dliteratum%253Aachs%26pmid%3D19848404%26genre%3Darticle%26aulast%3DNowak%26date%3D2009%26atitle%3DDiscovery%2Bof%2BPotent%2Band%2BSelective%2BInhibitors%2Bof%2Bthe%2BMammalian%2BTarget%2Bof%2BRapamycin%2B%2528mTOR%2529%2BKinase%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D52%26issue%3D22%26spage%3D7081%26epage%3D7089%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/52/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/medium/jm-2009-012642_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9012642&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The mammalian target of rapamycin (mTOR) is a central regulator of cell growth, metabolism, and angiogenesis and an emerging target in cancer research. High throughput screening (HTS) of our compound collection led to the identification of 3-(4-morpholin-4-yl-1-piperidin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl)phenol (<b>5a</b>), a modestly potent and nonselective inhibitor of mTOR and phosphoinositide 3-kinase (PI3K). Optimization of compound <b>5a</b>, employing an mTOR homology model based on an X-ray crystal structure of closely related PI3Kγ led to the discovery of 6-(1<i>H</i>-indol-5-yl)-4-morpholin-4-yl-1-[1-(pyridin-3-ylmethyl)piperidin-4-yl]-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>5u</b>), a potent and selective mTOR inhibitor (mTOR IC<sub>50</sub> = 9 nM; PI3Kα IC<sub>50</sub> = 1962 nM). Compound <b>5u</b> selectively inhibited cellular biomarker of mTORC1 (P-S6K, P-4EBP1) and mTORC2 (P-AKT S473) over the biomarker of PI3K/PDK1 (P-AKT T308) and did not inhibit PI3K-related kinases (PIKKs) in cellular assays. These pyrazolopyrimidines represent an exciting new series of mTOR-selective inhibitors with potential for development for cancer therapy.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67000" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67000" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The mammalian target of rapamycin (mTOR<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>) <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: mTOR, mammalian target of rapamycin; mTORC1, mammalian target of rapamycin complex 1; HTS, high-throughput screening; PI3K, phosphoinositide 3-kinase; PIKK, phosphoinositide 3-kinase related kinases; DNA-PK, DNA-dependent protein kinase; ATM, ataxia-telangiectasia mutated; ATR, ataxia-telangiectasia and Rad3-related; SMG-1, suppressor of morphogenesis in genitalia-1; Ras, rat sarcoma; MAPK, mitogen-activated protein kinase; FRB, FKBP12-rapamycin binding; ERK, extracellular signal-regulated kinase; DELFIA, dissociation-enhanced lanthanide fluorescent immunoassay; PRKCN, protein kinase C, NU; CLK1, CDC-like kinase 1; STK25, serine/threonine kinase 25; JAK2, Janus kinase 2; AMPK, AMP-activated protein kinase; PAK2, P21-activated kinase 2; CSK, c-src tyrosine kinase; FGFR1, fibroblast growth factor receptor 1; MST4, mammalian sterile twenty-like 4; TEK, TEK tyrosine kinase, endothelial; NTRK2, neurotrophic tyrosine kinase receptor type 2; PAK7, P21(CDKN1A)-activated kinase 7; SGKL, serum and glucocorticoid-inducible kinase-like kinase; HWT, 17-hydroxywortmannin; Rapa, rapamycin.</p></div> is an unconventional high molecular weight serine/threonine protein kinase that regulates cell growth, proliferation, metabolism, and angiogenesis.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5">(1-5)</a> mTOR is the founding member of the PI3K-related kinase (PIKK) family<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> that also includes DNA-PK, ATM, ATR, and SMG-1. The PIKKs collectively play important and diverse roles in cell growth and surveillance of the genome and transcriptome. The catalytic sites of the PIKK family are similar to that of PI3K but differ significantly from the rest of the human kinome. mTOR primarily resides in two functional multiprotein complexes, mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2), governing subcellular functions and/or substrate specificity. mTORC1 is a key regulator of cellular translation, while mTORC2 is anticipated to regulate the AKT survival pathway and cytoskeletal network in human cells. mTORC1 and mTORC2 are critical mediators of the PI3K/AKT and Ras/MAPK signaling pathways that are frequently deregulated in human tumors.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7-9)</a></div><div class="NLM_p">Rapamycins (rapamycin and its analogs) are allosteric inhibitors that bind (in complex with FKBP12) to mTOR at the FKBP12-rapamycin binding domain (FRB domain) adjacent to the catalytic site of mTOR.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> These agents are used clinically for treating a subset of tumors.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a> However, only the FRB domain of mTORC1 is inhibited by the rapamycin−FKBP12 complex while that of mTORC2 is insensitive to these inhibitors.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> Inhibition of mTORC1 by the rapamycins can also induce feedback activation of PI3K and ERK/MAPK in some settings.<a onclick="showRef(event, 'ref7 ref8 ref17'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref17">(7, 8, 17)</a> Therefore, although the rapalogs have validated mTOR clinically as a cancer target, their molecular mechanism of action does not fully exploit the antitumor potential of mTOR targeting in cancer. Small molecule ATP-competitive inhibitors of mTOR kinase should provide global inhibition of both mTORC1 and mTORC2 and hence minimize the feedback activation of PI3K signaling (via inhibition of the AKT pathway) to achieve more robust antitumor efficacy. The PI3K/mTOR pathway has been a subject of widespread and intense drug discovery efforts for a number of years and potent dual/pan-PI3K inhibitors have been reported,<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18-20)</a> but only recently have reports describing mTOR selective compounds appeared.<a onclick="showRef(event, 'ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24">(21-24)</a></div><div class="NLM_p last">Herein, we report the identification, characterization, and hit-to-lead optimization of a series of pyrazolopyrimidine mTOR kinase inhibitors exemplified by 4-(6-(1<i>H</i>-indol-5-yl)-1-(1-(pyridin-3-ylmethyl)piperidin-4-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-yl)morpholine (<b>5u</b>). This small molecule lead (MW = 495, clogP = 2.1) has low nanomolar mTOR enzyme inhibitory activity, inhibits signaling functions of both mTORC1 and mTORC2 complexes in cellular setting, and is selective over PI3Kα and other kinases.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68107" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68107" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of <b>5a</b> and related compounds begins with treatment of barbituric acid (<b>1</b>) with phosphorus oxychloride (POCl<sub>3</sub>) in dimethylformamide, resulting in formation of 2,4,6-trichloropyrimidine, which undergoes formylation leading to aldehyde <b>2</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Reaction with substituted hydrazine produces the dichloropyrazolopyrimidine <b>3</b>. The 4-chloro substituent on dichloropyrazolopyrimidines <b>3</b> is selectively displaced by morpholine, leading to <b>4</b>. Finally, Suzuki coupling with boronic acid derivatives gives the target compounds <b>5</b>. In cases where the piperidinyl substitution was varied, the benzyl protecting group is removed by hydrogenation and the resulting secondary amine acylated or reductively alkylated (steps e and f). Compounds <b>5a</b>−<b>v</b> were assayed for inhibitory activity against mTOR (dissociation-enhanced lanthanide fluorescent immunoassay assay) and PI3K isoforms (fluorescence polarization assay).</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/medium/jm-2009-012642_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0013.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9012642&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) POCl<sub>3</sub>, DMF, reflux, 60%; (b) 1-benzyl-4-hydrazinylpiperidine dihydrochloride, Et<sub>3</sub>N, EtOH, −78 to 0°C, 82%; (c) morpholine, EtOH, 61%; (d) ArB(OH)<sub>2</sub> or ArB(OCMe<sub>2</sub>)<sub>2</sub> Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, dioxane, water, 100°C; (e) H<sub>2</sub>, Pd(OH)<sub>2</sub>/C (10%), MeOH; (f) R<sub>2</sub>COCl, Et<sub>3</sub>N, THF or R<sub>2</sub>CHO, NaBH<sub>3</sub>CN, AcOH (cat.), MeOH.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56264" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56264" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">An mTOR inhibitor high-throughput screen (HTS) led to the identification of compound <b>5a</b>, a promising “leadlike” starting point for further optimization because of its favorable properties: low MW (297), clogP (1.86), high ligand efficiency<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (0.42), low LELP<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> (clogP/(ligand efficiency) = 4.4), and submicromolar potency (IC<sub>50</sub> = 215 nM). However, compound <b>5a</b> was 6-fold more potent for PI3Kα than mTOR kinase and alerted us to a potential hurdle of achieving selectivity versus this closely related member of PI3K family of kinases.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Enzyme Inhibition Data for <b>5a</b>−<b>f</b> against mTOR and PI3Kα<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/medium/jm-2009-012642_0001.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top"><td align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/medium/jm-2009-012642_0002.gif" alt="" id="fx2" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">The asterisk (∗) indicates that IC<sub>50</sub> determinations are the mean of two to three independent measurements with standard error of <20%.</p></div></div></div><div class="NLM_p">In order to better understand the binding of pyrazolopyrimidins to the mTOR binding site, we have constructed an mTOR binding model based on an X-ray crystal structure of related PI3Kγ kinase. The catalytic sites of mTOR and PI3Kα differ only by two amino acid residues within a radius of 3 Å around <b>5a</b>, namely, Trp2239 to Val850 and Leu2354 to Phe930, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Both these residues are near the morpholine but do not make specific hydrogen bonding interactions with the compound.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/medium/jm-2009-012642_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Putative binding mode of <b>5a</b> with the mTOR homology model. In this model, the morpholine of <b>5a</b> forms a key hinge-region hydrogen bond with the backbone of Val2240. At the rear of the binding pocket, Asp2195 is shown making a second key hydrogen bond to the phenol of <b>5a</b>. Residues within a 3 Å radius of <b>5a</b> that are conserved between the mTOR active site and PI3Kα are shown in green and include the catalytic Lys2187. The only two residues that change (highlighted in orange) are Trp2239 and Leu2354. The core forms hydrophobic contacts with Ile2163 and Leu2185 above the plane of the inhibitor and with Met2345 and Ile2356 below the plane of the inhibitor (not shown for clarity).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9012642&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We began modifying our lead <b>5a</b> by derivatizing the piperidine NH group. The acetylpiperidine derivative <b>5b</b> had 5-fold improved activity and almost equal potency in the two enzymes (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Introduction of the benzoyl (<b>5c</b>) and nicotinyl (<b>5d</b>) groups led to compounds with low nanomolar activity and, for the first time, more than 10-fold selectivity versus PI3Kα. The corresponding benzyl (<b>5e</b>) and 3-pyridylmethyl (<b>5f</b>) analogues were somewhat less potent and selective.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Enzyme Inhibition Data for <b>5g</b>−<b>s</b> against mTOR and PI3Kα<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/medium/jm-2009-012642_0004.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top"><td align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/medium/jm-2009-012642_0005.gif" alt="" id="fx4" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">The asterisk (∗) indicates that IC<sub>50</sub> determinations are the mean of two to three independent measurements with standard error of <20%.</p></div></div></div><div class="NLM_p">Simultaneous with the optimization of the piperidine substitution, the benzyl analogue <b>5e</b> was chosen as a starting point to explore the SAR of the pyrazolopyrimidine aryl substituent. Moving the phenolic hydroxyl group to the 2- or 4-position of the aryl ring (<b>5g</b> and <b>5h</b>) led to a loss in activity (see Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) which is explained by the loss of the key hydrogen bond to Asp2195 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). The metabolic liability associated with the presence of a phenol group, as evidenced by short rat hepatocyte clearance half-life (<i>t</i><sub>1/2</sub> = 13 min for <b>5e</b>), prompted a search for suitable replacements. In the pyridyl and quinolinyl series (<b>5i</b>−<b>l</b>), compounds having a nitrogen H-bond acceptor in the 3- position showed modest potency. The 5-benzimidazolonyl derivative <b>5m</b> was modestly active and >20-fold selective over PI3Kα. Further investigation of analogous indole substituents (<b>5n</b>−<b>r</b>) led to the identification of the 5-indolyl derivative <b>5p</b>, which was equipotent with the original phenol <b>5e</b> and had >10-fold selectivity. The <i>N</i>-Me indole <b>5s</b> was almost 6-fold less active, suggesting that either the N−H of <b>5p</b> is involved in the same hydrogen bonding interaction as the phenol with Asp2195, as predicted by modeling (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), or the <i>N</i>-Me results in a steric clash with the protein, resulting in the lower activity of <b>5s</b>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Enzyme Inhibition Data for <b>5t</b>−<b>v</b> against mTOR and PI3Kα<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/medium/jm-2009-012642_0006.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_bottom"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top"><td align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/medium/jm-2009-012642_0007.gif" alt="" id="_i7" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">The asterisk (∗) indicates that IC<sub>50</sub> determinations are the mean of two to three independent measurements with standard error of <20%.</p></div></div></div><div class="NLM_p">Having found that the indole substituent leads to potent and selective mTOR inhibitors, we further explored piperidine substituents (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Compound <b>5t</b>, having an unsubstituent piperidine group, had only modest potency; however, substitution of the piperidine with pyridin-3-ylmethyl (<b>5u</b>) and nicotinoyl (<b>5v</b>) groups gave, as expected (cf. <b>5d</b>,and <b>5f</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), compounds of excellent activity and highly amplified selectivity vs PI3Kα (>1000-fold). The selectivity increases associated with modifications of groups in positions 1 and 6 of the pyrazolopyrimidine appear to be cumulative. This selectivity enhancement may be a result of accessing the more hydrophobic region in mTOR (Ala2248 and Leu2249 versus Met858 and Gln859 in PI3Kα).</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/medium/jm-2009-012642_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Predicted binding mode of <b>5u</b> with the mTOR homology model. The predicted binding mode of <b>5u</b> with mTOR shows the hydrogen bonding interaction of the morpholine to Val2240 and the indole-NH to Asp2195. The pyridin-3-ylmethyl tailpiece of <b>5u</b> in the front of the binding site interacts with a region that contains Leu2249 and Ala2248 in mTOR. The corresponding residues in PI3Kα are Met858 and Gln859, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9012642&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>5u</b> was the earliest example in the “indole” series to display excellent selectivity over PI3Kα, and hence, it was the most fully characterized. In the Invitrogen kinase panel<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> compound <b>5u</b> had less than 50% inhibition at 2 μM against 219 of 231 kinases and had modest activity (50−85% inhibition at 2 μM) against 12 kinases, namely, PRKCN, CLK1, STK25, JAK2, AMPK, PAK2, CSK, FGFR1, MST4, TEK, NTRK2, PAK7, and SGKL.</div><div class="NLM_p">The ATP-competitive nature of inhibition of compound <b>5u</b> was confirmed in a Lineweaver−Burk double-reciprocal dose−response plot (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) of the mTOR enzyme rates against the ATP concentration.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/medium/jm-2009-012642_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. ATP competitive inhibition of mTOR kinase activity. Compound <b>5u</b> was assayed in an inhibitor versus ATP matrix competition. The initial enzyme rate (<i>V</i><sub>0</sub>) against 0, 0.009, 0.018, 0.027 μM <b>5u</b> at various concentrations of ATP was measured to generate the double-reciprocal plot.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9012642&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A498 renal cancer cells treated with <b>5u</b> or rapamycin showed a distinctive biochemical profile (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Rapamycin inhibited mTORC1 biomarkers P-S6K1(T389) and P-4EBP1(T70) but not the rapamycin-resistant mTORC1 biomarker P-4EBP1(T37/46) or the biomarker P-AKT(S473). In contrast, the global mTOR inhibitor <b>5u</b> inhibited both mTORC1 and mTORC2 biomarkers in a dose-dependent manner.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/medium/jm-2009-012642_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0010.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of cellular mTORC1 and mTORC2 signaling functions in actively proliferating cancer cells. Renal tumor A498 cells were treated in growth medium for 6 h with DMSO or the indicated concentrations of <b>5u</b> or 1 μM rapamycin (Rapa) or 17-hydroxywortmannin (HWT). Total cell lysates were prepared and subject to immunoblotting with antibodies against P-S6K1(T389), P-4EBP1(T70), P-4EBP1(T36/47), P-AKT(S473). The blots were also stained with Ponceau S, a total protein dye, for sample loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9012642&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Treatment of PTEN-negative, PI3K/AKT-hyperactive U87MG glioma cells with <b>5u</b> selectively inhibited P-S6K(T389) and P-AKT(S473) but not P-AKT(T308), an activity biomarker of PI3K/PDK1. In contrast, a nonselective inhibitor <b>5f</b> and the PI3K inhibitors HWT all indiscriminately inhibited P-AKT(S473) and P-AKT(T308) (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Thus, both the biochemical and cellular results support <b>5u</b> as an ATP-competitive and selective inhibitor of mTOR kinase.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/medium/jm-2009-012642_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0011.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Selective targeting of mTOR versus PI3K in PTEN-negative cancer cells. U87MG glioma cells were treated in growth medium for 6 h with DMSO or the indicated concentrations of <b>5f</b> or <b>5u</b> or 1 μM rapamycin (Rapa) or 17-hydroxywortmannin (HWT). Total cell lysates were prepared and subject to immunoblotting with antibodies against P-S6K1 (T389), P-AKT (S473), and P-AKT (T308).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9012642&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08347" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08347" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Through mTOR inhibitor HTS, we identified a “leadlike” small molecule inhibitor of mTOR kinase. The hit-to-lead optimization was guided by a PI3Kγ based mTOR homology model and led to the identification of an indolopyrazolopyrimidine series, exemplified by 4-(6-(1<i>H</i>-indol-5-yl)-1-(1-(pyridin-3-ylmethyl)piperidin-4-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-yl)morpholine (<b>5u</b>), a 9 nM ATP-competitive inhibitor of mTOR kinase with >200-fold selectivity over PI3Kα, which showed only modest activity against 12 out of the 231 protein kinases. <b>5u</b> selectively inhibited mTOR over PI3Kα and the related PIKK<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> in cellular settings and inhibited proliferation of a panel of histologically diverse cancer cell lines.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The results of continued optimization and in vivo efficacy studies of this promising series will be disclosed.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Experimental Methods</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86277" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86277" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">NMR spectra were recorded on a Bruker Avance 300 MHz spectrometer. All chemical shifts are reported in parts per million (δ) relative to tetramethylsilane. The following abbreviations are used to denote signal patterns: s = singlet, d = doublet, t = triplet, m = multiplet, and br = broad. The mass spectral data were determined on an Agilent 1100 series LC/MSD, and HRMS was carried out on a Bruker APEX II 9.4 T mass spectrometer. Silica gel flash chromatrography was carried out on a Teledyne Isco, Inc. CombiFlash Companion using RediSep silica gel cartridges. Reverse phase HPLC purifications were performed on a Gilson preparative HPLC system controlled by Unipoint software using either Phenomenex Gemini 100 mm × 21.2 mm or Waters Xterra Prep 5 μM, 100 mm × 19 mm C<sub>18</sub> columns and in a 10−90% acetonitrile in water solvent gradient with 0.02% TFA buffer or with 0.02% ammonium hydroxide buffer. The purity of all compounds was ≥95%. The purity was analyzed using Agilent Technologies 1200 series LCMS with Agilent XDB-C18 30 mm × 2.1 mm, 1.8 μm particle size column: solvent gradient = 90% A at 0 min, 5% A at 2.6 min, 5% A at 3 min; solvent A = 0.05% modifier in water; solvent B = 0.05% modifier in ACN; flow rate 1 mL/min. Modifiers used were NH<sub>4</sub>OH or HCO<sub>2</sub>H.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> 1-Benzyl-4-hydrazinylpiperidine Dihydrochloride<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></h3><div class="NLM_p last">Benzoic hydrazide (5.47 g, 40.2 mmol) was dissolved in methanol (30 mL) and 1-benzylpiperidin-4-one (7.60 g, 40.2 mmol) added, and the solution was stirred for 1 h at 30 °C and for 4 h at 60 °C. The solution was cooled in an ice bath, and sodium borohydride (1.52 g, 40.2 mmol) was slowly added. After 2 h the solvent was evaporated and the residue was partitioned between chloroform (50 mL) and saturated sodium bicarbonate (50 mL). The chloroform fraction was separated, dried with magnesium sulfate, and concentrated giving yellow oil (20.0 g). Water (16 mL) and concentrated hydrochloric acid (28 mL) were added. The solution was stirred for 15 min and the residual chloroform removed. The aqueous solution was refluxed overnight and then cooled in an ice bath, and the precipitated benzoic acid was filtered off. The filtrate was concentrated (∼20 mL volume), and ethanol (100 mL) was added. The solution was cooled, and white crystals were filtered off and washed with a small portion of ethanol followed by diethyl ether. The solid was dried in high vacuum overnight (5.30 g, 76%). Mp: 200 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.19−11.04 (br s, 1H), 7.67−7.60 (m, 2H), 7.47−7.42 (m, 3H), 4.31−4.22 (m, 2H), 3.40−3.28 (m, 2H), 3.18−3.03 (m, 2H), 3.02−2.89 (m, 1H), 2.17−1.99 (m, 3H), 1.85−1.72 (m, 1H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 131.8, 131.7, 130.2, 130.3, 129.7, 129.0, 58.7, 53.8, 49.6, 46.2, 26.9, 24.0. IR: 2964, 2464, 1063, 1037 cm<sup>−1</sup>. MS (ES+): <i>m</i>/<i>z</i> 206.2 [M + H]<sup>+</sup> (100%). HRMS: <i>m</i>/<i>z</i> 206.164 46, calcd [M + H]<sup>+</sup> 206.164 82, rel intens 100%, error −0.36 mAmu.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> 2,4,6-Trichloropyrimidine-5-carbaldehyde (<b>2</b>)<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></h3><div class="NLM_p last">Phosphorus oxychloride (46 mL) was added dropwise over 20 min to dimethylformamide cooled in an ice bath. The solution was stirred for further 20 min after, and barbituric acid (8.00 g, 62.4 mmol) was added in one portion. The solution was stirred for 1 h at room temperature, and then it was heated to 100 °C for 4 h. The solution was evaporated to half-volume, and while still warm it was poured onto ice (200 g). Water (200 mL) was added, and the suspension was stirred for 15 min. The yellow precipitate was filtered off, dissolved in chloroform (200 mL), and washed with water. The solution was dried with magnesium sulfate and filtered through small silica pad with the aid of dichloromethane. The solvents were evaporated, and the residue was triturated with hexanes. White crystals were filtered off and dried in high vacuum (8.00 g, 60%). Mp: 130−132 °C. <sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>): δ 10.42 (s). <sup>13</sup>C NMR (75 MHz, chloroform-<i>d</i>): δ 184.6, 164.1, 161.6. 122.9. IR: 2964, 1702, 1054. 1036 cm<sup>−1</sup>. MS (ES−): <i>m</i>/<i>z</i> 211.8 [M]<sup>+</sup> (23%), 209.8 [M]<sup>+</sup> (26%), 192.8 (69%), 190.8 (100%). Anal. Calcd for C<sub>5</sub>HCl<sub>3</sub>N<sub>2</sub>O: C 28.40; H 0.48; N 13.25. Found: C 28.51; H 0.77; N 13.28.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> 1-(1-Benzylpiperidin-4-yl)-4,6-dichloro-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>3</b>)</h3><div class="NLM_p last">2,4,6-Trichloro-5-pyrimidinecarboxaldehyde (<b>2</b>) (5.00 g, 23.65 mmol) was dissolved in ethanol (100 mL). The solution was cooled to −78 °C and 1-benzyl-4-hydrazinylpiperidine dihydrochloride (4.12 g, 23.65 mmol) added followed by triethylamine (9.9 mL, 70.90 mmol). The solution was stirred at −78 °C for 0.5 h and then warmed up to 0 °C and stirred at this temperature for 1.5 h. Ethyl acetate (500 mL) and saturated sodium bicarbonate (100 mL) were added, and the organic phase was separated, dried with anhydrous magnesium sulfate, and concentrated (bath temperature of <15 °C). The residue was dissolved in ethyl acetate (100 mL), and the solution was filtered through a plug of silica gel followed by elution with more ethyl acetate (20 mL). Removal of solvent (rotovap bath temperature of <15 °C) gave a thick yellow oil (7.01 g, 82%) which was unstable at room temperature and was immediately used in the next step. Analytical sample was converted to hydrochloride salt by dissolution in ethanol followed by saturation with gaseous hydrogen chloride and removal of solvent. The sample was stable enough to collect analytical data. Mp >230 °C (dec). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.78 (br s, 1H), 8.61 (s, 1H), 7.65−7.59 (m, 2H), 7.51−7.46 (m, 3H), 5.12−5.02 (m, 1H), 4.32 (s, 2H), 3.53−3.43 (m, 2H), 3.61−3.21 (m, 2H), 2.59−2.46 (m, 2H), 2.21−2.12 (m, 2H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 155.3, 154.4, 153.9, 133.6, 131.8, 130.0, 129.8, 129.1, 113.2, 59.3, 52.2, 50.4, 28.3. IR: 3432, 1026 cm<sup>−1</sup>. MS (ES+): <i>m</i>/<i>z</i> 362.1 [M + H]<sup>+</sup> (100%), 364.1 [M + H]<sup>+</sup> (48%). Anal. Calcd for C<sub>17</sub>H<sub>18</sub>Cl<sub>3</sub>N<sub>5</sub>·0.1EtOH: C 51.22; H 4.65; N 17.36. Found: C 51.58; H 4.28; N 16.87.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> 4-(1-(1-Benzylpiperidin-4-yl)-6-chloro-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-yl)morpholine (<b>4</b>)</h3><div class="NLM_p last">1-(1-Benzylpiperidin-4-yl)-4,6-dichloro-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>3</b>) (7.00 g 19.32 mmol) was dissolved in ethanol (100 mL). The solution was cooled to 0 °C, and morpholine (1.68 mL, 19.32 mmol) was added. The solution was stirred for 0.5 h at 0 °C and 0.5 h at room temperature, the solvent was evaporated, and the residue was dissolved in ethyl acetate (200 mL). The solution was washed with saturated sodium bicarbonate (50 mL), the insoluble particles were removed by filtration and the phases separated, and the organic solution was dried with magnesium sulfate. The solvents were evaporated, and the residue was redissolved in ethyl acetate (50 mL) and filtered through a small (5 g) pad of silica with ethyl acetate elution. The solvent was evaporated leaving thick oil. The oil was dissolved in diethyl ether (50 mL) which led to spontaneous crystallization. The yellow crystals were filtered off and dried in high vacuum overnight (7.98 g, 61%). Mp 144−146 °C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.35 (s, 1H), 7.35−7.31 (m, 4H), 7.30−7.27 (m, 1H), 4.64−4.50 (m, 1H), 3.91−3.85 (m, 4H), 3.73−3.69 (m, 4H), 3.53 (s, 2H), 2.97−2.84 (m, 2H), 2.22−2.02 (m, 4H), 1.87−1.78 (m, 2H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 156.5, 156.0, 153.9, 138.4, 133.2, 128.5, 128.0, 126.7, 98.7, 65.6, 61.7, 53.8, 51.9, 45.8 (low intensity), 30.8. IR: 32954, 1554, 1305, 945 cm<sup>−1</sup>. MS (ES+): <i>m</i>/<i>z</i> 413.2 [M + H]<sup>+</sup> (100%). Anal. Calcd for C<sub>21</sub>H<sub>25</sub>ClN<sub>6</sub>O: C 61.08; H 6.10; N 20.35. Found: C 60.98; H 5.94; N 20.33.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 4-(1-(1-Benzylpiperidin-4-yl)-6-(1<i>H</i>-indol-5-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-yl)morpholine (<b>5p</b>)</h3><div class="NLM_p last">4-(1-(1-Benzylpiperidin-4-yl)-6-chloro-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-yl)morpholine (<b>4</b>) (1.30 g, 3.15 mmol) was dissolved in dioxane (5 mL). 1<i>H</i>-Indol-5-ylboronic acid (633 mg, 3.94 mmol) followed by tetrakis(triphenylphosphine)palladium(0) (273 mg, 0.24 mmol) and 2 M aquieous sodium carbonate (5 mL) was added. The solution was degassed with a stream of nitrogen, and it was heated in a microwave reactor for 3 min at 120 °C. The reaction mixture was partition between ethyl acetate (25 mL) and 1 M aqueous sodium hydroxide (25 mL), and the organic fraction was separated, dried with magnesium sulfate, and evaporated. The oily residue was purified by flash chromatography (gradient of ethyl acetate to ethyl acetate/methanol/triethylamine, 8:1:1). Removal of solvent and drying in high vacuum gave an off-white, amorphous solid (1.31 g, 90%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.25 (s, 1H), 8.71 (s, 1H), 8.31−8.22 (m, 2H), 7.46 (d, <i>J</i> = 9.0 Hz, 1H), 7.41−7.23 (m, 6H), 6.57 (s, 1H), 4.90−4.86 (m, 1H), 4.07−3.98 (m, 4H), 3.83−3.76 (m, 4H), 3.56 (s, 2H), 3.02−2.94 (m, 2H), 2.31−2.13 (m, 4H), 1.96−1.85 (m, 2H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 160.7, 156.5, 154.6, 138.4, 137.2, 132.5, 128.8, 128.6, 128.0, 127.4, 126.8, 126.0, 121.6, 120.6, 110.8, 102.1, 98.4, 65.8, 61.8, 53.3, 52.1, 44.9 (low intensity), 31.0. IR 2928, 1580, 1065, 1030, 1005 cm<sup>−1</sup>. MS (ESI): <i>m</i>/<i>e</i> 247.6 (7%), 494.3 [M + H]<sup>+</sup> (100%). Anal. Calcd for C<sub>29</sub>H<sub>31</sub>N<sub>7</sub>O·<sup>2</sup>/<sub>3</sub>H<sub>2</sub>O: C 68.89; H 6.45; N 19.39. Found: C 68.88; H 5.92; N 19.57.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 4-(6-(1<i>H</i>-Indol-5-yl)-1-(piperidin-4-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-yl)morpholine (<b>5t</b>)</h3><div class="NLM_p last">4-(1-(1-Benzylpiperidin-4-yl)-6-(1<i>H</i>-indol-5-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-yl)morpholine <b>(5p)</b> (1.00 g, 20.3 mmol) was dissolved in tetrahydrofuran−methanol (50 mL, 1:1). Palladium hydroxide (0.75 g, 20% on carbon) was added, and the solution was hydrogenated at atmospheric pressure overnight. The catalyst was filtered off on a Cellite pad, and the solvent was evaporated. The residue was purified by flash chromatography (gradient of dichloromethane to dichloromethane/methanol/triethylamine, 3:1:1). Removal of solvent and drying in high vacuum gave an off-white, amorphous solid (0.45 g, 55%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.25 (s, 1H), 8.71 (s, 1H), 8.31−8.24 (m, 2H), 7.45 (d, <i>J</i> = 8.5 Hz, 1H), 7.39 (dd, <i>J</i> = 2.5, 2.5 Hz, 1H), 6.57 (s, 1H), 4.94−4.81 (m, 1H), 4.05−3.97 (m, 4H), 3.49−3.77 (m, 4H), 3.15−3.05 (m, 2H), 2.77−2.64 (m, 2H), 2.13−1.96 (m, 3H), 1.88−1.78 (m, 2H). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ 160.6, 156.5, 154.4, 137.3, 132.4, 128.9, 127.4, 126.0, 121.6, 120.6, 110.8, 102.1, 98.4, 65.9, 53.9, 45.3, 45.0 (low intensity), 32.5. IR: 3260, 2930, 1570 cm<sup>−1</sup>. MS (ESI): <i>m</i>/<i>e</i> 404.2 [M + H]<sup>+</sup> (100%). Anal. Calcd for C<sub>22</sub>H<sub>25</sub>N<sub>7</sub>O·2H<sub>2</sub>O: C, 60.12; H, 6.65; N, 22.31. Found: C 60.53; H 6.25; N 22.5.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General Procedures</h3><div id="sec5_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Procedure A: Suzuki Coupling</h4><div class="NLM_p last">The piperidine compound (0.25 mmol) was dissolved in dioxane (2 mL), and boronic acid (0.25 mmol) followed by tetrakis(triphenylphosphine)palladium(0) (28 mg, 0.025 mmol) and 2 M aquieous sodium carbonate (2 mL) was added. The solution was degassed with a stream of nitrogen, and it was heated in a microwave reactor for 3 min at 120 °C. The reaction mixture was partitioned between ethyl acetate (10 mL) and saturated aqueous sodium bicarbonate (10 mL). The organic fraction was separated, dried with anhydrous magnesium sulfate, and evaporated. The residue was purified by preparative HPLC.</div></div><div id="sec5_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Procedure B: Reductive Amination</h4><div class="NLM_p last">The piperidine compound (0.25 mmol) was dissolved in methanol (10 mL), and 3-pyridinecarboxaldehyde (80 mg, 0.75 mmol) was added followed by sodium cyanoborohydride (62 mg, 1.00 mmol) and acetic acid (0.05 mL). The solution was stirred overnight. Solvent was evaporated, and the residue was partitioned between ethyl acetate (10 mL) and saturated aqueous sodium bicarbonate (10 mL). The organic fraction was separated, dried with anhydrous magnesium sulfate, and evaporated. The residue was purified by preparative HPLC.</div></div><div id="sec5_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Procedure C: Conversion to Amide</h4><div class="NLM_p last">The piperidine compound (0.25 mmol) was dissolved in tetrahydrofuran (5 mL), and acid chloride (0.30 mmol) was added followed by triethylamine (0.09 mL, 0.60 mmol). The solution was stirred for 1 h. Ethyl acetate (10 mL) and saturated aqueous sodium bicarbonate (10 mL) were added, and the organic fraction was separated, dried with anhydrous magnesium sulfate, and evaporated. The residue was purified by preparative HPLC.</div></div><div id="sec5_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 3-(4-Morpholin-4-yl-1-piperidin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl)phenol (<b>5a</b>)</h4><div class="NLM_p last">This compound was prepared in an analogous manner to <b>5p</b> and <b>5v</b>, using 3-hydroxyphenylboronic acid instead of 1<i>H</i>-indol-5-ylboronic acid. Purification was by preparative reverse phase HPLC with 0.02% ammonium hydroxide buffer. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.57 (br s, 1H), 8.31−8.27 (m, 1H), 7.90−7.86 (m, 2H), 7.66−7.54 (m, 1H), 7.28 (dd, <i>J</i> = 8.0, 8.0 Hz, 1H), 6.90−6.84 (m, 1H), 4.93−4.80 (m, 1H), 4.03−3.69 (m, 8H), 3.18−3.03 (m, 2H), 2.79−2.65 (m, 2H), 2.14−1.78 (m, 4H). MS (ESI): <i>m</i>/<i>e</i> 381.2 [M + H]<sup>+</sup> (100%). HRMS <i>m</i>/<i>z</i> 381.203 63, calcd [M + H]<sup>+</sup> 381.203 35, rel intens 100%, error 0.28 mAmu.</div></div><div id="sec5_7_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 3-[1-(1-Acetylpiperidin-4-yl)-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl]phenol (<b>5b</b>)</h4><div class="NLM_p last">Procedure C was used. The piperidine substrate for procedure C was prepared in an analogous manner to <b>5p</b> and <b>5t</b>, using 3-hydroxyphenylboronic acid instead of 1<i>H</i>-indol-5-ylboronic acid. The product was purified by preparative reverse phase HPLC with 0.02% ammonium hydroxide buffer, giving an off-white amorphous solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.33−8.29 (m, 2H), 7.83−7.74 (m, 1H), 7.66−7.53 (m, 1H), 7.23−7.16 (m, 1H), 6.84−6.78 (m, 1H), 5.09−4.90 (m, 1H), 4.54−4.44 (m, 1H), 4.02−3.87 (m, 5H), 3.81−3.66 (m, 6H), 2.05 (s, 3H), 2.08−1.80 (m, 4H). MS (ESI): <i>m</i>/<i>e</i> 423.2 [M + H]<sup>+</sup> (100%), (M + K)<sup>+</sup> 461.2 (6%). HRMS <i>m</i>/<i>z</i> 423.213 69, calcd [M + H]<sup>+</sup> 423.213 92, rel intens 100%, error 0.23 mAmu.</div></div><div id="sec5_7_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 3-[1-(1-Benzoylpiperidin-4-yl)-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl]phenol (<b>5c</b>)</h4><div class="NLM_p last">Procedure C was used. The chloro substrate for procedure C was prepared in an analogous manner to <b>5p</b> and <b>5t</b>, using 3-hydroxyphenylboronic acid instead of 1<i>H</i>-indol-5-ylboronic acid. The product was purified by preparative reverse phase HPLC with 0.02% ammonium hydroxide buffer, giving an off-white amorphous solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.55 (s, 1H), 8.34 (s, 1H), 7.94−7.87 (m, 2H), 7.48 (s, 5H), 7.29 (dd, <i>J = 8.0, 8.0 Hz</i>, 1H), 6.89 (dd, <i>J</i> = 2.0, 8.5 Hz, 1H), 5.19−5.04 (m, 1H), 4.74−4.55 (m, 4H), 4.06−3.97 (m, 5H), 3.21−3.03 (m, 1H), 2.20−1.87 (m, 5H). MS (ESI): <i>m</i>/<i>e</i> 485.2 [M + H]<sup>+</sup> (100%). HRMS <i>m</i>/<i>z</i> 485.229 07, calcd [M + H]<sup>+</sup> 485.229 57, rel intens 100%, error 0.50 mAmu.</div></div><div id="sec5_7_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 3-{4-Morpholin-4-yl-1-[1-(pyridin-3-ylcarbonyl)piperidin-4-yl]-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl}phenol (<b>5d</b>)</h4><div class="NLM_p last">Procedure C was used. The chloro substrate for procedure C was prepared in an analogous manner to <b>5p</b> and <b>5t</b>, using 3-hydroxyphenylboronic acid instead of 1<i>H</i>-indol-5-ylboronic acid. The product was purified by preparative reverse phase HPLC with 0.02% ammonium hydroxide buffer, giving an off-white amorphous solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.53 (s, 1H), 8.69−8.65 (m, 2H), 8.33 (s, 1H), 7.94−7.85 (m, 3H), 7.51 (dd, <i>J</i> = 4.5, 8.0 Hz, 1H), 7.28 (dd, 7.5, 7.5, 1H), 6.87 (dd, <i>J</i> = 3.5, 8.0 Hz, 1H), 5.17−5.07 (m, 1H), 4.68−4.57 (m, 1H), 4.04−3.97 (m, 4H), 3.82−3.75 (m, 4H), 3.25−3.11 (m, 3H), 2.33−1.85 (m, 4H). MS (ESI): <i>m</i>/<i>e</i> 157.0 (15%), 486.2 [M + H]<sup>+</sup> (100%). HRMS <i>m</i>/<i>z</i> 486.22447, calcd [M + H]<sup>+</sup> 486.224 82, rel intens 100%, error 0.35.</div></div><div id="sec5_7_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 3-[1-(1-Benzylpiperidin-4-yl)-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl]phenol (<b>5e</b>)</h4><div class="NLM_p last">Procedure A was used. Purification was by preparative reverse phase HPLC with 0.02% ammonium hydroxide buffer, giving an off-white amorphous solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.51 (s, 1H), 8.30 (s, 1H), 7.89−7.84 (m, 2H), 7.38−7.32 (m, 4H), 6.89−6.85 (m, 1H), 4.83−4.74 (m, 1H), 4.03−3.96 (m, 4H), 3.81−3.76 (m, 4H), 3.57 (s, 2H), 3.02−2.94 (m, 2H), 2.27−2.15 (m, 4H), 1.96−1.85 (m, 2H). MS (ESI): <i>m</i>/<i>e</i> 413.2 (13%), 471.2 [M + H]<sup>+</sup> (100%). HRMS <i>m</i>/<i>z</i> 471.25107, calcd [M + H]<sup>+</sup> 471.250 30, rel intens 100%, error 0.77 mAmu.</div></div><div id="sec5_7_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 3-{4-Morpholin-4-yl-1-[1-(pyridin-3-ylmethyl)piperidin-4-yl]-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl}phenol (<b>5f</b>)</h4><div class="NLM_p last">Procedure A was used. The piperidine substrate for procedure B was prepared in an analogous manner to <b>5p</b> and <b>5t</b>, using 3-hydroxyphenylboronic acid instead of 1<i>H</i>-indol-5-ylboronic acid. The product was purified by preparative reverse phase HPLC with 0.02% ammonium hydroxide buffer, giving an off-white amorphous solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.52 (s, 1H), 8.57−8.46 (m, 2H), 8.31 (s, 1H), 7.90−7.75 (m, 3H), 7.39 (dd, <i>J</i> = 4.5, 7.0 Hz, 1H), 7.27 (dd, <i>J</i> = 8.0, 8.0 Hz, 1H), 6.89−6.87 (m, 1H), 4.85−4.72 (m, 1H), 4.04 (m, 4H), 3.83 (m, 4H), 3.61 (s, 2H), 3.03−2.93 (m, 2H), 2.32−2.13 (m, 4H), 1.97−1.89 (m, 2H). MS (ESI): <i>m</i>/<i>e</i> 236.5 (5%), 472.2 [M + H]<sup>+</sup> (100%). HRMS <i>m</i>/<i>z</i> 472.245 56, calcd [M + H]<sup>+</sup> 472.245 55, rel intens 100%, error 0.03 mAmu.</div></div><div id="sec5_7_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 2-[1-(1-Benzylpiperidin-4-yl)-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl]phenol (<b>5g</b>)</h4><div class="NLM_p last">Procedure A was used. Purification was by preparative reverse phase HPLC with 0.02% TFA buffer, giving an off-white amorphous solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 13.46 (m, 1H), 9.73 (m, 1H), 8.48−8.41 (m, 2H), 7.59−7.35 (m, 5H), 6.98−6.90 (m, 2H), 6.56 (m, 1H), 5.11−4.98 (m, 1H), 4.46−4.34 (m, 2H), 4.02−3.93 (m, 4H), 3.85−3.75 (m, 4H), 3.60−3.23 (m, 4H), 2.47−2.11 (m, 4H). MS (ESI): <i>m</i>/<i>e</i> 471.2 [M + H]<sup>+</sup> (100%). HRMS <i>m</i>/<i>z</i> 471.250 19, calcd [M + H]<sup>+</sup> 471.250 30, rel intens 100%, error 0.11 mAmu.</div></div><div id="sec5_7_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 4-[1-(1-Benzylpiperidin-4-yl)-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl]phenol Trifluoroacetic Acid Salt (<b>5h</b>)</h4><div class="NLM_p last">Procedure A was used. Purification was by preparative reverse phase HPLC with 0.02% TFA buffer, giving an off-white amorphous solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.29 (br s, 1H), 8.34−8.27 (m, 3H), 7.59−7.46 (m, 5H), 6.89−6.82 (m, 2H), 5.17−5.02 (m, 1H), 4.46−4.33 (m, 2H), 4.03−3.91 (m, 4H), 3.82−3.72 (m, 4H), 3.62−3.23 (m, 4H), 2.49−2.10 (m, 4H). MS (ESI): <i>m</i>/<i>e</i> 471.2 [M + H]<sup>+</sup> (100%). HRMS <i>m</i>/<i>z</i> 471.250 97, calcd [M + H]<sup>+</sup> 471.250 30, rel intens 100%, error 0.67 mAmu.</div></div><div id="sec5_7_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 1-(1-Benzylpiperidin-4-yl)-4-morpholin-4-yl-6-pyridin-3-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>5i</b>)</h4><div class="NLM_p last">Procedure A was used. Purification was by preparative reverse phase HPLC with 0.02% TFA buffer, giving an off-white amorphous solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.95 (br s, 1H), 9.61 (s, 1H), 8.40 (s, 1H), 8.77−8.68 (m, 2H), 7.62−7.46 (m, 6H), 5.21−5.07 (m, 1H), 4.43−4.35 (m, 2H), 4.08−3.98 (m, 4H), 3.83−3.74 (m, 4H), 3.61−3.24 (m, 4H), 2.51−2.14 (m, 4H). MS (ESI): <i>m</i>/<i>e</i> 228.2 (29%), 456.2 [M + H]<sup>+</sup> (100%). HRMS <i>m</i>/<i>z</i> 456.251 46, calcd [M + H]<sup>+</sup> 456.250 64, rel intens 100%, error 0.82 mAmu.</div></div><div id="sec5_7_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 1-(1-Benzylpiperidin-4-yl)-4-morpholin-4-yl-6-pyridin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine Trifluoroacetic Acid Salt (<b>5j</b>)</h4><div class="NLM_p last">Procedure A was used. Purification was by preparative reverse phase HPLC with 0.02% TFA buffer, giving an off-white amorphous solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.63 (br s, 1H), 8.77−8.73 (m, 2H), 8.43 (s, 1H), 8.34−8.30 (m, 2H), 7.57−7.49 (m, 5H), 5.20−5.09 (m, 1H), 4.17−4.35 (m, 2H), 4.07−3.98 (m, 4H), 3.92−3.47 (m, 6H), 2.39−2.10 (m, 4H). MS (ESI): <i>m</i>/<i>e</i> 228.6 (32%), 379.2 (17%), 456.2 [M + H]<sup>+</sup> (100%). HRMS <i>m</i>/<i>z</i> 456.251 37, calcd [M + H]<sup>+</sup> 456.250 64, rel intens 100%, error 0.73 mAmu.</div></div><div id="sec5_7_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 3-[1-(1-Benzylpiperidin-4-yl)-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl]quinoline Trifluoroacetic Acid Salt (<b>5k</b>)</h4><div class="NLM_p last">Procedure A was used. Purification was by preparative reverse phase HPLC with 0.02% TFA buffer, giving an off-white amorphous solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.94 (s, 1H), 9.30 (s, 1H), 8.42 (s, 1H), 8.14 (dd, <i>J</i> = 8.0, 21.5 Hz, 2H), 7.85 (dd, <i>J</i> = 7.5, 7.5 Hz, 1H), 7.7- (dd, <i>J</i> = 7.5, 7.5 Hz, 1H), 7.59−7.50 (m, 6H), 5.27−5.15 (m, 1H), 4.47−4.37 (m, 2H), 4.13−4.03 (m, 4H), 3.87−3.75 (m, 4H), 3.61−3.30 (m, 4H), 2.48−2.17 (m, 4H). MS (ESI): <i>m</i>/<i>e</i> 253.6 (62%), 506.3 [M + H]<sup>+</sup> (100%). HRMS <i>m</i>/<i>z</i> 506.266 99, calcd [M + H]<sup>+</sup> 506.266 29, rel intens 100%, error 0.70 mAmu.</div></div><div id="sec5_7_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 6-[1-(1-Benzylpiperidin-4-yl)-4-(morpholin-4-yl)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl]quinoline Trifluoroacetic Acid Salt (<b>5l</b>)</h4><div class="NLM_p last">Procedure A was used. Purification was by preparative reverse phase HPLC with 0.02% TFA buffer, giving an off-white amorphous solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.71 (s. 1H), 9.08 (d, <i>J</i> = 2.0 Hz, 1H), 8.99 (dd, <i>J</i> = 1.5, 4.5 Hz, 1H), 8.86 (dd, <i>J</i> = 2.0, 9.0 Hz, 1H), 8.59 (d, <i>J</i> = 8.0 Hz, 1H), 8.42 (s, 1H), 8.15 (d, <i>J</i> = 7.5 Hz, 1H), 7.64 (dd, <i>J</i> = 4.0, 8.5 Hz, 1H), 7.60−7.49 (m, 5H), 2.29−5.15 (m, 1H), 4.45−4.38 (m, 2H), 4.14−4.02 (m, 4H), 3.87−3.76 (m, 4H), 3.63−3.53 (m, 2H), 3.46−3.31 (m, 2H), 2.53−2.35 (m, 2H), 2.30−2.18 (m, 2H). MS (ESI): <i>m</i>/<i>e</i> 253.6 (66%), 506.3 [M + H]<sup>+</sup> (100%). HRMS <i>m</i>/<i>z</i> 506.267 21, calcd [M + H]<sup>+</sup> 506.266 29, rel intens 100%, error 0.92.</div></div><div id="sec5_7_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 5-[1-(1-Benzylpiperidin-4-yl)-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl]-1,3-dihydro-2<i>H</i>-benzimidazol-2-one Trifluoroacetic Acid Salt (<b>5m</b>)</h4><div class="NLM_p last">Procedure A was used. Purification was by preparative reverse phase HPLC with 0.02% TFA buffer, giving an off-white amorphous solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.88 (s, 1H), 10.74 (s, 1H), 8.34 (s, 1H), 8.16 (dd, <i>J</i> = 1.5, 5.5 Hz, 1H), 8.0 (s, 1H), 7.59−7.46 (m, 5H), 7.0 (s, 1H), 5.20−5.03 (m, 1H), 4.45−4.35 (m, 2H), 4.05−3.94 (m, 4H), 3.84−3.74 (m, 4H), 3.60−3.25 (m, 4H), 2.48−2.11 (m, 4H). MS (ESI): <i>m</i>/<i>e</i> 511.2 [M + H]<sup>+</sup> (100%). HRMS <i>m</i>/<i>z</i> 511.256 42, calcd [M + H]<sup>+</sup> 511.256 45, rel intens 100%, error 0.03 mAmu.</div></div><div id="sec5_7_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 1-(1-Benzylpiperidin-4-yl)-6-(1<i>H</i>-indol-2-yl)-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>5n</b>)</h4><div class="NLM_p last">Procedure A was used. Purification was by preparative reverse phase HPLC with 0.02% ammonium hydroxide buffer, giving an off-white amorphous solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.61 (s, 1H), 8.62−8.56 (m, 1H), 8.25−8.20 (m, 2H), 7.49−7.14 (m, 8H), 4.82−4.69 (m, 1H), 4.02−3.95 (m, 4H), 3.82−3.76 (m, 4H), 5.58 (s, 2H), 3.12−2.94 9 m, 4H), 2.34−1.89 (m, 4H). MS (ESI): <i>m</i>/<i>e</i> 247.6 (7%), 494.3 [M + H]<sup>+</sup> (100%). HRMS <i>m</i>/<i>z</i> 494.267 07, calcd [M + H]<sup>+</sup> 494.266 29, rel intens 100%, error 0.78 mAmu.</div></div><div id="sec5_7_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 1-(1-Benzylpiperidin-4-yl)-6-(1<i>H</i>-indol-4-yl)-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine Trifluoroacetic Acid Salt (<b>5o</b>)</h4><div class="NLM_p last">Procedure A was used. Purification was by preparative reverse phase HPLC with 0.02% TFA buffer, giving an off-white amorphous solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.29 (s, 1H), 9.68 (s, 1H), 8.37 (s, 1H), 8.18 (d, <i>J</i> = 7.0 Hz, 1H), 7.60−7.38 (m, 7H), 7.24−7.16 (1H), 6.56 (s, 1H), 5.22−5.10 (m, 1H), 4.46−4.37 (m, 2H), 4.08−3.98 (m, 4H), 3.85−3.75 (m, 4H), 3.60−3.51 (m, 2H), 2.52−2.33 (m, 2H), 2.30−2.17 (m, 4H). MS (ESI): <i>m</i>/<i>e</i> 247.6 (17%), 494.3 [M + H]<sup>+</sup> (100%). HRMS <i>m</i>/<i>z</i> 494.266 35, calcd [M + H]<sup>+</sup> 494.266 29, rel intens 100%, error 0.06.</div></div><div id="sec5_7_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 1-(1-Benzylpiperidin-4-yl)-6-(1<i>H</i>-indol-6-yl)-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine Trifluoroacetic Acid Salt (<b>5q</b>)</h4><div class="NLM_p last">Procedure A was used. Purification was by preparative reverse phase HPLC with 0.02% TFA buffer, giving an off-white amorphous solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.29 (a, 1H), 9.71 (br s, 1H), 8.53 (s, 1H), 8.34 (s, 1H), 8.21 (dd, <i>J</i> = 1.5, 8.5 Hz, 1H), 7.64−7.46 (m, 7H), 6.48 (s, 1H), 5.23−5.09 (m, 1H), 4.49−4.36 (m, 2H), 4.09−3.98 (m, 4H), 3.86−3.77 (m, 4H), 3.75−3.50 (m, 2H), 2.57−2.32 (m, 4H), 2.30−2.15 (m, 2H). MS (ESI): <i>m</i>/<i>e</i> 247.6 (11%), 494.3 [M + H]<sup>+</sup> (100%). HRMS <i>m</i>/<i>z</i> 494.265 80, calcd [M + H]<sup>+</sup> 494.266 29, rel intens 100%, error 0.49 mAmu.</div></div><div id="sec5_7_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 1-(1-Benzylpiperidin-4-yl)-6-(1<i>H</i>-indol-7-yl)-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>5r</b>)</h4><div class="NLM_p last">Procedure B was used. Purification was by preparative reverse phase HPLC with 0.02% ammonium hydroxide buffer, giving an off-white amorphous solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.14 (s, 1H), 9.95 (br s, 1H), 8.40 (s, 1H), 8.31 (d, <i>J</i> = 8.0 Hz, 1H), 7.45 (d, <i>J</i> = 8.0 Hz, 1H), 7.65−7.45 (m, 7H), 7.16 (dd, <i>J</i> = 7.0, 7.0 Hz, 1H), 6.60 (s, 1H), 5.47−5.34 (m, 1H), 4.47−4.38 (m, 2H), 4.08−4.00 (m, 4H), 3.85−3.78 (m, 4H), 3.62−3.30 (m, 4H), 2.49−2.16 (m, 4H). MS (ESI): <i>m</i>/<i>e</i> 494.3 [M + H]<sup>+</sup> (100%). HRMS <i>m</i>/<i>z</i> 494.266 41, calcd [M + H]<sup>+</sup> 494.266 29, rel intens 100%, error 0.12 mAmu.</div></div><div id="sec5_7_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 1-(1-Benzylpiperidin-4-yl)-6-(1-methyl-1<i>H</i>-indol-5-yl)-4-morpholin-4-yl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>5s</b>)</h4><div class="NLM_p last">Procedure A was used. Purification was by preparative reverse phase HPLC with 0.02% ammonium hydroxide buffer, giving an off-white amorphous solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.71 (s, 1H), 8.32 (d, <i>J</i> = 9.5 Hz, 1H), 8.27 (s, 1H), 7.49 (d, <i>J</i> = 8.5 Hz, 1H), 7.40−7.31 (m, 5H), 7.31−7.24 (m, 1H), 6.57 (d, <i>J</i> = 3.0 Hz, 1H), 4.91−4.77 (m, 1H), 4.07−3.98 (m, 4H), 3.83 (s, 3H), 3.84−3.75 (m, 4H), 3.57 (s, 2H), 3.04−2.93 (m, 2H), 2.32−2.13 (m, 4H), 1.96−1.85 (m, 2H). MS (ESI): <i>m</i>/<i>e</i> 254.6 (13%), 508.3 [M + H]<sup>+</sup> (100%). HRMS <i>m</i>/<i>z</i> 508.281 44, calcd [M + H]<sup>+</sup> 508.281 94, rel intens 100%, error 0.50 mAmu.</div></div><div id="sec5_7_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 6-(1<i>H</i>-Indol-5-yl)-4-morpholin-4-yl-1-[1-(pyridin-3-ylmethyl)piperidin-4-yl]-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine Trifluoroacetic Acid Salt (<b>5u</b>)</h4><div class="NLM_p last">Procedure B was used. Purification was by preparative reverse phase HPLC with 0.02% TFA buffer, giving an off-white amorphous solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 1.85 (brs, 1H), 11.35 (s, 1H), 9.19 (s, 1H), 8.97 (d, <i>J</i> = 5.4 Hz, 1H), 8.77 (d, <i>J</i> = 8.5 Hz, 1H), 8.74 (s, 1H), 8.32 (s, 1H), 8.30 (dd, <i>J</i> = 7.5, 0.5 Hz, 1H), 8.06 (dd, <i>J</i> = 5.5, 8.5 Hz, 1H), 7.46 (d, <i>J</i> = 9.0 Hz, 1H), 7.41 (dd, <i>J</i> = 2.5, 2.5 Hz, 1 h), 6.56 (s, 1H), 5.21−5.08 (m, 1H), 4.60 (s, 1H), 4.03 (br s, 4H), 3.08 (br s, 4H), 3.64−3.53 (m, 2H), 3.47−3.53 (m, 2H), 2.71−2.54 (m, 2H), 2.23−2.11 (m, 2H). MS (ESI): <i>m</i>/<i>e</i> 248.1 (24%), 495.3 [M + H]<sup>+</sup> (100%). HRMS <i>m</i>/<i>z</i> 495.261 73, calcd [M + H]<sup>+</sup> 495.261 54, rel intens 100%, error 0.19 mAmu.</div></div><div id="sec5_7_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 6-(1<i>H</i>-Indol-5-yl)-4-morpholin-4-yl-1-[1-(pyridin-3-ylcarbonyl)piperidin-4-yl]-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>5v</b>)</h4><div class="NLM_p last">Procedure C was used. Purification was by preparative reverse phase HPLC with 0.02% ammonium hydroxide buffer, giving an off-white amorphous solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.26 (s, 1H), 8.74−8.65 (m, 2H), 8.31−8.26 (m, 2H), 7.94−7.88 (m, 1H), 7.66 −7.50 (m, 4H), 6.56 (s, 1H), 5.21−5.11 (m, 1H), 4.69−4.59 (m, 1H), 4.06−3.99 (m, 1H), 3.84−3.77 (m, 4H), 3.31−3.12 (m, 3H), 2.41−1.90 (m, 4H). MS (ESI): <i>m</i>/<i>e</i> 279.1 (19%), 509.2 [M + H]<sup>+</sup> (100%). HRMS <i>m</i>/<i>z</i> 509.241 37, calcd [M + H]<sup>+</sup> 509.240 80, rel intens 100%, error 0.57.</div></div><div id="hplc" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> HPLC Data for <b>5a</b>−<b>v</b></h4><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> lists the HPLC retention times and purities for <b>5a</b>−<b>v</b>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. HPLC Retention Times and Purity Data for <b>5a</b>−<b>v</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th class="colsep1" colspan="2" align="center" char=".">method A<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep1" colspan="2" align="center" char=".">method B<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th></tr><tr valign="top"><th align="center">compd</th><th align="center" char="."><i>t</i><sub>R</sub> (min)</th><th align="center" char=".">purity (%)</th><th align="center" char="."><i>t</i><sub>R</sub> (min)</th><th align="center" char=".">purity (%)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>5a</b></td><td align="char" char=".">1.86</td><td align="char" char=".">95</td><td align="char" char=".">1.25</td><td align="char" char=".">95</td></tr><tr valign="top"><td align="left"><b>5b</b></td><td align="char" char=".">2.34</td><td align="char" char=".">95</td><td align="char" char=".">1.28</td><td align="char" char=".">96</td></tr><tr valign="top"><td align="left"><b>5c</b></td><td align="char" char=".">2.07</td><td align="char" char=".">95</td><td align="char" char=".">2.81</td><td align="char" char=".">99</td></tr><tr valign="top"><td align="left"><b>5d</b></td><td align="char" char=".">2.33</td><td align="char" char=".">95</td><td align="char" char=".">1.38</td><td align="char" char=".">99</td></tr><tr valign="top"><td align="left"><b>5e</b></td><td align="char" char=".">2.12</td><td align="char" char=".">97</td><td align="char" char=".">2.34</td><td align="char" char=".">99</td></tr><tr valign="top"><td align="left"><b>5f</b></td><td align="char" char=".">1.90</td><td align="char" char=".">100</td><td align="char" char=".">1.85</td><td align="char" char=".">98</td></tr><tr valign="top"><td align="left"><b>5g</b></td><td align="char" char=".">2.26</td><td align="char" char=".">100</td><td align="char" char=".">2.91</td><td align="char" char=".">100</td></tr><tr valign="top"><td align="left"><b>5h</b></td><td align="char" char=".">2.08</td><td align="char" char=".">96</td><td align="char" char=".">2.25</td><td align="char" char=".">97</td></tr><tr valign="top"><td align="left"><b>5i</b></td><td align="char" char=".">1.92</td><td align="char" char=".">98</td><td align="char" char=".">2.21</td><td align="char" char=".">95</td></tr><tr valign="top"><td align="left"><b>5j</b></td><td align="char" char=".">1.87</td><td align="char" char=".">100</td><td align="char" char=".">2.29</td><td align="char" char=".">94</td></tr><tr valign="top"><td align="left"><b>5k</b></td><td align="char" char=".">2.26</td><td align="char" char=".">95</td><td align="char" char=".">3.51</td><td align="char" char=".">99</td></tr><tr valign="top"><td align="left"><b>5l</b></td><td align="char" char=".">2.13</td><td align="char" char=".">99</td><td align="char" char=".">2.57</td><td align="char" char=".">98</td></tr><tr valign="top"><td align="left"><b>5m</b></td><td align="char" char=".">2.00</td><td align="char" char=".">95</td><td align="char" char=".">1.93</td><td align="char" char=".">95</td></tr><tr valign="top"><td align="left"><b>5n</b></td><td align="char" char=".">2.16</td><td align="char" char=".">99</td><td align="char" char=".">2.51</td><td align="char" char=".">99</td></tr><tr valign="top"><td align="left"><b>5o</b></td><td align="char" char=".">2.26</td><td align="char" char=".">90</td><td align="char" char=".">2.47</td><td align="char" char=".">95</td></tr><tr valign="top"><td align="left"><b>5p</b></td><td align="char" char=".">2.15</td><td align="char" char=".">100</td><td align="char" char=".">2.54</td><td align="char" char=".">100</td></tr><tr valign="top"><td align="left"><b>5q</b></td><td align="char" char=".">2.31</td><td align="char" char=".">98</td><td align="char" char=".">2.65</td><td align="char" char=".">94</td></tr><tr valign="top"><td align="left"><b>5r</b></td><td align="char" char=".">2.12</td><td align="char" char=".">95</td><td align="char" char=".">2.50</td><td align="char" char=".">97</td></tr><tr valign="top"><td align="left"><b>5s</b></td><td align="char" char=".">2.37</td><td align="char" char=".">99</td><td align="char" char=".">2.84</td><td align="char" char=".">99</td></tr><tr valign="top"><td align="left"><b>5t</b></td><td align="char" char=".">2.04</td><td align="char" char=".">100</td><td align="char" char=".">1.66</td><td align="char" char=".">100</td></tr><tr valign="top"><td align="left"><b>5u</b></td><td align="char" char=".">2.02</td><td align="char" char=".">100</td><td align="char" char=".">1.80</td><td align="char" char=".">92</td></tr><tr valign="top"><td align="left"><b>5v</b></td><td align="char" char=".">2.45</td><td align="char" char=".">95</td><td align="char" char=".">1.77</td><td align="char" char=".">96</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">HPLC method A: solvent gradient = 90% A at 0 min, 5% A at 2.6 min, 5% A at 3 min; solvent A = 0.05% HCO<sub>2</sub>H in water; solvent B = 0.05% HCO<sub>2</sub>H in ACN; flow rate = 1 mL/min; column = Agilent XDB-C18 30 mm × 2.1 mm, 1.8 μm particle size; temperature = 70 °C.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">HPLC method B: 90% A at 0 min, 5% A at 2.6 min, 5% A at 3 min; solvent A = 0.05% NH<sub>4</sub>OH in water; solvent B = 0.05% NH<sub>4</sub>OH in ACN; flow rate = 1 mL/min; column = Agilent SB-C18, 50 mm × 2.1 mm, 1.8 μm particle size; temperature = 70 °C.</p></div></div></div></div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Assays of mTOR, PI3K, and Other Kinases</h3><div class="NLM_p last">mTOR assays were performed in 96-well plates for 2 h at room temperature in 25 μL containing 6 nM Flag-TOR(3.5), 1 μM His6-S6K1, and 100 μM ATP. The assays were performed and detected by DELFIA employing an Eu-phospho-p70S6K T389 antibody as described previously.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> For inhibitor versus ATP matrix competition, mTOR kinase reactions were carried out with varying concentrations of ATP in combination with varying concentrations of inhibitor. The assays contained 12 nM Flag-TOR(3.5) and were incubated for 30 min. The assay results were similarly detected by DELFIA and processed for generation of double-reciprocal plots. PI3K assays were performed in a fluorescence polarization (FP) assay with 25 μM ATP as described.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The assays of <b>5u</b> (2 μM) against a broad panel of protein kinases were performed by Invitrogen SelectScreen profiling.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Inhibition of Cellular mTOR Signaling</h3><div class="NLM_p last">Human A498 renal cancer and U87MG glioma cells were cultured employing standard cell culture methods, treated with DMSO or inhibitors for 6 h. Total cell lysates were prepared using NuPAGE-LDS sample buffer (Invitrogen), quantified, and subject to immonoblotting analysis using NuPAGE electrophoresis system (Invitrogen). Antibodies against P-S6K1 (T389), P-4EBP1 (T70), P-4EBP1 (T37/46), P-AKT (S473), and P-AKT (T308) were purchased from Cell Signaling Technology.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Molecular Modeling</h3><div class="NLM_p last">An mTOR homology model was built based on an in-house PI3K-γ crystal structure in complex with a compound from the pyrazolopyrimidine series. The structure has a resolution of 2.8 Å and an <i>R</i><sub>free</sub> of 0.28. The structure has been made publicly available through the Protein Data Bank (<a href="http://www.rcsb.org" class="extLink">www.rcsb.org</a>) with identifier <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE">3IBE</a>. PRIME 1.5 (Prime, version 1.5, Schrödinger, LLC, New York, NY, 2005) was used to build the initial model, which was further optimized using EMBRACE (MacroModel, version 9.1, Schrödinger, LLC, New York, NY, 2005) minimizations in complex with the cocrystallized ligand. Subsequent docking studies were performed using Glide 4.0 (Glide, version 4.0, Schrödinger, LLC, New York, NY, 2005) and 4.5 (Glide, version 4.5, Schrödinger, LLC, New York, NY, 2005) with the Single Precision (SP) scoring function and a pregenerated docking grid. The box size used for docking was 10 Å in each direction around the centroid of the ligand. To minimize the conformational search space, a hydrogen bonding constraint to valine-2240 of the hinge region was used during the docking.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm9012642" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37433" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37433" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pawel Nowak</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1977766e787269596e607c6d71377a7674"><span class="__cf_email__" data-cfemail="d8b6b7afb9b3a898afa1bdacb0f6bbb7b5">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Derek C. Cole</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Natasja Brooijmans</span> - <span class="hlFld-Affiliation affiliation">Structural Biology</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew G. Bursavich</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin J. Curran</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John W. Ellingboe</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James J. Gibbons</span> - <span class="hlFld-Affiliation affiliation">Discovery Oncology</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Irwin Hollander</span> - <span class="hlFld-Affiliation affiliation">Discovery Oncology</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">YongBo Hu</span> - <span class="hlFld-Affiliation affiliation">Structural Biology</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joshua Kaplan</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David J. Malwitz</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lourdes Toral-Barza</span> - <span class="hlFld-Affiliation affiliation">Discovery Oncology</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeroen C. Verheijen</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arie Zask</span> - <span class="hlFld-Affiliation affiliation">Chemical Sciences</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei-Guo Zhang</span> - <span class="hlFld-Affiliation affiliation">Discovery Oncology</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ker Yu</span> - <span class="hlFld-Affiliation affiliation">Discovery Oncology</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50328" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50328" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the Wyeth HTS group for mTOR HTS, Xidong Feng for HRMS data, Michael Kelly for HPLC purity analyses, Frank Loganzo for kinase panel assay results, Li Di for rat hepatocytes clearance measurements, and Tarek S. Mansour, Dennis Powell, and Semiramis Ayral-Kaloustian for helpful suggestions.</p></div><div class="postAsapNotesSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="postAsapNotesSection">Note Added After ASAP Publication</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24657" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24657" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This paper was published on October 19, 2009 with an incomplete author list.  The revised version was published on October 22, 2009.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i47">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46442" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46442" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 31 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Sarbassov, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Growing roled of the mTOR pathway</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">603</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm9012642&amp;key=10.1016%2Fj.ceb.2005.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm9012642&amp;key=16226444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm9012642&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFyksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2005&pages=596-603&author=D.+D.+Sarbassovauthor=S.+M.+Aliauthor=D.+M.+Sabatini&title=Growing+roled+of+the+mTOR+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Growing roles for the mTOR pathway</span></div><div class="casAuthors">Sarbassov, Dos D.; Ali, Siraj M.; Sabatini, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">596-603</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The mammalian TOR (mTOR; mammalian target of rapamycin) pathway is a key regulator of cell growth and proliferation and increasing evidence suggests that its deregulation is assocd. with human diseases, including cancer and diabetes.  The mTOR pathway integrates signals from nutrients, energy status, and growth factors to regulate many processes, including autophagy, ribosome biogenesis, and metab.  Recent work identifying 2 structurally and functionally distinct mTOR-contg. multiprotein complexes, and TSC1/2, rheb, and AMPK as upstream regulators of mTOR, is beginning to reveal how mTOR can sense diverse signals and produce a myriad of responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMOIIVMYJG0LVg90H21EOLACvtfcHk0ljlKyfEfOXYfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFyksL7F&md5=e24e27de16bd9f8e7219b684c7242f8e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2005.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2005.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DSarbassov%26aufirst%3DD.%2BD.%26aulast%3DAli%26aufirst%3DS.%2BM.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DGrowing%2520roled%2520of%2520the%2520mTOR%2520pathway%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2005%26volume%3D17%26spage%3D596%26epage%3D603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Wullschleger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, M. N.</span><span> </span><span class="NLM_article-title">TOR signaling in growth and metabolism</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">484</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm9012642&amp;key=10.1016%2Fj.cell.2006.01.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm9012642&amp;key=16469695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm9012642&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslaqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2006&pages=471-484&author=S.+Wullschlegerauthor=R.+Loewithauthor=M.+N.+Hall&title=TOR+signaling+in+growth+and+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">TOR signaling in growth and metabolism</span></div><div class="casAuthors">Wullschleger, Stephan; Loewith, Robbie; Hall, Michael N.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">471-484</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The target of rapamycin (TOR) is a conserved Ser/Thr kinase that regulates cell growth and metab. in response to environmental cues.  Here, highlighting contributions from studies in model organisms, we review mammalian TOR complexes and the signaling branches they mediate.  TOR is part of two distinct multiprotein complexes, TOR complex 1 (TORC1), which is sensitive to rapamycin, and TORC2, which is not.  The physiol. consequences of mammalian TORC1 dysregulation suggest that inhibitors of mammalian TOR may be useful in the treatment of cancer, cardiovascular disease, autoimmunity, and metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdwzZ5NGx9YrVg90H21EOLACvtfcHk0ljlKyfEfOXYfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslaqs74%253D&md5=d8128a86651c824e725f56b90cafb88d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DWullschleger%26aufirst%3DS.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DHall%26aufirst%3DM.%2BN.%26atitle%3DTOR%2520signaling%2520in%2520growth%2520and%2520metabolism%26jtitle%3DCell%26date%3D2006%26volume%3D124%26spage%3D471%26epage%3D484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Defining the role of mTOR in cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=9-22&author=D.+A.+Guertinauthor=D.+M.+Sabatini&title=Defining+the+role+of+mTOR+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DDefining%2520the%2520role%2520of%2520mTOR%2520in%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D9%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Chiang, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span> </span><span class="NLM_article-title">Targeting the mTOR signaling network in cancer</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">442</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=433-442&author=G.+G.+Chiangauthor=R.+T.+Abraham&title=Targeting+the+mTOR+signaling+network+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiang%26aufirst%3DG.%2BG.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26atitle%3DTargeting%2520the%2520mTOR%2520signaling%2520network%2520in%2520cancer%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2007%26volume%3D13%26spage%3D433%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">The pharmacology of mTOR inhibition</span> <span class="citation_source-journal">Sci. Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm9012642&amp;key=10.1126%2Fscisignal.267pe24" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm9012642&amp;key=19318623" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=1-6&author=D.+A.+Guertinauthor=D.+M.+Sabatini&title=The+pharmacology+of+mTOR+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.267pe24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.267pe24%26sid%3Dliteratum%253Aachs%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DThe%2520pharmacology%2520of%2520mTOR%2520inhibition%26jtitle%3DSci.%2520Signaling%26date%3D2009%26volume%3D2%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Abraham, R. T.</span><span> </span><span class="NLM_article-title">PI 3-kinase related kinases: “big” players in stress-induced signaling pathways</span> <span class="citation_source-journal">DNA Repair</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">–</span> <span class="NLM_lpage">887</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=883-887&author=R.+T.+Abraham&title=PI+3-kinase+related+kinases%3A+%E2%80%9Cbig%E2%80%9D+players+in+stress-induced+signaling+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26atitle%3DPI%25203-kinase%2520related%2520kinases%253A%2520%25E2%2580%259Cbig%25E2%2580%259D%2520players%2520in%2520stress-induced%2520signaling%2520pathways%26jtitle%3DDNA%2520Repair%26date%3D2004%26volume%3D3%26spage%3D883%26epage%3D887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Yuan, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">PI3K pathway alterations in cancer: variations on a theme</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">5497</span><span class="NLM_x">–</span> <span class="NLM_lpage">5510</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=5497-5510&author=T.+L.+Yuanauthor=L.+C.+Cantley&title=PI3K+pathway+alterations+in+cancer%3A+variations+on+a+theme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DT.%2BL.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DPI3K%2520pathway%2520alterations%2520in%2520cancer%253A%2520variations%2520on%2520a%2520theme%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D5497%26epage%3D5510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Carracedo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandolfi, P. P.</span><span> </span><span class="NLM_article-title">The PTEN-PI3K pathway: of feedbacks and cross-talks</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">5527</span><span class="NLM_x">–</span> <span class="NLM_lpage">5541</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=5527-5541&author=A.+Carracedoauthor=P.+P.+Pandolfi&title=The+PTEN-PI3K+pathway%3A+of+feedbacks+and+cross-talks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarracedo%26aufirst%3DA.%26aulast%3DPandolfi%26aufirst%3DP.%2BP.%26atitle%3DThe%2520PTEN-PI3K%2520pathway%253A%2520of%2520feedbacks%2520and%2520cross-talks%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D5527%26epage%3D5541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Inoki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corradetti, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, K. L.</span><span> </span><span class="NLM_article-title">Dysregulation of the TSC-mTOR pathway in human disease</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm9012642&amp;key=10.1038%2Fng1494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm9012642&amp;key=15624019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm9012642&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFChsL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2005&pages=19-24&author=K.+Inokiauthor=M.+N.+Corradettiauthor=K.+L.+Guan&title=Dysregulation+of+the+TSC-mTOR+pathway+in+human+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Dysregulation of the TSC-mTOR pathway in human disease</span></div><div class="casAuthors">Inoki, Ken; Corradetti, Michael N.; Guan, Kun-Liang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-24</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The mammalian target of rapamycin (mTOR) has a central role in the regulation of cell growth. mTOR receives input from multiple signaling pathways, including growth factors and nutrients, to stimulate protein synthesis by phosphorylating key translation regulators such as ribosomal S6 kinase and eukaryote initiation factor 4E binding protein 1.  High levels of dysregulated mTOR activity are assocd. with several hamartoma syndromes, including tuberous sclerosis complex, the PTEN-related hamartoma syndromes and Peutz-Jeghers syndrome.  These disorders are all caused by mutations in tumor-suppressor genes that neg. regulate mTOR.  Here we discuss the emerging evidence for a functional relationship between the mTOR signaling pathway and several genetic diseases, and we present evidence supporting a model in which dysregulation of mTOR may be a common mol. basis, not only for hamartoma syndromes, but also for other cellular hypertrophic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcM0DjY6r9LVg90H21EOLACvtfcHk0lgE71qpgBVxfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFChsL3M&md5=7cc3c4b4f1b02265816de0737a078fc7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fng1494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1494%26sid%3Dliteratum%253Aachs%26aulast%3DInoki%26aufirst%3DK.%26aulast%3DCorradetti%26aufirst%3DM.%2BN.%26aulast%3DGuan%26aufirst%3DK.%2BL.%26atitle%3DDysregulation%2520of%2520the%2520TSC-mTOR%2520pathway%2520in%2520human%2520disease%26jtitle%3DNat.%2520Genet.%26date%3D2005%26volume%3D37%26spage%3D19%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Choi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clardy, J.</span><span> </span><span class="NLM_article-title">Structure of the FKBP12−rapamycin complex interacting with the binding domain of human FRAP</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1996&pages=239-242&author=J.+Choiauthor=J.+Chenauthor=S.+L.+Schreiberauthor=J.+Clardy&title=Structure+of+the+FKBP12%E2%88%92rapamycin+complex+interacting+with+the+binding+domain+of+human+FRAP"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DClardy%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520the%2520FKBP12%25E2%2588%2592rapamycin%2520complex%2520interacting%2520with%2520the%2520binding%2520domain%2520of%2520human%2520FRAP%26jtitle%3DScience%26date%3D1996%26volume%3D273%26spage%3D239%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Liang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clardy, J.</span><span> </span><span class="NLM_article-title">Refined structure of the FKBP12−rapamycin−FRB ternary complex at 2.2 Å resolution</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">736</span><span class="NLM_x">–</span> <span class="NLM_lpage">744</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=736-744&author=J.+Liangauthor=J.+Choiauthor=J.+Clardy&title=Refined+structure+of+the+FKBP12%E2%88%92rapamycin%E2%88%92FRB+ternary+complex+at+2.2+%C3%85+resolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DClardy%26aufirst%3DJ.%26atitle%3DRefined%2520structure%2520of%2520the%2520FKBP12%25E2%2588%2592rapamycin%25E2%2588%2592FRB%2520ternary%2520complex%2520at%25202.2%2520%25C3%2585%2520resolution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1999%26volume%3D55%26spage%3D736%26epage%3D744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Easton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, P. J.</span><span> </span><span class="NLM_article-title">mTOR and cancer therapy</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">6436</span><span class="NLM_x">–</span> <span class="NLM_lpage">6446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=6436-6446&author=J.+B.+Eastonauthor=P.+J.+Houghton&title=mTOR+and+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEaston%26aufirst%3DJ.%2BB.%26aulast%3DHoughton%26aufirst%3DP.%2BJ.%26atitle%3DmTOR%2520and%2520cancer%2520therapy%26jtitle%3DOncogene%26date%3D2006%26volume%3D25%26spage%3D6436%26epage%3D6446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Dancey, J. E.</span><span> </span><span class="NLM_article-title">Therapeutic targets: MTOR and related pathways</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1065</span><span class="NLM_x">–</span> <span class="NLM_lpage">1073</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm9012642&amp;key=10.4161%2Fcbt.5.9.3175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm9012642&amp;key=16969122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm9012642&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktlejsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=1065-1073&author=J.+E.+Dancey&title=Therapeutic+targets%3A+MTOR+and+related+pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targets. MTOR and related pathways</span></div><div class="casAuthors">Dancey, Janet E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1065-1073</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  The mammalian target of rapamycin (mTOR), a protein kinase of the phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway, has a central role in controlling malignant cellular growth.  As a result, mTOR is viewed as an important target for anticancer drug development.  Inhibitors of mTOR currently under evaluation in cancer clin. trials are rapamycin (also known as sirolimus, Wyeth) and derivs. temsirolimus (CCI-779, Wyeth), everolimus, (RAD001, Novartis Pharma AG), and AP23573 (Ariad Pharmaceuticals).  Preclin. studies suggest that sensitivity to mTOR inhibitors may correlate with activation of the PI3K pathway and/or with aberrant expression of cell cycle regulatory or anti-apoptotic proteins.  Clin. trial results show that mTOR inhibitors are well tolerated and may induce prolonged stable disease and tumor regressions in cancer patients.  Future research should evaluate optimal, schedule, patient selection, and combination strategies for this novel class of agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz_taiC5i3ALVg90H21EOLACvtfcHk0lgE71qpgBVxfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktlejsQ%253D%253D&md5=be06e2ae7e26fcb0dfe54c3f38011c5e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.4161%2Fcbt.5.9.3175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.5.9.3175%26sid%3Dliteratum%253Aachs%26aulast%3DDancey%26aufirst%3DJ.%2BE.%26atitle%3DTherapeutic%2520targets%253A%2520MTOR%2520and%2520related%2520pathways%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D1065%26epage%3D1073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span> </span><span class="NLM_article-title">The mammalian target of rapamycin signaling pathway: twists and turns in the road to cancer therapy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3109</span><span class="NLM_x">–</span> <span class="NLM_lpage">3114</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm9012642&amp;key=10.1158%2F1078-0432.CCR-06-2798" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm9012642&amp;key=17545512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm9012642&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVajtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=3109-3114&author=R.+T.+Abrahamauthor=J.+J.+Gibbons&title=The+mammalian+target+of+rapamycin+signaling+pathway%3A+twists+and+turns+in+the+road+to+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The Mammalian Target of Rapamycin Signaling Pathway: Twists and Turns in the Road to Cancer Therapy</span></div><div class="casAuthors">Abraham, Robert T.; Gibbons, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3109-3114</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The immunosuppressive drug rapamycin played a key role in the functional characterization of mammalian target of rapamycin (mTOR), an unusual protein kinase that coordinates growth factor and nutrient availability with cell growth and proliferation.  Several rapamycin-related compds. are now in various stages of clin. development as anticancer agents.  This article highlights recent advances in our understanding of the mTOR signaling pathway and the implications of these findings for the clin. application of mTOR inhibitors in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyaHT0dJasgbVg90H21EOLACvtfcHk0lhBXwAg3PkpSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVajtb8%253D&md5=b393422d11958a97b7c5a31e60b2a88b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2798%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520mammalian%2520target%2520of%2520rapamycin%2520signaling%2520pathway%253A%2520twists%2520and%2520turns%2520in%2520the%2520road%2520to%2520cancer%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D3109%26epage%3D3114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Sarbassov, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latek, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdjument-Bromage, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tempst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1296</span><span class="NLM_x">–</span> <span class="NLM_lpage">1302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm9012642&amp;key=10.1016%2Fj.cub.2004.06.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm9012642&amp;key=15268862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm9012642&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVamsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1296-1302&author=D.+D.+Sarbassovauthor=S.+M.+Aliauthor=D.+H.+Kimauthor=D.+A.+Guertinauthor=R.+R.+Latekauthor=H.+Erdjument-Bromageauthor=P.+Tempstauthor=D.+M.+Sabatini&title=Rictor%2C+a+novel+binding+partner+of+mTOR%2C+defines+a+rapamycin-insensitive+and+raptor-independent+pathway+that+regulates+the+cytoskeleton"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton</span></div><div class="casAuthors">Sarbassov, Dos D.; Ali, Siraj M.; Kim, Do-Hyung; Guertin, David A.; Latek, Robert R.; Erdjument-Bromage, Hediye; Tempst, Paul; Sabatini, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1296-1302</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The mammalian TOR (mTOR) pathway integrates nutrient- and growth factor-derived signals to regulate growth, the process whereby cells accumulate mass and increase in size.  MTOR is a large protein kinase and the target of rapamycin, an immunosuppressant that also blocks vessel restenosis and has potential anticancer applications.  MTOR interacts with the raptor and GβL proteins to form a complex that is the target of rapamycin.  Here, we demonstrate that mTOR is also part of a distinct complex defined by the novel protein rictor (rapamycin-insensitive companion of mTOR).  Rictor shares homol. with the previously described pianissimo from D. discoidieum, STE20p from S. pombe, and AVO3p from S. cerevisiae.  Interestingly, AVO3p is part of a rapamycin-insensitive TOR complex that does not contain the yeast homolog of raptor and signals to the actin cytoskeleton through PKC1.  Consistent with this finding, the rictor-contg. mTOR complex contains GβL but not raptor and it neither regulates the mTOR effector S6K1 nor is it bound by FKBP12-rapamycin.  We find that the rictor-mTOR complex modulates the phosphorylation of Protein Kinase C α (PKCα) and the actin cytoskeleton, suggesting that this aspect of TOR signaling is conserved between yeast and mammals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXWNgQt5KXB7Vg90H21EOLACvtfcHk0lhBXwAg3PkpSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVamsLs%253D&md5=78362bf097ed96b9bfc0053e3a54818c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2004.06.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2004.06.054%26sid%3Dliteratum%253Aachs%26aulast%3DSarbassov%26aufirst%3DD.%2BD.%26aulast%3DAli%26aufirst%3DS.%2BM.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DLatek%26aufirst%3DR.%2BR.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DTempst%26aufirst%3DP.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DRictor%252C%2520a%2520novel%2520binding%2520partner%2520of%2520mTOR%252C%2520defines%2520a%2520rapamycin-insensitive%2520and%2520raptor-independent%2520pathway%2520that%2520regulates%2520the%2520cytoskeleton%26jtitle%3DCurr.%2520Biol.%26date%3D2004%26volume%3D14%26spage%3D1296%26epage%3D1302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Jacinto, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rüegg, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, M. N.</span><span> </span><span class="NLM_article-title">Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1122</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm9012642&amp;key=10.1038%2Fncb1183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm9012642&amp;key=15467718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm9012642&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFentL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=1122-8&author=E.+Jacintoauthor=R.+Loewithauthor=A.+Schmidtauthor=S.+Linauthor=M.+A.+R%C3%BCeggauthor=A.+Hallauthor=M.+N.+Hall&title=Mammalian+TOR+complex+2+controls+the+actin+cytoskeleton+and+is+rapamycin+insensitive"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive</span></div><div class="casAuthors">Jacinto, Estela; Loewith, Robbie; Schmidt, Anja; Lin, Shuo; Rueegg, Markus A.; Hall, Alan; Hall, Michael N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1122-1128</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The target of rapamycin (TOR) is a highly conserved protein kinase and a central controller of cell growth.  In budding yeast, TOR is found in structurally and functionally distinct protein complexes: TORC1 and TORC2.  A mammalian counterpart of TORC1 (mTORC1) has been described, but it is not known whether TORC2 is conserved in mammals.  Here, the authors report that a mammalian counterpart of TORC2 (mTORC2) also exists.  The mTORC2 contains mTOR, mLST8 and mAVO3, but not raptor.  Like yeast TORC2, mTORC2 is rapamycin insensitive and seems to function upstream of Rho GTPases to regulate the actin cytoskeleton.  The mTORC2 is not upstream of the mTORC1 effector S6K.  Thus, two distinct TOR complexes constitute a primordial signaling network conserved in eukaryotic evolution to control the fundamental process of cell growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcnbO542vXw7Vg90H21EOLACvtfcHk0lhBXwAg3PkpSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFentL8%253D&md5=42d53ee5d9dfc24287cf05fd29f41aa8</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fncb1183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1183%26sid%3Dliteratum%253Aachs%26aulast%3DJacinto%26aufirst%3DE.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DSchmidt%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DR%25C3%25BCegg%26aufirst%3DM.%2BA.%26aulast%3DHall%26aufirst%3DA.%26aulast%3DHall%26aufirst%3DM.%2BN.%26atitle%3DMammalian%2520TOR%2520complex%25202%2520controls%2520the%2520actin%2520cytoskeleton%2520and%2520is%2520rapamycin%2520insensitive%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2004%26volume%3D6%26spage%3D1122%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Carracedo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teruya-Feldstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmena, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alimonti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozma, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nardella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandolfi, P. P.</span><span> </span><span class="NLM_article-title">Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">3065</span><span class="NLM_x">–</span> <span class="NLM_lpage">3074</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=3065-3074&author=A.+Carracedoauthor=L.+Maauthor=J.+Teruya-Feldsteinauthor=F.+Rojoauthor=L.+Salmenaauthor=A.+Alimontiauthor=A.+Egiaauthor=A.+T.+Sasakiauthor=G.+Thomasauthor=S.+C.+Kozmaauthor=A.+Papaauthor=C.+Nardellaauthor=L.+C.+Cantleyauthor=J.+Baselgaauthor=P.+P.+Pandolfi&title=Inhibition+of+mTORC1+leads+to+MAPK+pathway+activation+through+a+PI3K-dependent+feedback+loop+in+human+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarracedo%26aufirst%3DA.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DTeruya-Feldstein%26aufirst%3DJ.%26aulast%3DRojo%26aufirst%3DF.%26aulast%3DSalmena%26aufirst%3DL.%26aulast%3DAlimonti%26aufirst%3DA.%26aulast%3DEgia%26aufirst%3DA.%26aulast%3DSasaki%26aufirst%3DA.%2BT.%26aulast%3DThomas%26aufirst%3DG.%26aulast%3DKozma%26aufirst%3DS.%2BC.%26aulast%3DPapa%26aufirst%3DA.%26aulast%3DNardella%26aufirst%3DC.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DPandolfi%26aufirst%3DP.%2BP.%26atitle%3DInhibition%2520of%2520mTORC1%2520leads%2520to%2520MAPK%2520pathway%2520activation%2520through%2520a%2520PI3K-dependent%2520feedback%2520loop%2520in%2520human%2520cancer%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2008%26volume%3D118%26spage%3D3065%26epage%3D3074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Sauveur-Michel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brachmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chene, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoemaker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1851</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm9012642&amp;key=10.1158%2F1535-7163.MCT-08-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm9012642&amp;key=18606717" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1851-1863&author=M.+Sauveur-Michelauthor=F.+Staufferauthor=J.+Brueggenauthor=P.+Furetauthor=C.+Schnellauthor=C.+Fritschauthor=S.+Brachmannauthor=P.+Cheneauthor=A.+De+Poverauthor=K.+Schoemakerauthor=D.+Fabbroauthor=D.+Gabrielauthor=M.+Simonenauthor=L.+Murphyauthor=P.+Finanauthor=W.+Sellersauthor=C.+Garcia-Echeverria&title=Identification+and+characterization+of+NVP-BEZ235%2C+a+new+orally+available+dual+phosphatidylinositol+3-kinase%2Fmammalian+target+of+rapamycin+inhibitor+with+potent+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0017%26sid%3Dliteratum%253Aachs%26aulast%3DSauveur-Michel%26aufirst%3DM.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DBrachmann%26aufirst%3DS.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DDe%2BPover%26aufirst%3DA.%26aulast%3DSchoemaker%26aufirst%3DK.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGabriel%26aufirst%3DD.%26aulast%3DSimonen%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520NVP-BEZ235%252C%2520a%2520new%2520orally%2520available%2520dual%2520phosphatidylinositol%25203-kinase%252Fmammalian%2520target%2520of%2520rapamycin%2520inhibitor%2520with%2520potent%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D1851%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angela, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di-Stefano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjerke, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelland, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Haven Brandon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghir, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterfield, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">5840</span><span class="NLM_x">–</span> <span class="NLM_lpage">5850</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=5840-5850&author=F.+I.+Raynaudauthor=S.+Ecclesauthor=P.+A.+Clarkeauthor=H.+Angelaauthor=N.+Bernardauthor=A.+Soniaauthor=A.+Henleyauthor=F.+Di-Stefanoauthor=Z.+Ahmadauthor=S.+Guillardauthor=L.+M.+Bjerkeauthor=L.+Kellandauthor=M.+Valentiauthor=L.+Pattersonauthor=S.+Gowanauthor=A.+De+Haven+Brandonauthor=M.+Hayakawaauthor=H.+Kaizawaauthor=T.+Koizumiauthor=T.+Ohishiauthor=S.+Patelauthor=N.+Saghirauthor=P.+Parkerauthor=M.+Waterfieldauthor=P.+Workman&title=Pharmacologic+characterization+of+a+potent+inhibitor+of+class+I+phosphatidylinositide+3-kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DEccles%26aufirst%3DS.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DAngela%26aufirst%3DH.%26aulast%3DBernard%26aufirst%3DN.%26aulast%3DSonia%26aufirst%3DA.%26aulast%3DHenley%26aufirst%3DA.%26aulast%3DDi-Stefano%26aufirst%3DF.%26aulast%3DAhmad%26aufirst%3DZ.%26aulast%3DGuillard%26aufirst%3DS.%26aulast%3DBjerke%26aufirst%3DL.%2BM.%26aulast%3DKelland%26aufirst%3DL.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DPatterson%26aufirst%3DL.%26aulast%3DGowan%26aufirst%3DS.%26aulast%3DDe%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DHayakawa%26aufirst%3DM.%26aulast%3DKaizawa%26aufirst%3DH.%26aulast%3DKoizumi%26aufirst%3DT.%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DParker%26aufirst%3DP.%26aulast%3DWaterfield%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DPharmacologic%2520characterization%2520of%2520a%2520potent%2520inhibitor%2520of%2520class%2520I%2520phosphatidylinositide%25203-kinases%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D5840%26epage%3D5850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Folkes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alderton, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alix, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depledge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancox, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugendradas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergl-Wilson, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghir, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhyvoloup, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvelebil, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuttleworth, S. J.</span><span> </span><span class="NLM_article-title">The identification of 2-(1<i>H</i>-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-<i>d</i>]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5532</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800295d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm9012642&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5522-5532&author=A.+J.+Folkesauthor=K.+Ahmadiauthor=W.+K.+Aldertonauthor=S.+Alixauthor=S.+J.+Bakerauthor=G.+Boxauthor=I.+S.+Chuckowreeauthor=P.+A.+Clarkeauthor=P.+Depledgeauthor=S.+A.+Ecclesauthor=L.+S.+Friedmanauthor=A.+Hayesauthor=T.+C.+Hancoxauthor=A.+Kugendradasauthor=L.+Lensunauthor=P.+Mooreauthor=A.+G.+Oliveroauthor=J.+Pangauthor=S.+Patelauthor=G.+H.+Pergl-Wilsonauthor=F.+I.+Raynaudauthor=A.+Robsonauthor=N.+Saghirauthor=L.+Salphatiauthor=S.+Sohalauthor=M.+H.+Ultschauthor=M.+Valentiauthor=H.+J.+A.+Wallweberauthor=N.+C.+Wanauthor=C.+Wiesmannauthor=P.+Workmanauthor=A.+Zhyvoloupauthor=M.+J.+Zvelebilauthor=S.+J.+Shuttleworth&title=The+identification+of+2-%281H-indazol-4-yl%29-6-%284-methanesulfonyl-piperazin-1-ylmethyl%29-4-morpholin-4-yl-thieno%5B3%2C2-d%5Dpyrimidine+%28GDC-0941%29+as+a+potent%2C+selective%2C+orally+bioavailable+inhibitor+of+class+I+PI3+kinase+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span></div><div class="casAuthors">Folkes, Adrian J.; Ahmadi, Khatereh; Alderton, Wendy K.; Alix, Sonia; Baker, Stewart J.; Box, Gary; Chuckowree, Irina S.; Clarke, Paul A.; Depledge, Paul; Eccles, Suzanne A.; Friedman, Lori S.; Hayes, Angela; Hancox, Timothy C.; Kugendradas, Arumugam; Lensun, Letitia; Moore, Pauline; Olivero, Alan G.; Pang, Jodie; Patel, Sonal; Pergl-Wilson, Giles H.; Raynaud, Florence I.; Robson, Anthony; Saghir, Nahid; Salphati, Laurent; Sohal, Sukhjit; Ultsch, Mark H.; Valenti, Melanie; Wallweber, Heidi J. A.; Wan, Nan Chi; Wiesmann, Christian; Workman, Paul; Zhyvoloup, Alexander; Zvelebil, Marketa J.; Shuttleworth, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5522-5532</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphatidylinositol-3-kinase (PI3K) is an important target in cancer due to the deregulation of the PI3K/Akt signaling pathway in a wide variety of tumors.  A series of thieno[3,2-d]pyrimidine derivs. were prepd. and evaluated as inhibitors of PI3 kinase p110α.  The synthesis, biol. activity, and further profiling of these compds. are described.  This work resulted in the discovery of GDC-0941 (I) which is a potent, selective, orally bioavailable inhibitor of PI3K and is currently being evaluated in human clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojkFv29FXqO7Vg90H21EOLACvtfcHk0ljlHrCqkzeT5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E&md5=742084954685353ceaf18660ab3a0703</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm800295d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800295d%26sid%3Dliteratum%253Aachs%26aulast%3DFolkes%26aufirst%3DA.%2BJ.%26aulast%3DAhmadi%26aufirst%3DK.%26aulast%3DAlderton%26aufirst%3DW.%2BK.%26aulast%3DAlix%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DChuckowree%26aufirst%3DI.%2BS.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DDepledge%26aufirst%3DP.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHancox%26aufirst%3DT.%2BC.%26aulast%3DKugendradas%26aufirst%3DA.%26aulast%3DLensun%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DP.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPergl-Wilson%26aufirst%3DG.%2BH.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobson%26aufirst%3DA.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%2BH.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DZhyvoloup%26aufirst%3DA.%26aulast%3DZvelebil%26aufirst%3DM.%2BJ.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520identification%2520of%25202-%25281H-indazol-4-yl%2529-6-%25284-methanesulfonyl-piperazin-1-ylmethyl%2529-4-morpholin-4-yl-thieno%255B3%252C2-d%255Dpyrimidine%2520%2528GDC-0941%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520orally%2520bioavailable%2520inhibitor%2520of%2520class%2520I%2520PI3%2520kinase%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5522%26epage%3D5532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malwitz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingboe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Biochemical, cellular and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">6232</span><span class="NLM_x">–</span> <span class="NLM_lpage">6240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=6232-6240&author=K.+Yuauthor=L.+Toral-Barzaauthor=C.+Shiauthor=W.-G.+Zhangauthor=J.+Lucasauthor=B.+Shorauthor=J.+Kimauthor=J.+Verheijenauthor=K.+Curranauthor=D.+J.+Malwitzauthor=D.+C.+Coleauthor=J.+Ellingboeauthor=S.+Ayral-Kaloustianauthor=T.+S.+Mansourauthor=J.+J.+Gibbonsauthor=R.+T.+Abrahamauthor=P.+Nowakauthor=A.+Zask&title=Biochemical%2C+cellular+and+in+vivo+activity+of+novel+ATP-competitive+and+selective+inhibitors+of+the+mammalian+target+of+rapamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DK.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.-G.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DShor%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DVerheijen%26aufirst%3DJ.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DMalwitz%26aufirst%3DD.%2BJ.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DEllingboe%26aufirst%3DJ.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DBiochemical%252C%2520cellular%2520and%2520in%2520vivo%2520activity%2520of%2520novel%2520ATP-competitive%2520and%2520selective%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D6232%26epage%3D6240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Feldman, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apsel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uotila, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=371-383&author=M.+E.+Feldmanauthor=B.+Apselauthor=A.+Uotilaauthor=R.+Loewithauthor=Z.+A.+Knightauthor=D.+Ruggeroauthor=K.+M.+Shokat&title=Active-site+inhibitors+of+mTOR+target+rapamycin-resistant+outputs+of+mTORC1+and+mTORC2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeldman%26aufirst%3DM.%2BE.%26aulast%3DApsel%26aufirst%3DB.%26aulast%3DUotila%26aufirst%3DA.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DRuggero%26aufirst%3DD.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DActive-site%2520inhibitors%2520of%2520mTOR%2520target%2520rapamycin-resistant%2520outputs%2520of%2520mTORC1%2520and%2520mTORC2%26jtitle%3DPLoS%2520Biol.%26date%3D2009%26volume%3D7%26spage%3D371%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">García-Martínez, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosulich, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chresta, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">421</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2009&pages=29-42&author=J.+M.+Garc%C3%ADa-Mart%C3%ADnezauthor=J.+Moranauthor=R.+G.+Clarkeauthor=A.+Grayauthor=S.+C.+Cosulichauthor=C.+M.+Chrestaauthor=D.+R.+Alessi&title=Ku-0063794+is+a+specific+inhibitor+of+the+mammalian+target+of+rapamycin+%28mTOR%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa-Mart%25C3%25ADnez%26aufirst%3DJ.%2BM.%26aulast%3DMoran%26aufirst%3DJ.%26aulast%3DClarke%26aufirst%3DR.%2BG.%26aulast%3DGray%26aufirst%3DA.%26aulast%3DCosulich%26aufirst%3DS.%2BC.%26aulast%3DChresta%26aufirst%3DC.%2BM.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DKu-0063794%2520is%2520a%2520specific%2520inhibitor%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D421%26spage%3D29%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Thoreen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichling, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">8023</span><span class="NLM_x">–</span> <span class="NLM_lpage">8032</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm9012642&amp;key=10.1074%2Fjbc.M900301200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm9012642&amp;key=19150980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm9012642&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtVSmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=8023-8032&author=C.+C.+Thoreenauthor=S.+A.+Kangauthor=J.+W.+Changauthor=Q.+Liuauthor=J.+Zhangauthor=Y.+Gaoauthor=L.+J.+Reichlingauthor=T.+Simauthor=D.+M.+Sabatiniauthor=N.+S.+Gray&title=An+ATP-competitive+mammalian+target+of+rapamycin+inhibitor+reveals+rapamycin-resistant+functions+of+mTORC1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1</span></div><div class="casAuthors">Thoreen, Carson C.; Kang, Seong A.; Chang, Jae Won; Liu, Qingsong; Zhang, Jianming; Gao, Yi; Reichling, Laurie J.; Sim, Taebo; Sabatini, David M.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8023-8032</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The mammalian target of rapamycin (mTOR) kinase is the catalytic subunit of two functionally distinct complexes, mTORC1 and mTORC2, that coordinately promote cell growth, proliferation, and survival.  Rapamycin is a potent allosteric mTORC1 inhibitor with clin. applications as an immunosuppressant and anti-cancer agent.  Here we find that Torin1, a highly potent and selective ATP-competitive mTOR inhibitor that directly inhibits both complexes, impairs cell growth and proliferation to a far greater degree than rapamycin.  Surprisingly, these effects are independent of mTORC2 inhibition and are instead because of suppression of rapamycin-resistant functions of mTORC1 that are necessary for cap-dependent translation and suppression of autophagy.  These effects are at least partly mediated by mTORC1-dependent and rapamycin-resistant phosphorylation of 4E-BP1.  Our findings challenge the assumption that rapamycin completely inhibits mTORC1 and indicate that direct inhibitors of mTORC1 kinase activity may be more successful than rapamycin at inhibiting tumors that depend on mTORC1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiRNo9IcTXArVg90H21EOLACvtfcHk0lgEONUy046qdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtVSmtLY%253D&md5=ea4476b6a55a6b8964fc5c041c80039f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M900301200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M900301200%26sid%3Dliteratum%253Aachs%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DKang%26aufirst%3DS.%2BA.%26aulast%3DChang%26aufirst%3DJ.%2BW.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DReichling%26aufirst%3DL.%2BJ.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DAn%2520ATP-competitive%2520mammalian%2520target%2520of%2520rapamycin%2520inhibitor%2520reveals%2520rapamycin-resistant%2520functions%2520of%2520mTORC1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D8023%26epage%3D8032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Hopkins, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm9012642&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm9012642&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm9012642&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=L.+A.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2ea2WCHcSbqInbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DL.%2BA.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Keseru, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makara, G. M.</span><span> </span><span class="NLM_article-title">The influence of lead discovery strategies on the properties of drug candidates</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm9012642&amp;key=10.1038%2Fnrd2796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm9012642&amp;key=19247303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm9012642&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ntV2qug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=203-212&author=G.+M.+Keseruauthor=G.+M.+Makara&title=The+influence+of+lead+discovery+strategies+on+the+properties+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of lead discovery strategies on the properties of drug candidates</span></div><div class="casAuthors">Keseru Gyorgy M; Makara Gergely M</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Drug discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Despite the widespread acceptance of guidelines related to desirable physicochemical properties of potential small-molecule drugs, key properties - such as lipophilicity - of recently developed clinical candidates and advanced lead compounds have been shown to differ significantly from those of historical leads and drugs.  By analysing the physicochemical properties of a large database of hits and corresponding leads identified in the past decade, we show that this undesirable phenomenon can be traced back to the nature of high-throughput screening hits and hit-to-lead optimization practices.  Conceptual and organizational adjustments may be required to enable a smooth lead-evolution process that reduces the chance of high compound-related attrition in clinical trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCjUjH8uzRfyM8MEzWGjS9fW6udTcc2ebOwCxphgouZ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ntV2qug%253D%253D&md5=57f8228cf7f46bd4f3c3ff48f34da32c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnrd2796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2796%26sid%3Dliteratum%253Aachs%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DMakara%26aufirst%3DG.%2BM.%26atitle%3DThe%2520influence%2520of%2520lead%2520discovery%2520strategies%2520on%2520the%2520properties%2520of%2520drug%2520candidates%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D203%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><a href="http://www.invitrogen.com/kinaseprofiling" class="extLink">http://www.invitrogen.com/kinaseprofiling</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.invitrogen.com%2Fkinaseprofiling."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Matsushita, K.; Hasegawa, H.; Kuribayashi, Y.; Ohashi, N.</span><span> </span><span class="NLM_article-title">Preparation of Sulfonylureidopyrazole Derivatives as Endothelin Converter Enzyme Inhibitors</span>. PCT Int. Appl. WO 9730978 A1,<span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">; </span>Sumitomo Pharmaceuticals Co., Ltd., Japan.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=K.+Matsushita&author=H.+Hasegawa&author=Y.+Kuribayashi&author=N.+Ohashi&title=Preparation+of+Sulfonylureidopyrazole+Derivatives+as+Endothelin+Converter+Enzyme+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMatsushita%26aufirst%3DK.%26atitle%3DPreparation%2520of%2520Sulfonylureidopyrazole%2520Derivatives%2520as%2520Endothelin%2520Converter%2520Enzyme%2520Inhibitors%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Muller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaplovsky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woggon, W.-D.</span><span> </span><span class="NLM_article-title">Synthesis and photophysical properties of a deazaflavin-bridged porphyrinatoiron(III) that mimics the interaction of a deazaflavin inhibitor with the heme-thiolate cofactor of cytochrome P450 3A4</span> <span class="citation_source-journal">Helv. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">2987</span><span class="NLM_x">–</span> <span class="NLM_lpage">3001</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2006&pages=2987-3001&author=M.+A.+Mullerauthor=M.+Gaplovskyauthor=J.+Wirzauthor=W.-D.+Woggon&title=Synthesis+and+photophysical+properties+of+a+deazaflavin-bridged+porphyrinatoiron%28III%29+that+mimics+the+interaction+of+a+deazaflavin+inhibitor+with+the+heme-thiolate+cofactor+of+cytochrome+P450+3A4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DM.%2BA.%26aulast%3DGaplovsky%26aufirst%3DM.%26aulast%3DWirz%26aufirst%3DJ.%26aulast%3DWoggon%26aufirst%3DW.-D.%26atitle%3DSynthesis%2520and%2520photophysical%2520properties%2520of%2520a%2520deazaflavin-bridged%2520porphyrinatoiron%2528III%2529%2520that%2520mimics%2520the%2520interaction%2520of%2520a%2520deazaflavin%2520inhibitor%2520with%2520the%2520heme-thiolate%2520cofactor%2520of%2520cytochrome%2520P450%25203A4%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D2006%26volume%3D89%26spage%3D2987%26epage%3D3001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamison, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaRocque, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">Characterization of the cloned full-length and a truncated human target of rapamycin: activity, specificity, and enzyme inhibition as studied by a high capacity assay</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">304</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2005&pages=304-310&author=L.+Toral-Barzaauthor=W.+G.+Zhangauthor=C.+Lamisonauthor=J.+LaRocqueauthor=J.+Gibbonsauthor=K.+Yu&title=Characterization+of+the+cloned+full-length+and+a+truncated+human+target+of+rapamycin%3A+activity%2C+specificity%2C+and+enzyme+inhibition+as+studied+by+a+high+capacity+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%2BG.%26aulast%3DLamison%26aufirst%3DC.%26aulast%3DLaRocque%26aufirst%3DJ.%26aulast%3DGibbons%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DCharacterization%2520of%2520the%2520cloned%2520full-length%2520and%2520a%2520truncated%2520human%2520target%2520of%2520rapamycin%253A%2520activity%252C%2520specificity%252C%2520and%2520enzyme%2520inhibition%2520as%2520studied%2520by%2520a%2520high%2520capacity%2520assay%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D332%26spage%3D304%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tischler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaydos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinque, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">Synthesis and structure−activity relationship of ring-opened 17-hydroxywortmannins: potent phosphoinositide 3-kinase inhibitors with improved properties and anticancer efficacy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1319</span><span class="NLM_x">–</span> <span class="NLM_lpage">1323</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7012858" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1319-1323&author=A.+Zaskauthor=J.+Kaplanauthor=L.+Toral-Barzaauthor=I.+Hollanderauthor=M.+Youngauthor=M.+Tischlerauthor=C.+Gaydosauthor=M.+Cinqueauthor=J.+Lucasauthor=K.+Yu&title=Synthesis+and+structure%E2%88%92activity+relationship+of+ring-opened+17-hydroxywortmannins%3A+potent+phosphoinositide+3-kinase+inhibitors+with+improved+properties+and+anticancer+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm7012858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7012858%26sid%3Dliteratum%253Aachs%26aulast%3DZask%26aufirst%3DA.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DYoung%26aufirst%3DM.%26aulast%3DTischler%26aufirst%3DM.%26aulast%3DGaydos%26aufirst%3DC.%26aulast%3DCinque%26aufirst%3DM.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520structure%25E2%2588%2592activity%2520relationship%2520of%2520ring-opened%252017-hydroxywortmannins%253A%2520potent%2520phosphoinositide%25203-kinase%2520inhibitors%2520with%2520improved%2520properties%2520and%2520anticancer%2520efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1319%26epage%3D1323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 42 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Chiara Borsari, Denise Rageot, Alix Dall’Asen, Thomas Bohnacker, Anna Melone, Alexander M. Sele, Eileen Jackson, Jean-Baptiste Langlois, Florent Beaufils, Paul Hebeisen, Doriano Fabbro, Petra Hillmann, <span class="NLM_string-name hlFld-ContribAuthor">Matthias P. Wymann</span>. </span><span class="cited-content_cbyCitation_article-title">A Conformational Restriction Strategy for the Identification of a Highly Selective Pyrimido-pyrrolo-oxazine mTOR Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (18)
                                     , 8609-8630. <a href="https://doi.org/10.1021/acs.jmedchem.9b00972" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00972</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00972%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BConformational%252BRestriction%252BStrategy%252Bfor%252Bthe%252BIdentification%252Bof%252Ba%252BHighly%252BSelective%252BPyrimido-pyrrolo-oxazine%252BmTOR%252BInhibitor%26aulast%3DBorsari%26aufirst%3DChiara%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D19062019%26date%3D11092019%26date%3D29082019%26volume%3D62%26issue%3D18%26spage%3D8609%26epage%3D8630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akshay A.  Shah</span>, <span class="hlFld-ContribAuthor ">Lois K.  Chenard</span>, <span class="hlFld-ContribAuthor ">Joseph W.  Tucker</span>, and <span class="hlFld-ContribAuthor ">Christopher J.  Helal</span>  . </span><span class="cited-content_cbyCitation_article-title">Parallel Synthesis of 1H-Pyrazolo[3,4-d]pyrimidines via Condensation of N-Pyrazolylamides and Nitriles. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2017,</strong> <em>19 </em>
                                    (11)
                                     , 675-680. <a href="https://doi.org/10.1021/acscombsci.7b00116" title="DOI URL">https://doi.org/10.1021/acscombsci.7b00116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.7b00116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.7b00116%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DParallel%252BSynthesis%252Bof%252B1H-Pyrazolo%25255B3%25252C4-d%25255Dpyrimidines%252Bvia%252BCondensation%252Bof%252BN-Pyrazolylamides%252Band%252BNitriles%26aulast%3DShah%26aufirst%3DAkshay%2BA.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D26072017%26date%3D01102017%26date%3D20102017%26date%3D13112017%26date%3D06102017%26volume%3D19%26issue%3D11%26spage%3D675%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Andrs</span>, <span class="hlFld-ContribAuthor ">Jan  Korabecny</span>, <span class="hlFld-ContribAuthor ">Daniel  Jun</span>, <span class="hlFld-ContribAuthor ">Zdenek  Hodny</span>, <span class="hlFld-ContribAuthor ">Jiri  Bartek</span>, and <span class="hlFld-ContribAuthor ">Kamil  Kuca</span>  . </span><span class="cited-content_cbyCitation_article-title">Phosphatidylinositol 3-Kinase (PI3K) and Phosphatidylinositol 3-Kinase-Related Kinase (PIKK) Inhibitors: Importance of the Morpholine Ring. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 41-71. <a href="https://doi.org/10.1021/jm501026z" title="DOI URL">https://doi.org/10.1021/jm501026z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501026z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501026z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPhosphatidylinositol%252B3-Kinase%252B%252528PI3K%252529%252Band%252BPhosphatidylinositol%252B3-Kinase-Related%252BKinase%252B%252528PIKK%252529%252BInhibitors%25253A%252BImportance%252Bof%252Bthe%252BMorpholine%252BRing%26aulast%3DAndrs%26aufirst%3DMartin%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D08072014%26date%3D05122014%26date%3D08012015%26date%3D11112014%26volume%3D58%26issue%3D1%26spage%3D41%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvia  Schenone</span>, <span class="hlFld-ContribAuthor ">Marco  Radi</span>, <span class="hlFld-ContribAuthor ">Francesca  Musumeci</span>, <span class="hlFld-ContribAuthor ">Chiara  Brullo</span>, and <span class="hlFld-ContribAuthor ">Maurizio  Botta</span>  . </span><span class="cited-content_cbyCitation_article-title">Biologically Driven Synthesis of Pyrazolo[3,4-d]pyrimidines As Protein Kinase Inhibitors: An Old Scaffold As a New Tool for Medicinal Chemistry and Chemical Biology Studies. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2014,</strong> <em>114 </em>
                                    (14)
                                     , 7189-7238. <a href="https://doi.org/10.1021/cr400270z" title="DOI URL">https://doi.org/10.1021/cr400270z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr400270z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr400270z%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DBiologically%252BDriven%252BSynthesis%252Bof%252BPyrazolo%25255B3%25252C4-d%25255Dpyrimidines%252BAs%252BProtein%252BKinase%252BInhibitors%25253A%252BAn%252BOld%252BScaffold%252BAs%252Ba%252BNew%252BTool%252Bfor%252BMedicinal%252BChemistry%252Band%252BChemical%252BBiology%252BStudies%26aulast%3DSchenone%26aufirst%3DSilvia%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D16052013%26date%3D29052014%26date%3D23072014%26volume%3D114%26issue%3D14%26spage%3D7189%26epage%3D7238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad A.  Khanfar</span> and <span class="hlFld-ContribAuthor ">Mutasem O.  Taha</span>  . </span><span class="cited-content_cbyCitation_article-title">Elaborate Ligand-Based Modeling Coupled with Multiple Linear Regression and k Nearest Neighbor QSAR Analyses Unveiled New Nanomolar mTOR Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2013,</strong> <em>53 </em>
                                    (10)
                                     , 2587-2612. <a href="https://doi.org/10.1021/ci4003798" title="DOI URL">https://doi.org/10.1021/ci4003798</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci4003798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci4003798%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DElaborate%252BLigand-Based%252BModeling%252BCoupled%252Bwith%252BMultiple%252BLinear%252BRegression%252Band%252Bk%252BNearest%252BNeighbor%252BQSAR%252BAnalyses%252BUnveiled%252BNew%252BNanomolar%252BmTOR%252BInhibitors%26aulast%3DKhanfar%26aufirst%3DMohammad%2BA.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D01072013%26date%3D04102013%26date%3D28102013%26date%3D19092013%26volume%3D53%26issue%3D10%26spage%3D2587%26epage%3D2612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathan R.  Guz</span>, <span class="hlFld-ContribAuthor ">Helena  Leuser</span>, and <span class="hlFld-ContribAuthor ">Erick  Goldman</span>  . </span><span class="cited-content_cbyCitation_article-title">Process Development and Multikilogram Syntheses of XL228 Utilizing a Regioselective Isoxazole Formation and a Selective SNAr Reaction to a Pyrimidine Core. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2013,</strong> <em>17 </em>
                                    (8)
                                     , 1066-1073. <a href="https://doi.org/10.1021/op400137m" title="DOI URL">https://doi.org/10.1021/op400137m</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op400137m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop400137m%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DProcess%252BDevelopment%252Band%252BMultikilogram%252BSyntheses%252Bof%252BXL228%252BUtilizing%252Ba%252BRegioselective%252BIsoxazole%252BFormation%252Band%252Ba%252BSelective%252BSNAr%252BReaction%252Bto%252Ba%252BPyrimidine%252BCore%26aulast%3DGuz%26aufirst%3DNathan%2BR.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D29052013%26date%3D06082013%26date%3D16082013%26volume%3D17%26issue%3D8%26spage%3D1066%26epage%3D1073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anthony A.  Estrada</span>, <span class="hlFld-ContribAuthor ">Daniel G.  Shore</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Blackwood</span>, <span class="hlFld-ContribAuthor ">Yung-Hsiang  Chen</span>, <span class="hlFld-ContribAuthor ">Gauri  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Antonio G.  DiPasquale</span>, <span class="hlFld-ContribAuthor ">Jennifer A.  Epler</span>, <span class="hlFld-ContribAuthor ">Lori S.  Friedman</span>, <span class="hlFld-ContribAuthor ">Michael F. T.  Koehler</span>, <span class="hlFld-ContribAuthor ">Lichuan  Liu</span>, <span class="hlFld-ContribAuthor ">Shiva  Malek</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Ortwine</span>, <span class="hlFld-ContribAuthor ">Zhonghua  Pei</span>, <span class="hlFld-ContribAuthor ">Steve  Sideris</span>, <span class="hlFld-ContribAuthor ">Frederic  St-Jean</span>, <span class="hlFld-ContribAuthor ">Lan  Trinh</span>, <span class="hlFld-ContribAuthor ">Tom  Truong</span>, and <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>  . </span><span class="cited-content_cbyCitation_article-title">Pyrimidoaminotropanes as Potent, Selective, and Efficacious Small Molecule Kinase Inhibitors of the Mammalian Target of Rapamycin (mTOR). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (7)
                                     , 3090-3101. <a href="https://doi.org/10.1021/jm400194n" title="DOI URL">https://doi.org/10.1021/jm400194n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400194n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400194n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyrimidoaminotropanes%252Bas%252BPotent%25252C%252BSelective%25252C%252Band%252BEfficacious%252BSmall%252BMolecule%252BKinase%252BInhibitors%252Bof%252Bthe%252BMammalian%252BTarget%252Bof%252BRapamycin%252B%252528mTOR%252529%26aulast%3DEstrada%26aufirst%3DAnthony%2BA.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D06022013%26date%3D29032013%26date%3D11042013%26date%3D08032013%26volume%3D56%26issue%3D7%26spage%3D3090%26epage%3D3101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael F. T.  Koehler</span>, <span class="hlFld-ContribAuthor ">Philippe  Bergeron</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Blackwood</span>, <span class="hlFld-ContribAuthor ">Krista K.  Bowman</span>, <span class="hlFld-ContribAuthor ">Yung-Hsiang  Chen</span>, <span class="hlFld-ContribAuthor ">Gauri  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Jennifer  Epler</span>, <span class="hlFld-ContribAuthor ">Kevin  Lau</span>, <span class="hlFld-ContribAuthor ">Leslie  Lee</span>, <span class="hlFld-ContribAuthor ">Lichuan  Liu</span>, <span class="hlFld-ContribAuthor ">Cuong  Ly</span>, <span class="hlFld-ContribAuthor ">Shiva  Malek</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Jason  Oeh</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Ortwine</span>, <span class="hlFld-ContribAuthor ">Deepak  Sampath</span>, <span class="hlFld-ContribAuthor ">Steve  Sideris</span>, <span class="hlFld-ContribAuthor ">Lan  Trinh</span>, <span class="hlFld-ContribAuthor ">Tom  Truong</span>, <span class="hlFld-ContribAuthor ">Jiansheng  Wu</span>, <span class="hlFld-ContribAuthor ">Zhonghua  Pei</span>, and <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>  . </span><span class="cited-content_cbyCitation_article-title">Potent, Selective, and Orally Bioavailable Inhibitors of the Mammalian Target of Rapamycin Kinase Domain Exhibiting Single Agent Antiproliferative Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (24)
                                     , 10958-10971. <a href="https://doi.org/10.1021/jm301389h" title="DOI URL">https://doi.org/10.1021/jm301389h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301389h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301389h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BBioavailable%252BInhibitors%252Bof%252Bthe%252BMammalian%252BTarget%252Bof%252BRapamycin%252BKinase%252BDomain%252BExhibiting%252BSingle%252BAgent%252BAntiproliferative%252BActivity%26aulast%3DKoehler%26aufirst%3DMichael%2BF.%2BT.%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D24092012%26date%3D12122012%26date%3D27122012%26date%3D30112012%26volume%3D55%26issue%3D24%26spage%3D10958%26epage%3D10971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frederick  Cohen</span>, <span class="hlFld-ContribAuthor ">Philippe  Bergeron</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Blackwood</span>, <span class="hlFld-ContribAuthor ">Krista K.  Bowman</span>, <span class="hlFld-ContribAuthor ">Huifen  Chen</span>, <span class="hlFld-ContribAuthor ">Antonio G.  DiPasquale</span>, <span class="hlFld-ContribAuthor ">Jennifer A.  Epler</span>, <span class="hlFld-ContribAuthor ">Michael F. T.  Koehler</span>, <span class="hlFld-ContribAuthor ">Kevin  Lau</span>, <span class="hlFld-ContribAuthor ">Cristina  Lewis</span>, <span class="hlFld-ContribAuthor ">Lichuan  Liu</span>, <span class="hlFld-ContribAuthor ">Cuong Q.  Ly</span>, <span class="hlFld-ContribAuthor ">Shiva  Malek</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Ortwine</span>, <span class="hlFld-ContribAuthor ">Zhonghua  Pei</span>, <span class="hlFld-ContribAuthor ">Kirk D.  Robarge</span>, <span class="hlFld-ContribAuthor ">Steve  Sideris</span>, <span class="hlFld-ContribAuthor ">Lan  Trinh</span>, <span class="hlFld-ContribAuthor ">Tom  Truong</span>, <span class="hlFld-ContribAuthor ">Jiansheng  Wu</span>, <span class="hlFld-ContribAuthor ">Xianrui  Zhao</span>, and <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>  . </span><span class="cited-content_cbyCitation_article-title">Potent, Selective, and Orally Bioavailable Inhibitors of Mammalian Target of Rapamycin (mTOR) Kinase Based on a Quaternary Substituted Dihydrofuropyrimidine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (9)
                                     , 3426-3435. <a href="https://doi.org/10.1021/jm200215y" title="DOI URL">https://doi.org/10.1021/jm200215y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200215y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200215y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BBioavailable%252BInhibitors%252Bof%252BMammalian%252BTarget%252Bof%252BRapamycin%252B%252528mTOR%252529%252BKinase%252BBased%252Bon%252Ba%252BQuaternary%252BSubstituted%252BDihydrofuropyrimidine%26aulast%3DCohen%26aufirst%3DFrederick%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D24022011%26date%3D15042011%26date%3D12052011%26volume%3D54%26issue%3D9%26spage%3D3426%26epage%3D3435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeroen C.  Verheijen</span>, <span class="hlFld-ContribAuthor ">David J.  Richard</span>, <span class="hlFld-ContribAuthor ">Kevin  Curran</span>, <span class="hlFld-ContribAuthor ">Joshua  Kaplan</span>, <span class="hlFld-ContribAuthor ">Mark  Lefever</span>, <span class="hlFld-ContribAuthor ">Pawel  Nowak</span>, <span class="hlFld-ContribAuthor ">David J.  Malwitz</span>, <span class="hlFld-ContribAuthor ">Natasja  Brooijmans</span>, <span class="hlFld-ContribAuthor ">Lourdes  Toral-Barza</span>, <span class="hlFld-ContribAuthor ">Wei-Guo  Zhang</span>, <span class="hlFld-ContribAuthor ">Judy  Lucas</span>, <span class="hlFld-ContribAuthor ">Irwin  Hollander</span>, <span class="hlFld-ContribAuthor ">Semiramis  Ayral-Kaloustian</span>, <span class="hlFld-ContribAuthor ">Tarek S.  Mansour</span>, <span class="hlFld-ContribAuthor ">Ker  Yu</span> and <span class="hlFld-ContribAuthor ">Arie  Zask</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-Morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as Highly Potent and Selective ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin (mTOR): Optimization of the 6-Aryl Substituent. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (24)
                                     , 8010-8024. <a href="https://doi.org/10.1021/jm9013828" title="DOI URL">https://doi.org/10.1021/jm9013828</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm9013828&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm9013828%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B4-Morpholino-6-aryl-1H-pyrazolo%25255B3%25252C4-d%25255Dpyrimidines%252Bas%252BHighly%252BPotent%252Band%252BSelective%252BATP-Competitive%252BInhibitors%252Bof%252Bthe%252BMammalian%252BTarget%252Bof%252BRapamycin%252B%252528mTOR%252529%25253A%252BOptimization%252Bof%252Bthe%252B6-Aryl%252BSubstituent%26aulast%3DVerheijen%26aufirst%3DJeroen%2BC.%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D23072009%26date%3D06112009%26date%3D24122009%26volume%3D52%26issue%3D24%26spage%3D8010%26epage%3D8024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas W.  Sturgill</span> and <span class="hlFld-ContribAuthor ">Michael N.  Hall</span>  . </span><span class="cited-content_cbyCitation_article-title">Activating Mutations in TOR Are in Similar Structures As Oncogenic Mutations in PI3KCα. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2009,</strong> <em>4 </em>
                                    (12)
                                     , 999-1015. <a href="https://doi.org/10.1021/cb900193e" title="DOI URL">https://doi.org/10.1021/cb900193e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb900193e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb900193e%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DActivating%252BMutations%252Bin%252BTOR%252BAre%252Bin%252BSimilar%252BStructures%252BAs%252BOncogenic%252BMutations%252Bin%252BPI3KC%2525CE%2525B1%26aulast%3DSturgill%26aufirst%3DThomas%2BW.%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D02%252008%25202009%26date%3D09%252011%25202009%26date%3D03122009%26date%3D18122009%26date%3D10112009%26volume%3D4%26issue%3D12%26spage%3D999%26epage%3D1015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chiara  Borsari</span>, <span class="hlFld-ContribAuthor ">Martina  De Pascale</span>, <span class="hlFld-ContribAuthor ">Matthias P.  Wymann</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical and Structural Strategies to Selectively Target mTOR Kinase. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.1002/cmdc.202100332" title="DOI URL">https://doi.org/10.1002/cmdc.202100332</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100332%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DChemical%252Band%252BStructural%252BStrategies%252Bto%252BSelectively%252BTarget%252BmTOR%252BKinase%26aulast%3DBorsari%26aufirst%3DChiara%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R. Nishanth  Rao</span>, <span class="hlFld-ContribAuthor ">Kaushik  Chanda</span>. </span><span class="cited-content_cbyCitation_article-title">An assessment study of known pyrazolopyrimidines: Chemical methodology and cellular activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>99 </em>, 103801. <a href="https://doi.org/10.1016/j.bioorg.2020.103801" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103801</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103801&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103801%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DAn%252Bassessment%252Bstudy%252Bof%252Bknown%252Bpyrazolopyrimidines%25253A%252BChemical%252Bmethodology%252Band%252Bcellular%252Bactivity%26aulast%3DRao%26aufirst%3DR.%2BNishanth%26date%3D2020%26volume%3D99%26spage%3D103801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-Jen  Liao</span>, <span class="hlFld-ContribAuthor ">Shih-Ming  Hsu</span>, <span class="hlFld-ContribAuthor ">Chia-Ying  Chien</span>, <span class="hlFld-ContribAuthor ">Yuan-Hsi  Wang</span>, <span class="hlFld-ContribAuthor ">Ming-Hua  Hsu</span>, <span class="hlFld-ContribAuthor ">Fat-Moon  Suk</span>. </span><span class="cited-content_cbyCitation_article-title">Treatment with a New Barbituric Acid Derivative Exerts Antiproliferative and Antimigratory Effects against Sorafenib Resistance in Hepatocellular Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (12)
                                     , 2856. <a href="https://doi.org/10.3390/molecules25122856" title="DOI URL">https://doi.org/10.3390/molecules25122856</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25122856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25122856%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DTreatment%252Bwith%252Ba%252BNew%252BBarbituric%252BAcid%252BDerivative%252BExerts%252BAntiproliferative%252Band%252BAntimigratory%252BEffects%252Bagainst%252BSorafenib%252BResistance%252Bin%252BHepatocellular%252BCarcinoma%26aulast%3DLiao%26aufirst%3DYi-Jen%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D12%26spage%3D2856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Supreet  Gaonkar</span>, <span class="hlFld-ContribAuthor ">Mohammed Azharuddin  Savanur</span>, <span class="hlFld-ContribAuthor ">AfraQuasar A.  Nadaf</span>, <span class="hlFld-ContribAuthor ">Mahesh S.  Najare</span>, <span class="hlFld-ContribAuthor ">Shivaraj  Mantur</span>, <span class="hlFld-ContribAuthor ">Manjunatha  Garbhagudi</span>, <span class="hlFld-ContribAuthor ">Sikandar I.  Mulla</span>, <span class="hlFld-ContribAuthor ">Imtiyaz Ahmed M.  Khazi</span>. </span><span class="cited-content_cbyCitation_article-title">Novel pyrazolo[3,4‐
              d
              ]pyrimidine derivatives inhibit human cancer cell proliferation and induce apoptosis by ROS generation. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2020,</strong> <em>353 </em>
                                    (4)
                                     , 1900296. <a href="https://doi.org/10.1002/ardp.201900296" title="DOI URL">https://doi.org/10.1002/ardp.201900296</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201900296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201900296%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DNovel%252Bpyrazolo%25255B3%25252C4%2525E2%252580%252590%252Bd%252B%25255Dpyrimidine%252Bderivatives%252Binhibit%252Bhuman%252Bcancer%252Bcell%252Bproliferation%252Band%252Binduce%252Bapoptosis%252Bby%252BROS%252Bgeneration%26aulast%3DGaonkar%26aufirst%3DSupreet%26date%3D2020%26volume%3D353%26issue%3D4%26spage%3D1900296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marie-Hélène  Montané</span>, <span class="hlFld-ContribAuthor ">Benoît  Menand</span>. </span><span class="cited-content_cbyCitation_article-title">TOR inhibitors: from mammalian outcomes to pharmacogenetics in plants and algae. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental Botany</span><span> <strong>2019,</strong> <em>70 </em>
                                    (8)
                                     , 2297-2312. <a href="https://doi.org/10.1093/jxb/erz053" title="DOI URL">https://doi.org/10.1093/jxb/erz053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/jxb/erz053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fjxb%2Ferz053%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520Botany%26atitle%3DTOR%252Binhibitors%25253A%252Bfrom%252Bmammalian%252Boutcomes%252Bto%252Bpharmacogenetics%252Bin%252Bplants%252Band%252Balgae%26aulast%3DMontan%25C3%25A9%26aufirst%3DMarie-H%25C3%25A9l%25C3%25A8ne%26date%3D2019%26date%3D2019%26volume%3D70%26issue%3D8%26spage%3D2297%26epage%3D2312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Costantino</span>, <span class="hlFld-ContribAuthor ">Daniela  Barlocco</span>. </span><span class="cited-content_cbyCitation_article-title">Designing Approaches to Multitarget Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 161-205. <a href="https://doi.org/10.1002/9783527674381.ch7" title="DOI URL">https://doi.org/10.1002/9783527674381.ch7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527674381.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527674381.ch7%26sid%3Dliteratum%253Aachs%26atitle%3DDesigning%252BApproaches%252Bto%252BMultitarget%252BDrugs%26aulast%3DCostantino%26aufirst%3DLuca%26date%3D2017%26date%3D2017%26spage%3D161%26epage%3D205%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DDrug%252BSelectivity%26aulast%3DHandler%26aufirst%3DNorbert%26date%3D2017%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Liu</span>, <span class="hlFld-ContribAuthor ">Wen-zhu  Wan</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">Guan-lian  Zhou</span>, <span class="hlFld-ContribAuthor ">Xin-guang  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Recent development of ATP-competitive small molecule phosphatidylinostitol-3-kinase inhibitors as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (4)
                                     , 7181-7200. <a href="https://doi.org/10.18632/oncotarget.12742" title="DOI URL">https://doi.org/10.18632/oncotarget.12742</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.12742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.12742%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DRecent%252Bdevelopment%252Bof%252BATP-competitive%252Bsmall%252Bmolecule%252Bphosphatidylinostitol-3-kinase%252Binhibitors%252Bas%252Banticancer%252Bagents%26aulast%3DLiu%26aufirst%3DYu%26date%3D2017%26date%3D2016%26volume%3D8%26issue%3D4%26spage%3D7181%26epage%3D7200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaomin  Wang</span>, <span class="hlFld-ContribAuthor ">Yajing  Chu</span>, <span class="hlFld-ContribAuthor ">Weili  Wang</span>, <span class="hlFld-ContribAuthor ">Weiping  Yuan</span>. </span><span class="cited-content_cbyCitation_article-title">mTORC signaling in hematopoiesis. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Hematology</span><span> <strong>2016,</strong> <em>103 </em>
                                    (5)
                                     , 510-518. <a href="https://doi.org/10.1007/s12185-016-1944-z" title="DOI URL">https://doi.org/10.1007/s12185-016-1944-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12185-016-1944-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12185-016-1944-z%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Hematology%26atitle%3DmTORC%252Bsignaling%252Bin%252Bhematopoiesis%26aulast%3DWang%26aufirst%3DXiaomin%26date%3D2016%26date%3D2016%26volume%3D103%26issue%3D5%26spage%3D510%26epage%3D518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaodong  Ma</span>, <span class="hlFld-ContribAuthor ">Xiaoqing  Lv</span>, <span class="hlFld-ContribAuthor ">Ni  Qiu</span>, <span class="hlFld-ContribAuthor ">Bo  Yang</span>, <span class="hlFld-ContribAuthor ">Qiaojun  He</span>, <span class="hlFld-ContribAuthor ">Yongzhou  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel quinoline-based mTOR inhibitors via introducing intra-molecular hydrogen bonding scaffold (iMHBS): The design, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (24)
                                     , 7585-7596. <a href="https://doi.org/10.1016/j.bmc.2015.11.003" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.11.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.11.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bquinoline-based%252BmTOR%252Binhibitors%252Bvia%252Bintroducing%252Bintra-molecular%252Bhydrogen%252Bbonding%252Bscaffold%252B%252528iMHBS%252529%25253A%252BThe%252Bdesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DMa%26aufirst%3DXiaodong%26date%3D2015%26volume%3D23%26issue%3D24%26spage%3D7585%26epage%3D7596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wendy  Lee</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Ortwine</span>, <span class="hlFld-ContribAuthor ">Philippe  Bergeron</span>, <span class="hlFld-ContribAuthor ">Kevin  Lau</span>, <span class="hlFld-ContribAuthor ">Lichuan  Lin</span>, <span class="hlFld-ContribAuthor ">Shiva  Malek</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Zhonghua  Pei</span>, <span class="hlFld-ContribAuthor ">Kirk D.  Robarge</span>, <span class="hlFld-ContribAuthor ">Stephen  Schmidt</span>, <span class="hlFld-ContribAuthor ">Steve  Sideris</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>. </span><span class="cited-content_cbyCitation_article-title">A hit to lead discovery of novel N-methylated imidazolo-, pyrrolo-, and pyrazolo-pyrimidines as potent and selective mTOR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (18)
                                     , 5097-5104. <a href="https://doi.org/10.1016/j.bmcl.2013.07.027" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.07.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.07.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.07.027%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DA%252Bhit%252Bto%252Blead%252Bdiscovery%252Bof%252Bnovel%252BN-methylated%252Bimidazolo-%25252C%252Bpyrrolo-%25252C%252Band%252Bpyrazolo-pyrimidines%252Bas%252Bpotent%252Band%252Bselective%252BmTOR%252Binhibitors%26aulast%3DLee%26aufirst%3DWendy%26date%3D2013%26volume%3D23%26issue%3D18%26spage%3D5097%26epage%3D5104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Evelyn  Sauer</span>, <span class="hlFld-ContribAuthor ">Stefan  Imseng</span>, <span class="hlFld-ContribAuthor ">Timm  Maier</span>, <span class="hlFld-ContribAuthor ">Michael N.  Hall</span>. </span><span class="cited-content_cbyCitation_article-title">Conserved sequence motifs and the structure of the mTOR kinase domain. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Society Transactions</span><span> <strong>2013,</strong> <em>41 </em>
                                    (4)
                                     , 889-895. <a href="https://doi.org/10.1042/BST20130113" title="DOI URL">https://doi.org/10.1042/BST20130113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BST20130113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBST20130113%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Society%2520Transactions%26atitle%3DConserved%252Bsequence%252Bmotifs%252Band%252Bthe%252Bstructure%252Bof%252Bthe%252BmTOR%252Bkinase%252Bdomain%26aulast%3DSauer%26aufirst%3DEvelyn%26date%3D2013%26date%3D2013%26volume%3D41%26issue%3D4%26spage%3D889%26epage%3D895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Stella</span>, <span class="hlFld-ContribAuthor ">Kristien  Van Belle</span>, <span class="hlFld-ContribAuthor ">Steven  De Jonghe</span>, <span class="hlFld-ContribAuthor ">Thierry  Louat</span>, <span class="hlFld-ContribAuthor ">Jean  Herman</span>, <span class="hlFld-ContribAuthor ">Jef  Rozenski</span>, <span class="hlFld-ContribAuthor ">Mark  Waer</span>, <span class="hlFld-ContribAuthor ">Piet  Herdewijn</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of a 2,4,6-trisubstituted 5-cyano-pyrimidine library and evaluation of its immunosuppressive activity in a Mixed Lymphocyte Reaction assay. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (5)
                                     , 1209-1218. <a href="https://doi.org/10.1016/j.bmc.2012.12.032" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.12.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.12.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.12.032%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252Ba%252B2%25252C4%25252C6-trisubstituted%252B5-cyano-pyrimidine%252Blibrary%252Band%252Bevaluation%252Bof%252Bits%252Bimmunosuppressive%252Bactivity%252Bin%252Ba%252BMixed%252BLymphocyte%252BReaction%252Bassay%26aulast%3DStella%26aufirst%3DAlessandro%26date%3D2013%26volume%3D21%26issue%3D5%26spage%3D1209%26epage%3D1218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karunakar  Tanneeru</span>, <span class="hlFld-ContribAuthor ">Bandi Madhusudhan  Reddy</span>, <span class="hlFld-ContribAuthor ">Lalitha  Guruprasad</span>. </span><span class="cited-content_cbyCitation_article-title">Three-dimensional quantitative structure–activity relationship (3D-QSAR) analysis and molecular docking of ATP-competitive triazine analogs of human mTOR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2012,</strong> <em>21 </em>
                                    (7)
                                     , 1207-1217. <a href="https://doi.org/10.1007/s00044-011-9629-x" title="DOI URL">https://doi.org/10.1007/s00044-011-9629-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-011-9629-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-011-9629-x%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DThree-dimensional%252Bquantitative%252Bstructure%2525E2%252580%252593activity%252Brelationship%252B%2525283D-QSAR%252529%252Banalysis%252Band%252Bmolecular%252Bdocking%252Bof%252BATP-competitive%252Btriazine%252Banalogs%252Bof%252Bhuman%252BmTOR%252Binhibitors%26aulast%3DTanneeru%26aufirst%3DKarunakar%26date%3D2012%26date%3D2011%26volume%3D21%26issue%3D7%26spage%3D1207%26epage%3D1217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. Raymond V.  Finlay</span>, <span class="hlFld-ContribAuthor ">David  Buttar</span>, <span class="hlFld-ContribAuthor ">Susan E.  Critchlow</span>, <span class="hlFld-ContribAuthor ">Allan P.  Dishington</span>, <span class="hlFld-ContribAuthor ">Shaun M.  Fillery</span>, <span class="hlFld-ContribAuthor ">Eric  Fisher</span>, <span class="hlFld-ContribAuthor ">Steve C.  Glossop</span>, <span class="hlFld-ContribAuthor ">Mark A.  Graham</span>, <span class="hlFld-ContribAuthor ">Trevor  Johnson</span>, <span class="hlFld-ContribAuthor ">Gillian M.  Lamont</span>, <span class="hlFld-ContribAuthor ">Simon  Mutton</span>, <span class="hlFld-ContribAuthor ">Paula  Perkins</span>, <span class="hlFld-ContribAuthor ">Kurt G.  Pike</span>, <span class="hlFld-ContribAuthor ">Anthony M.  Slater.</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfonyl-morpholino-pyrimidines: SAR and development of a novel class of selective mTOR kinase inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (12)
                                     , 4163-4168. <a href="https://doi.org/10.1016/j.bmcl.2012.04.036" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.04.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.04.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.04.036%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSulfonyl-morpholino-pyrimidines%25253A%252BSAR%252Band%252Bdevelopment%252Bof%252Ba%252Bnovel%252Bclass%252Bof%252Bselective%252BmTOR%252Bkinase%252Binhibitor%26aulast%3DFinlay%26aufirst%3DM.%2BRaymond%2BV.%26date%3D2012%26volume%3D22%26issue%3D12%26spage%3D4163%26epage%3D4168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karunakar  Tanneeru</span>, <span class="hlFld-ContribAuthor ">Lalitha  Guruprasad</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand-based 3-D pharmacophore generation and molecular docking of mTOR kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2012,</strong> <em>18 </em>
                                    (4)
                                     , 1611-1624. <a href="https://doi.org/10.1007/s00894-011-1184-3" title="DOI URL">https://doi.org/10.1007/s00894-011-1184-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-011-1184-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-011-1184-3%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DLigand-based%252B3-D%252Bpharmacophore%252Bgeneration%252Band%252Bmolecular%252Bdocking%252Bof%252BmTOR%252Bkinase%252Binhibitors%26aulast%3DTanneeru%26aufirst%3DKarunakar%26date%3D2012%26date%3D2011%26volume%3D18%26issue%3D4%26spage%3D1611%26epage%3D1624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingxiang  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">An In Vitro Assay for the Kinase Activity of mTOR Complex 2. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 75-86. <a href="https://doi.org/10.1007/978-1-61779-430-8_6" title="DOI URL">https://doi.org/10.1007/978-1-61779-430-8_6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-61779-430-8_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-61779-430-8_6%26sid%3Dliteratum%253Aachs%26atitle%3DAn%252BIn%252BVitro%252BAssay%252Bfor%252Bthe%252BKinase%252BActivity%252Bof%252BmTOR%252BComplex%252B2%26aulast%3DHuang%26aufirst%3DJingxiang%26date%3D2012%26date%3D2011%26spage%3D75%26epage%3D86%26pub%3DHumana%2520Press%26atitle%3DmTOR%26aulast%3DWeichhart%26aufirst%3DThomas%26date%3D2012%26volume%3D821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting  Ran</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>, <span class="hlFld-ContribAuthor ">Haoliang  Yuan</span>, <span class="hlFld-ContribAuthor ">Haichun  Liu</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Weiwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Ying  Leng</span>, <span class="hlFld-ContribAuthor ">Guowu  Lin</span>, <span class="hlFld-ContribAuthor ">Shulin  Zhuang</span>, <span class="hlFld-ContribAuthor ">Yadong  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">A selectivity study on mTOR/PI3Kα inhibitors by homology modeling and 3D-QSAR. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2012,</strong> <em>18 </em>
                                    (1)
                                     , 171-186. <a href="https://doi.org/10.1007/s00894-011-1034-3" title="DOI URL">https://doi.org/10.1007/s00894-011-1034-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-011-1034-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-011-1034-3%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DA%252Bselectivity%252Bstudy%252Bon%252BmTOR%25252FPI3K%2525CE%2525B1%252Binhibitors%252Bby%252Bhomology%252Bmodeling%252Band%252B3D-QSAR%26aulast%3DRan%26aufirst%3DTing%26date%3D2012%26date%3D2011%26volume%3D18%26issue%3D1%26spage%3D171%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deborah S.  Mortensen</span>, <span class="hlFld-ContribAuthor ">Sophie M.  Perrin-Ninkovic</span>, <span class="hlFld-ContribAuthor ">Roy  Harris</span>, <span class="hlFld-ContribAuthor ">Branden G.S.  Lee</span>, <span class="hlFld-ContribAuthor ">Graziella  Shevlin</span>, <span class="hlFld-ContribAuthor ">Matt  Hickman</span>, <span class="hlFld-ContribAuthor ">Gody  Khambatta</span>, <span class="hlFld-ContribAuthor ">Rene R.  Bisonette</span>, <span class="hlFld-ContribAuthor ">Kimberly E.  Fultz</span>, <span class="hlFld-ContribAuthor ">Sabita  Sankar</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and SAR exploration of a novel series of imidazo[4,5-b]pyrazin-2-ones as potent and selective mTOR kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (22)
                                     , 6793-6799. <a href="https://doi.org/10.1016/j.bmcl.2011.09.035" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.09.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.09.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.09.035%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252BSAR%252Bexploration%252Bof%252Ba%252Bnovel%252Bseries%252Bof%252Bimidazo%25255B4%25252C5-b%25255Dpyrazin-2-ones%252Bas%252Bpotent%252Band%252Bselective%252BmTOR%252Bkinase%252Binhibitors%26aulast%3DMortensen%26aufirst%3DDeborah%2BS.%26date%3D2011%26volume%3D21%26issue%3D22%26spage%3D6793%26epage%3D6799" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chenzhong  Liao</span>, <span class="hlFld-ContribAuthor ">Markus  Sitzmann</span>, <span class="hlFld-ContribAuthor ">Angelo  Pugliese</span>, <span class="hlFld-ContribAuthor ">Marc C  Nicklaus</span>. </span><span class="cited-content_cbyCitation_article-title">Software and resources for computational medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2011,</strong> <em>3 </em>
                                    (8)
                                     , 1057-1085. <a href="https://doi.org/10.4155/fmc.11.63" title="DOI URL">https://doi.org/10.4155/fmc.11.63</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.11.63&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.11.63%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSoftware%252Band%252Bresources%252Bfor%252Bcomputational%252Bmedicinal%252Bchemistry%26aulast%3DLiao%26aufirst%3DChenzhong%26date%3D2011%26volume%3D3%26issue%3D8%26spage%3D1057%26epage%3D1085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emily B.  Borders</span>, <span class="hlFld-ContribAuthor ">Cory  Bivona</span>, <span class="hlFld-ContribAuthor ">Patrick J.  Medina</span>. </span><span class="cited-content_cbyCitation_article-title">Mammalian target of rapamycin: Biological function and target for novel anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">American Journal of Health-System Pharmacy</span><span> <strong>2010,</strong> <em>67 </em>
                                    (24)
                                     , 2095-2106. <a href="https://doi.org/10.2146/ajhp100020" title="DOI URL">https://doi.org/10.2146/ajhp100020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2146/ajhp100020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2146%2Fajhp100020%26sid%3Dliteratum%253Aachs%26jtitle%3DAmerican%2520Journal%2520of%2520Health-System%2520Pharmacy%26atitle%3DMammalian%252Btarget%252Bof%252Brapamycin%25253A%252BBiological%252Bfunction%252Band%252Btarget%252Bfor%252Bnovel%252Banticancer%252Bagents%26aulast%3DBorders%26aufirst%3DEmily%2BB.%26date%3D2010%26volume%3D67%26issue%3D24%26spage%3D2095%26epage%3D2106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shomit  Sengupta</span>, <span class="hlFld-ContribAuthor ">Timothy R.  Peterson</span>, <span class="hlFld-ContribAuthor ">David M.  Sabatini</span>. </span><span class="cited-content_cbyCitation_article-title">Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and Stress. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cell</span><span> <strong>2010,</strong> <em>40 </em>
                                    (2)
                                     , 310-322. <a href="https://doi.org/10.1016/j.molcel.2010.09.026" title="DOI URL">https://doi.org/10.1016/j.molcel.2010.09.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molcel.2010.09.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molcel.2010.09.026%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cell%26atitle%3DRegulation%252Bof%252Bthe%252BmTOR%252BComplex%252B1%252BPathway%252Bby%2525C2%2525A0Nutrients%25252C%252BGrowth%252BFactors%25252C%252Band%252BStress%26aulast%3DSengupta%26aufirst%3DShomit%26date%3D2010%26volume%3D40%26issue%3D2%26spage%3D310%26epage%3D322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carlos  García-Echeverría</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric and ATP-competitive kinase inhibitors of mTOR for cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (15)
                                     , 4308-4312. <a href="https://doi.org/10.1016/j.bmcl.2010.05.099" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.05.099</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.05.099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.05.099%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAllosteric%252Band%252BATP-competitive%252Bkinase%252Binhibitors%252Bof%252BmTOR%252Bfor%252Bcancer%252Btreatment%26aulast%3DGarc%25C3%25ADa-Echeverr%25C3%25ADa%26aufirst%3DCarlos%26date%3D2010%26volume%3D20%26issue%3D15%26spage%3D4308%26epage%3D4312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alberto M.  Martelli</span>, <span class="hlFld-ContribAuthor ">Camilla  Evangelisti</span>, <span class="hlFld-ContribAuthor ">Francesca  Chiarini</span>, <span class="hlFld-ContribAuthor ">James A.  McCubrey</span>. </span><span class="cited-content_cbyCitation_article-title">The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2010,</strong> <em>1 </em>
                                    (2)
                                     , 89-103. <a href="https://doi.org/10.18632/oncotarget.114" title="DOI URL">https://doi.org/10.18632/oncotarget.114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.114%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DThe%252Bphosphatidylinositol%252B3-kinase%25252FAkt%25252FmTOR%252Bsignaling%252Bnetwork%252Bas%252Ba%252Btherapeutic%252Btarget%252Bin%252Bacute%252Bmyelogenous%252Bleukemia%252Bpatients%26aulast%3DMartelli%26aufirst%3DAlberto%2BM.%26date%3D2010%26date%3D2010%26volume%3D1%26issue%3D2%26spage%3D89%26epage%3D103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hwei-Ru  Tsou</span>, <span class="hlFld-ContribAuthor ">Gloria  MacEwan</span>, <span class="hlFld-ContribAuthor ">Gary  Birnberg</span>, <span class="hlFld-ContribAuthor ">George  Grosu</span>, <span class="hlFld-ContribAuthor ">Matthew G.  Bursavich</span>, <span class="hlFld-ContribAuthor ">Joel  Bard</span>, <span class="hlFld-ContribAuthor ">Natasja  Brooijmans</span>, <span class="hlFld-ContribAuthor ">Lourdes  Toral-Barza</span>, <span class="hlFld-ContribAuthor ">Irwin  Hollander</span>, <span class="hlFld-ContribAuthor ">Tarek S.  Mansour</span>, <span class="hlFld-ContribAuthor ">Semiramis  Ayral-Kaloustian</span>, <span class="hlFld-ContribAuthor ">Ker  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and optimization of 2-(4-substituted-pyrrolo[2,3-b]pyridin-3-yl)methylene-4-hydroxybenzofuran-3(2H)-ones as potent and selective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (7)
                                     , 2321-2325. <a href="https://doi.org/10.1016/j.bmcl.2010.01.135" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.01.135</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.01.135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.01.135%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252Boptimization%252Bof%252B2-%2525284-substituted-pyrrolo%25255B2%25252C3-b%25255Dpyridin-3-yl%252529methylene-4-hydroxybenzofuran-3%2525282H%252529-ones%252Bas%252Bpotent%252Band%252Bselective%252BATP-competitive%252Binhibitors%252Bof%252Bthe%252Bmammalian%252Btarget%252Bof%252Brapamycin%252B%252528mTOR%252529%26aulast%3DTsou%26aufirst%3DHwei-Ru%26date%3D2010%26volume%3D20%26issue%3D7%26spage%3D2321%26epage%3D2325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hwei-Ru  Tsou</span>, <span class="hlFld-ContribAuthor ">Gloria  MacEwan</span>, <span class="hlFld-ContribAuthor ">Gary  Birnberg</span>, <span class="hlFld-ContribAuthor ">Nan  Zhang</span>, <span class="hlFld-ContribAuthor ">Natasja  Brooijmans</span>, <span class="hlFld-ContribAuthor ">Lourdes  Toral-Barza</span>, <span class="hlFld-ContribAuthor ">Irwin  Hollander</span>, <span class="hlFld-ContribAuthor ">Semiramis  Ayral-Kaloustian</span>, <span class="hlFld-ContribAuthor ">Ker  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">4-Substituted-7-azaindoles bearing a ureidobenzofuranone moiety as potent and selective, ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (7)
                                     , 2259-2263. <a href="https://doi.org/10.1016/j.bmcl.2010.02.012" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.02.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.02.012%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D4-Substituted-7-azaindoles%252Bbearing%252Ba%252Bureidobenzofuranone%252Bmoiety%252Bas%252Bpotent%252Band%252Bselective%25252C%252BATP-competitive%252Binhibitors%252Bof%252Bthe%252Bmammalian%252Btarget%252Bof%252Brapamycin%252B%252528mTOR%252529%26aulast%3DTsou%26aufirst%3DHwei-Ru%26date%3D2010%26volume%3D20%26issue%3D7%26spage%3D2259%26epage%3D2263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeroen C.  Verheijen</span>, <span class="hlFld-ContribAuthor ">David J.  Richard</span>, <span class="hlFld-ContribAuthor ">Kevin  Curran</span>, <span class="hlFld-ContribAuthor ">Joshua  Kaplan</span>, <span class="hlFld-ContribAuthor ">Ker  Yu</span>, <span class="hlFld-ContribAuthor ">Arie  Zask</span>. </span><span class="cited-content_cbyCitation_article-title">2-Arylureidophenyl-4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)triazines as highly potent and selective ATP competitive mTOR inhibitors: Optimization of human microsomal stability. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (8)
                                     , 2648-2653. <a href="https://doi.org/10.1016/j.bmcl.2010.02.031" title="DOI URL">https://doi.org/10.1016/j.bmcl.2010.02.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2010.02.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2010.02.031%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D2-Arylureidophenyl-4-%2525283-oxa-8-azabicyclo%25255B3.2.1%25255Doctan-8-yl%252529triazines%252Bas%252Bhighly%252Bpotent%252Band%252Bselective%252BATP%252Bcompetitive%252BmTOR%252Binhibitors%25253A%252BOptimization%252Bof%252Bhuman%252Bmicrosomal%252Bstability%26aulast%3DVerheijen%26aufirst%3DJeroen%2BC.%26date%3D2010%26volume%3D20%26issue%3D8%26spage%3D2648%26epage%3D2653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gary K.  Smith</span>, <span class="hlFld-ContribAuthor ">Edgar R.  Wood</span>. </span><span class="cited-content_cbyCitation_article-title">Cell-based assays for kinase drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today: Technologies</span><span> <strong>2010,</strong> <em>7 </em>
                                    (1)
                                     , e13-e19. <a href="https://doi.org/10.1016/j.ddtec.2010.04.002" title="DOI URL">https://doi.org/10.1016/j.ddtec.2010.04.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ddtec.2010.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ddtec.2010.04.002%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technologies%26atitle%3DCell-based%252Bassays%252Bfor%252Bkinase%252Bdrug%252Bdiscovery%26aulast%3DSmith%26aufirst%3DGary%2BK.%26date%3D2010%26volume%3D7%26issue%3D1%26spage%3De13%26epage%3De19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Morris E.  Feldman</span>, <span class="hlFld-ContribAuthor ">Kevan M.  Shokat</span>. </span><span class="cited-content_cbyCitation_article-title">New Inhibitors of the PI3K-Akt-mTOR Pathway: Insights into mTOR Signaling from a New Generation of Tor Kinase Domain Inhibitors (TORKinibs). </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 241-262. <a href="https://doi.org/10.1007/82_2010_64" title="DOI URL">https://doi.org/10.1007/82_2010_64</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/82_2010_64&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F82_2010_64%26sid%3Dliteratum%253Aachs%26atitle%3DNew%252BInhibitors%252Bof%252Bthe%252BPI3K-Akt-mTOR%252BPathway%25253A%252BInsights%252Binto%252BmTOR%252BSignaling%252Bfrom%252Ba%252BNew%252BGeneration%252Bof%252BTor%252BKinase%252BDomain%252BInhibitors%252B%252528TORKinibs%252529%26aulast%3DFeldman%26aufirst%3DMorris%2BE.%26date%3D2010%26date%3D2010%26spage%3D241%26epage%3D262%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DPhosphoinositide%252B3-kinase%252Bin%252BHealth%252Band%252BDisease%26aulast%3DRommel%26aufirst%3DChristian%26date%3D2011%26volume%3D347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter K.  Vogt</span>, <span class="hlFld-ContribAuthor ">Jonathan R.  Hart</span>, <span class="hlFld-ContribAuthor ">Marco  Gymnopoulos</span>, <span class="hlFld-ContribAuthor ">Hao  Jiang</span>, <span class="hlFld-ContribAuthor ">Sohye  Kang</span>, <span class="hlFld-ContribAuthor ">Andreas G.  Bader</span>, <span class="hlFld-ContribAuthor ">Li  Zhao</span>, <span class="hlFld-ContribAuthor ">Adam  Denley</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphatidylinositol 3-Kinase: The Oncoprotein. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 79-104. <a href="https://doi.org/10.1007/82_2010_80" title="DOI URL">https://doi.org/10.1007/82_2010_80</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/82_2010_80&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F82_2010_80%26sid%3Dliteratum%253Aachs%26atitle%3DPhosphatidylinositol%252B3-Kinase%25253A%252BThe%252BOncoprotein%26aulast%3DVogt%26aufirst%3DPeter%2BK.%26date%3D2010%26date%3D2010%26spage%3D79%26epage%3D104%26pub%3DSpringer%2520Berlin%2520Heidelberg%26atitle%3DPhosphoinositide%252B3-kinase%252Bin%252BHealth%252Band%252BDisease%26aulast%3DRommel%26aufirst%3DChristian%26date%3D2011%26volume%3D347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeroen C.  Verheijen</span>, <span class="hlFld-ContribAuthor ">Ker  Yu</span>, <span class="hlFld-ContribAuthor ">Lourdes  Toral-Barza</span>, <span class="hlFld-ContribAuthor ">Irwin  Hollander</span>, <span class="hlFld-ContribAuthor ">Arie  Zask</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-arylthieno[3,2-d]pyrimidines containing 8-oxa-3-azabi-cyclo[3.2.1]octane in the 4-position as potent inhibitors of mTOR with selectivity over PI3K. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (1)
                                     , 375-379. <a href="https://doi.org/10.1016/j.bmcl.2009.10.075" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.10.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.10.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.10.075%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B2-arylthieno%25255B3%25252C2-d%25255Dpyrimidines%252Bcontaining%252B8-oxa-3-azabi-cyclo%25255B3.2.1%25255Doctane%252Bin%252Bthe%252B4-position%252Bas%252Bpotent%252Binhibitors%252Bof%252BmTOR%252Bwith%252Bselectivity%252Bover%252BPI3K%26aulast%3DVerheijen%26aufirst%3DJeroen%2BC.%26date%3D2010%26volume%3D20%26issue%3D1%26spage%3D375%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joshua  Kaplan</span>, <span class="hlFld-ContribAuthor ">Jeroen C.  Verheijen</span>, <span class="hlFld-ContribAuthor ">Natasja  Brooijmans</span>, <span class="hlFld-ContribAuthor ">Lourdes  Toral-Barza</span>, <span class="hlFld-ContribAuthor ">Irwin  Hollander</span>, <span class="hlFld-ContribAuthor ">Ker  Yu</span>, <span class="hlFld-ContribAuthor ">Arie  Zask</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3,6-dihydro-2H-pyran as a morpholine replacement in 6-aryl-1H-pyrazolo[3,4-d]pyrimidines and 2-arylthieno[3,2-d]pyrimidines: ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (2)
                                     , 640-643. <a href="https://doi.org/10.1016/j.bmcl.2009.11.050" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.11.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.11.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.11.050%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B3%25252C6-dihydro-2H-pyran%252Bas%252Ba%252Bmorpholine%252Breplacement%252Bin%252B6-aryl-1H-pyrazolo%25255B3%25252C4-d%25255Dpyrimidines%252Band%252B2-arylthieno%25255B3%25252C2-d%25255Dpyrimidines%25253A%252BATP-competitive%252Binhibitors%252Bof%252Bthe%252Bmammalian%252Btarget%252Bof%252Brapamycin%252B%252528mTOR%252529%26aulast%3DKaplan%26aufirst%3DJoshua%26date%3D2010%26volume%3D20%26issue%3D2%26spage%3D640%26epage%3D643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/medium/jm-2009-012642_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9012642&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/medium/jm-2009-012642_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0013.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9012642&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) POCl<sub>3</sub>, DMF, reflux, 60%; (b) 1-benzyl-4-hydrazinylpiperidine dihydrochloride, Et<sub>3</sub>N, EtOH, −78 to 0°C, 82%; (c) morpholine, EtOH, 61%; (d) ArB(OH)<sub>2</sub> or ArB(OCMe<sub>2</sub>)<sub>2</sub> Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, dioxane, water, 100°C; (e) H<sub>2</sub>, Pd(OH)<sub>2</sub>/C (10%), MeOH; (f) R<sub>2</sub>COCl, Et<sub>3</sub>N, THF or R<sub>2</sub>CHO, NaBH<sub>3</sub>CN, AcOH (cat.), MeOH.</p></p></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/medium/jm-2009-012642_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Putative binding mode of <b>5a</b> with the mTOR homology model. In this model, the morpholine of <b>5a</b> forms a key hinge-region hydrogen bond with the backbone of Val2240. At the rear of the binding pocket, Asp2195 is shown making a second key hydrogen bond to the phenol of <b>5a</b>. Residues within a 3 Å radius of <b>5a</b> that are conserved between the mTOR active site and PI3Kα are shown in green and include the catalytic Lys2187. The only two residues that change (highlighted in orange) are Trp2239 and Leu2354. The core forms hydrophobic contacts with Ile2163 and Leu2185 above the plane of the inhibitor and with Met2345 and Ile2356 below the plane of the inhibitor (not shown for clarity).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9012642&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/medium/jm-2009-012642_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Predicted binding mode of <b>5u</b> with the mTOR homology model. The predicted binding mode of <b>5u</b> with mTOR shows the hydrogen bonding interaction of the morpholine to Val2240 and the indole-NH to Asp2195. The pyridin-3-ylmethyl tailpiece of <b>5u</b> in the front of the binding site interacts with a region that contains Leu2249 and Ala2248 in mTOR. The corresponding residues in PI3Kα are Met858 and Gln859, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9012642&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/medium/jm-2009-012642_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. ATP competitive inhibition of mTOR kinase activity. Compound <b>5u</b> was assayed in an inhibitor versus ATP matrix competition. The initial enzyme rate (<i>V</i><sub>0</sub>) against 0, 0.009, 0.018, 0.027 μM <b>5u</b> at various concentrations of ATP was measured to generate the double-reciprocal plot.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9012642&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/medium/jm-2009-012642_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0010.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of cellular mTORC1 and mTORC2 signaling functions in actively proliferating cancer cells. Renal tumor A498 cells were treated in growth medium for 6 h with DMSO or the indicated concentrations of <b>5u</b> or 1 μM rapamycin (Rapa) or 17-hydroxywortmannin (HWT). Total cell lysates were prepared and subject to immunoblotting with antibodies against P-S6K1(T389), P-4EBP1(T70), P-4EBP1(T36/47), P-AKT(S473). The blots were also stained with Ponceau S, a total protein dye, for sample loading control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9012642&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/medium/jm-2009-012642_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0011.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Selective targeting of mTOR versus PI3K in PTEN-negative cancer cells. U87MG glioma cells were treated in growth medium for 6 h with DMSO or the indicated concentrations of <b>5f</b> or <b>5u</b> or 1 μM rapamycin (Rapa) or 17-hydroxywortmannin (HWT). Total cell lysates were prepared and subject to immunoblotting with antibodies against P-S6K1 (T389), P-AKT (S473), and P-AKT (T308).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2009/jmcmar.2009.52.issue-22/jm9012642/production/images/large/jm-2009-012642_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9012642&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i47">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04203" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04203" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 31 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Sarbassov, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Growing roled of the mTOR pathway</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">603</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm9012642&amp;key=10.1016%2Fj.ceb.2005.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm9012642&amp;key=16226444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm9012642&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFyksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2005&pages=596-603&author=D.+D.+Sarbassovauthor=S.+M.+Aliauthor=D.+M.+Sabatini&title=Growing+roled+of+the+mTOR+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Growing roles for the mTOR pathway</span></div><div class="casAuthors">Sarbassov, Dos D.; Ali, Siraj M.; Sabatini, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">596-603</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The mammalian TOR (mTOR; mammalian target of rapamycin) pathway is a key regulator of cell growth and proliferation and increasing evidence suggests that its deregulation is assocd. with human diseases, including cancer and diabetes.  The mTOR pathway integrates signals from nutrients, energy status, and growth factors to regulate many processes, including autophagy, ribosome biogenesis, and metab.  Recent work identifying 2 structurally and functionally distinct mTOR-contg. multiprotein complexes, and TSC1/2, rheb, and AMPK as upstream regulators of mTOR, is beginning to reveal how mTOR can sense diverse signals and produce a myriad of responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMOIIVMYJG0LVg90H21EOLACvtfcHk0lioxwpOr_Ij_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFyksL7F&md5=e24e27de16bd9f8e7219b684c7242f8e</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2005.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2005.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DSarbassov%26aufirst%3DD.%2BD.%26aulast%3DAli%26aufirst%3DS.%2BM.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DGrowing%2520roled%2520of%2520the%2520mTOR%2520pathway%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2005%26volume%3D17%26spage%3D596%26epage%3D603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Wullschleger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, M. N.</span><span> </span><span class="NLM_article-title">TOR signaling in growth and metabolism</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">484</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm9012642&amp;key=10.1016%2Fj.cell.2006.01.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm9012642&amp;key=16469695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm9012642&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslaqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2006&pages=471-484&author=S.+Wullschlegerauthor=R.+Loewithauthor=M.+N.+Hall&title=TOR+signaling+in+growth+and+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">TOR signaling in growth and metabolism</span></div><div class="casAuthors">Wullschleger, Stephan; Loewith, Robbie; Hall, Michael N.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">471-484</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The target of rapamycin (TOR) is a conserved Ser/Thr kinase that regulates cell growth and metab. in response to environmental cues.  Here, highlighting contributions from studies in model organisms, we review mammalian TOR complexes and the signaling branches they mediate.  TOR is part of two distinct multiprotein complexes, TOR complex 1 (TORC1), which is sensitive to rapamycin, and TORC2, which is not.  The physiol. consequences of mammalian TORC1 dysregulation suggest that inhibitors of mammalian TOR may be useful in the treatment of cancer, cardiovascular disease, autoimmunity, and metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdwzZ5NGx9YrVg90H21EOLACvtfcHk0lhwytGzXXvVcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslaqs74%253D&md5=d8128a86651c824e725f56b90cafb88d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2006.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2006.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DWullschleger%26aufirst%3DS.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DHall%26aufirst%3DM.%2BN.%26atitle%3DTOR%2520signaling%2520in%2520growth%2520and%2520metabolism%26jtitle%3DCell%26date%3D2006%26volume%3D124%26spage%3D471%26epage%3D484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Defining the role of mTOR in cancer</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=9-22&author=D.+A.+Guertinauthor=D.+M.+Sabatini&title=Defining+the+role+of+mTOR+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DDefining%2520the%2520role%2520of%2520mTOR%2520in%2520cancer%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D9%26epage%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Chiang, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span> </span><span class="NLM_article-title">Targeting the mTOR signaling network in cancer</span> <span class="citation_source-journal">Trends Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">–</span> <span class="NLM_lpage">442</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=433-442&author=G.+G.+Chiangauthor=R.+T.+Abraham&title=Targeting+the+mTOR+signaling+network+in+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChiang%26aufirst%3DG.%2BG.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26atitle%3DTargeting%2520the%2520mTOR%2520signaling%2520network%2520in%2520cancer%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2007%26volume%3D13%26spage%3D433%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">The pharmacology of mTOR inhibition</span> <span class="citation_source-journal">Sci. Signaling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm9012642&amp;key=10.1126%2Fscisignal.267pe24" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm9012642&amp;key=19318623" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2009&pages=1-6&author=D.+A.+Guertinauthor=D.+M.+Sabatini&title=The+pharmacology+of+mTOR+inhibition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscisignal.267pe24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscisignal.267pe24%26sid%3Dliteratum%253Aachs%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DThe%2520pharmacology%2520of%2520mTOR%2520inhibition%26jtitle%3DSci.%2520Signaling%26date%3D2009%26volume%3D2%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Abraham, R. T.</span><span> </span><span class="NLM_article-title">PI 3-kinase related kinases: “big” players in stress-induced signaling pathways</span> <span class="citation_source-journal">DNA Repair</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">883</span><span class="NLM_x">–</span> <span class="NLM_lpage">887</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=883-887&author=R.+T.+Abraham&title=PI+3-kinase+related+kinases%3A+%E2%80%9Cbig%E2%80%9D+players+in+stress-induced+signaling+pathways"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26atitle%3DPI%25203-kinase%2520related%2520kinases%253A%2520%25E2%2580%259Cbig%25E2%2580%259D%2520players%2520in%2520stress-induced%2520signaling%2520pathways%26jtitle%3DDNA%2520Repair%26date%3D2004%26volume%3D3%26spage%3D883%26epage%3D887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Yuan, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span> </span><span class="NLM_article-title">PI3K pathway alterations in cancer: variations on a theme</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">5497</span><span class="NLM_x">–</span> <span class="NLM_lpage">5510</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=5497-5510&author=T.+L.+Yuanauthor=L.+C.+Cantley&title=PI3K+pathway+alterations+in+cancer%3A+variations+on+a+theme"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DT.%2BL.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26atitle%3DPI3K%2520pathway%2520alterations%2520in%2520cancer%253A%2520variations%2520on%2520a%2520theme%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D5497%26epage%3D5510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Carracedo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandolfi, P. P.</span><span> </span><span class="NLM_article-title">The PTEN-PI3K pathway: of feedbacks and cross-talks</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">5527</span><span class="NLM_x">–</span> <span class="NLM_lpage">5541</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=5527-5541&author=A.+Carracedoauthor=P.+P.+Pandolfi&title=The+PTEN-PI3K+pathway%3A+of+feedbacks+and+cross-talks"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarracedo%26aufirst%3DA.%26aulast%3DPandolfi%26aufirst%3DP.%2BP.%26atitle%3DThe%2520PTEN-PI3K%2520pathway%253A%2520of%2520feedbacks%2520and%2520cross-talks%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D5527%26epage%3D5541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Inoki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corradetti, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guan, K. L.</span><span> </span><span class="NLM_article-title">Dysregulation of the TSC-mTOR pathway in human disease</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm9012642&amp;key=10.1038%2Fng1494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm9012642&amp;key=15624019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm9012642&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFChsL3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2005&pages=19-24&author=K.+Inokiauthor=M.+N.+Corradettiauthor=K.+L.+Guan&title=Dysregulation+of+the+TSC-mTOR+pathway+in+human+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Dysregulation of the TSC-mTOR pathway in human disease</span></div><div class="casAuthors">Inoki, Ken; Corradetti, Michael N.; Guan, Kun-Liang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-24</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The mammalian target of rapamycin (mTOR) has a central role in the regulation of cell growth. mTOR receives input from multiple signaling pathways, including growth factors and nutrients, to stimulate protein synthesis by phosphorylating key translation regulators such as ribosomal S6 kinase and eukaryote initiation factor 4E binding protein 1.  High levels of dysregulated mTOR activity are assocd. with several hamartoma syndromes, including tuberous sclerosis complex, the PTEN-related hamartoma syndromes and Peutz-Jeghers syndrome.  These disorders are all caused by mutations in tumor-suppressor genes that neg. regulate mTOR.  Here we discuss the emerging evidence for a functional relationship between the mTOR signaling pathway and several genetic diseases, and we present evidence supporting a model in which dysregulation of mTOR may be a common mol. basis, not only for hamartoma syndromes, but also for other cellular hypertrophic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcM0DjY6r9LVg90H21EOLACvtfcHk0lhwytGzXXvVcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFChsL3M&md5=7cc3c4b4f1b02265816de0737a078fc7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fng1494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1494%26sid%3Dliteratum%253Aachs%26aulast%3DInoki%26aufirst%3DK.%26aulast%3DCorradetti%26aufirst%3DM.%2BN.%26aulast%3DGuan%26aufirst%3DK.%2BL.%26atitle%3DDysregulation%2520of%2520the%2520TSC-mTOR%2520pathway%2520in%2520human%2520disease%26jtitle%3DNat.%2520Genet.%26date%3D2005%26volume%3D37%26spage%3D19%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Choi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clardy, J.</span><span> </span><span class="NLM_article-title">Structure of the FKBP12−rapamycin complex interacting with the binding domain of human FRAP</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1996&pages=239-242&author=J.+Choiauthor=J.+Chenauthor=S.+L.+Schreiberauthor=J.+Clardy&title=Structure+of+the+FKBP12%E2%88%92rapamycin+complex+interacting+with+the+binding+domain+of+human+FRAP"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DClardy%26aufirst%3DJ.%26atitle%3DStructure%2520of%2520the%2520FKBP12%25E2%2588%2592rapamycin%2520complex%2520interacting%2520with%2520the%2520binding%2520domain%2520of%2520human%2520FRAP%26jtitle%3DScience%26date%3D1996%26volume%3D273%26spage%3D239%26epage%3D242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Liang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clardy, J.</span><span> </span><span class="NLM_article-title">Refined structure of the FKBP12−rapamycin−FRB ternary complex at 2.2 Å resolution</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">736</span><span class="NLM_x">–</span> <span class="NLM_lpage">744</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=736-744&author=J.+Liangauthor=J.+Choiauthor=J.+Clardy&title=Refined+structure+of+the+FKBP12%E2%88%92rapamycin%E2%88%92FRB+ternary+complex+at+2.2+%C3%85+resolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DClardy%26aufirst%3DJ.%26atitle%3DRefined%2520structure%2520of%2520the%2520FKBP12%25E2%2588%2592rapamycin%25E2%2588%2592FRB%2520ternary%2520complex%2520at%25202.2%2520%25C3%2585%2520resolution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1999%26volume%3D55%26spage%3D736%26epage%3D744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Easton, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, P. J.</span><span> </span><span class="NLM_article-title">mTOR and cancer therapy</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">6436</span><span class="NLM_x">–</span> <span class="NLM_lpage">6446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=6436-6446&author=J.+B.+Eastonauthor=P.+J.+Houghton&title=mTOR+and+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEaston%26aufirst%3DJ.%2BB.%26aulast%3DHoughton%26aufirst%3DP.%2BJ.%26atitle%3DmTOR%2520and%2520cancer%2520therapy%26jtitle%3DOncogene%26date%3D2006%26volume%3D25%26spage%3D6436%26epage%3D6446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Dancey, J. E.</span><span> </span><span class="NLM_article-title">Therapeutic targets: MTOR and related pathways</span> <span class="citation_source-journal">Cancer Biol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1065</span><span class="NLM_x">–</span> <span class="NLM_lpage">1073</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm9012642&amp;key=10.4161%2Fcbt.5.9.3175" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm9012642&amp;key=16969122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm9012642&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktlejsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=1065-1073&author=J.+E.+Dancey&title=Therapeutic+targets%3A+MTOR+and+related+pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targets. MTOR and related pathways</span></div><div class="casAuthors">Dancey, Janet E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1065-1073</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">A review.  The mammalian target of rapamycin (mTOR), a protein kinase of the phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway, has a central role in controlling malignant cellular growth.  As a result, mTOR is viewed as an important target for anticancer drug development.  Inhibitors of mTOR currently under evaluation in cancer clin. trials are rapamycin (also known as sirolimus, Wyeth) and derivs. temsirolimus (CCI-779, Wyeth), everolimus, (RAD001, Novartis Pharma AG), and AP23573 (Ariad Pharmaceuticals).  Preclin. studies suggest that sensitivity to mTOR inhibitors may correlate with activation of the PI3K pathway and/or with aberrant expression of cell cycle regulatory or anti-apoptotic proteins.  Clin. trial results show that mTOR inhibitors are well tolerated and may induce prolonged stable disease and tumor regressions in cancer patients.  Future research should evaluate optimal, schedule, patient selection, and combination strategies for this novel class of agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz_taiC5i3ALVg90H21EOLACvtfcHk0lgjaGKDnlM5-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktlejsQ%253D%253D&md5=be06e2ae7e26fcb0dfe54c3f38011c5e</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.4161%2Fcbt.5.9.3175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.5.9.3175%26sid%3Dliteratum%253Aachs%26aulast%3DDancey%26aufirst%3DJ.%2BE.%26atitle%3DTherapeutic%2520targets%253A%2520MTOR%2520and%2520related%2520pathways%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D1065%26epage%3D1073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span> </span><span class="NLM_article-title">The mammalian target of rapamycin signaling pathway: twists and turns in the road to cancer therapy</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3109</span><span class="NLM_x">–</span> <span class="NLM_lpage">3114</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm9012642&amp;key=10.1158%2F1078-0432.CCR-06-2798" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm9012642&amp;key=17545512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm9012642&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVajtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=3109-3114&author=R.+T.+Abrahamauthor=J.+J.+Gibbons&title=The+mammalian+target+of+rapamycin+signaling+pathway%3A+twists+and+turns+in+the+road+to+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The Mammalian Target of Rapamycin Signaling Pathway: Twists and Turns in the Road to Cancer Therapy</span></div><div class="casAuthors">Abraham, Robert T.; Gibbons, James J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3109-3114</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The immunosuppressive drug rapamycin played a key role in the functional characterization of mammalian target of rapamycin (mTOR), an unusual protein kinase that coordinates growth factor and nutrient availability with cell growth and proliferation.  Several rapamycin-related compds. are now in various stages of clin. development as anticancer agents.  This article highlights recent advances in our understanding of the mTOR signaling pathway and the implications of these findings for the clin. application of mTOR inhibitors in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyaHT0dJasgbVg90H21EOLACvtfcHk0lgjaGKDnlM5-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVajtb8%253D&md5=b393422d11958a97b7c5a31e60b2a88b</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2798%26sid%3Dliteratum%253Aachs%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26atitle%3DThe%2520mammalian%2520target%2520of%2520rapamycin%2520signaling%2520pathway%253A%2520twists%2520and%2520turns%2520in%2520the%2520road%2520to%2520cancer%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D3109%26epage%3D3114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Sarbassov, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guertin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latek, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdjument-Bromage, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tempst, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span> </span><span class="NLM_article-title">Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1296</span><span class="NLM_x">–</span> <span class="NLM_lpage">1302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm9012642&amp;key=10.1016%2Fj.cub.2004.06.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm9012642&amp;key=15268862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm9012642&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVamsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=1296-1302&author=D.+D.+Sarbassovauthor=S.+M.+Aliauthor=D.+H.+Kimauthor=D.+A.+Guertinauthor=R.+R.+Latekauthor=H.+Erdjument-Bromageauthor=P.+Tempstauthor=D.+M.+Sabatini&title=Rictor%2C+a+novel+binding+partner+of+mTOR%2C+defines+a+rapamycin-insensitive+and+raptor-independent+pathway+that+regulates+the+cytoskeleton"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton</span></div><div class="casAuthors">Sarbassov, Dos D.; Ali, Siraj M.; Kim, Do-Hyung; Guertin, David A.; Latek, Robert R.; Erdjument-Bromage, Hediye; Tempst, Paul; Sabatini, David M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1296-1302</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The mammalian TOR (mTOR) pathway integrates nutrient- and growth factor-derived signals to regulate growth, the process whereby cells accumulate mass and increase in size.  MTOR is a large protein kinase and the target of rapamycin, an immunosuppressant that also blocks vessel restenosis and has potential anticancer applications.  MTOR interacts with the raptor and GβL proteins to form a complex that is the target of rapamycin.  Here, we demonstrate that mTOR is also part of a distinct complex defined by the novel protein rictor (rapamycin-insensitive companion of mTOR).  Rictor shares homol. with the previously described pianissimo from D. discoidieum, STE20p from S. pombe, and AVO3p from S. cerevisiae.  Interestingly, AVO3p is part of a rapamycin-insensitive TOR complex that does not contain the yeast homolog of raptor and signals to the actin cytoskeleton through PKC1.  Consistent with this finding, the rictor-contg. mTOR complex contains GβL but not raptor and it neither regulates the mTOR effector S6K1 nor is it bound by FKBP12-rapamycin.  We find that the rictor-mTOR complex modulates the phosphorylation of Protein Kinase C α (PKCα) and the actin cytoskeleton, suggesting that this aspect of TOR signaling is conserved between yeast and mammals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXWNgQt5KXB7Vg90H21EOLACvtfcHk0ljYkgt5m4pcIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVamsLs%253D&md5=78362bf097ed96b9bfc0053e3a54818c</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2004.06.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2004.06.054%26sid%3Dliteratum%253Aachs%26aulast%3DSarbassov%26aufirst%3DD.%2BD.%26aulast%3DAli%26aufirst%3DS.%2BM.%26aulast%3DKim%26aufirst%3DD.%2BH.%26aulast%3DGuertin%26aufirst%3DD.%2BA.%26aulast%3DLatek%26aufirst%3DR.%2BR.%26aulast%3DErdjument-Bromage%26aufirst%3DH.%26aulast%3DTempst%26aufirst%3DP.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26atitle%3DRictor%252C%2520a%2520novel%2520binding%2520partner%2520of%2520mTOR%252C%2520defines%2520a%2520rapamycin-insensitive%2520and%2520raptor-independent%2520pathway%2520that%2520regulates%2520the%2520cytoskeleton%26jtitle%3DCurr.%2520Biol.%26date%3D2004%26volume%3D14%26spage%3D1296%26epage%3D1302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Jacinto, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rüegg, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, M. N.</span><span> </span><span class="NLM_article-title">Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1122</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm9012642&amp;key=10.1038%2Fncb1183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm9012642&amp;key=15467718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm9012642&amp;key=1%3ACAS%3A528%3ADC%252BD2cXptFentL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=1122-8&author=E.+Jacintoauthor=R.+Loewithauthor=A.+Schmidtauthor=S.+Linauthor=M.+A.+R%C3%BCeggauthor=A.+Hallauthor=M.+N.+Hall&title=Mammalian+TOR+complex+2+controls+the+actin+cytoskeleton+and+is+rapamycin+insensitive"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive</span></div><div class="casAuthors">Jacinto, Estela; Loewith, Robbie; Schmidt, Anja; Lin, Shuo; Rueegg, Markus A.; Hall, Alan; Hall, Michael N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1122-1128</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The target of rapamycin (TOR) is a highly conserved protein kinase and a central controller of cell growth.  In budding yeast, TOR is found in structurally and functionally distinct protein complexes: TORC1 and TORC2.  A mammalian counterpart of TORC1 (mTORC1) has been described, but it is not known whether TORC2 is conserved in mammals.  Here, the authors report that a mammalian counterpart of TORC2 (mTORC2) also exists.  The mTORC2 contains mTOR, mLST8 and mAVO3, but not raptor.  Like yeast TORC2, mTORC2 is rapamycin insensitive and seems to function upstream of Rho GTPases to regulate the actin cytoskeleton.  The mTORC2 is not upstream of the mTORC1 effector S6K.  Thus, two distinct TOR complexes constitute a primordial signaling network conserved in eukaryotic evolution to control the fundamental process of cell growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcnbO542vXw7Vg90H21EOLACvtfcHk0ljYkgt5m4pcIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXptFentL8%253D&md5=42d53ee5d9dfc24287cf05fd29f41aa8</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fncb1183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1183%26sid%3Dliteratum%253Aachs%26aulast%3DJacinto%26aufirst%3DE.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DSchmidt%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DR%25C3%25BCegg%26aufirst%3DM.%2BA.%26aulast%3DHall%26aufirst%3DA.%26aulast%3DHall%26aufirst%3DM.%2BN.%26atitle%3DMammalian%2520TOR%2520complex%25202%2520controls%2520the%2520actin%2520cytoskeleton%2520and%2520is%2520rapamycin%2520insensitive%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2004%26volume%3D6%26spage%3D1122%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Carracedo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teruya-Feldstein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salmena, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alimonti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozma, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nardella, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandolfi, P. P.</span><span> </span><span class="NLM_article-title">Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">3065</span><span class="NLM_x">–</span> <span class="NLM_lpage">3074</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=3065-3074&author=A.+Carracedoauthor=L.+Maauthor=J.+Teruya-Feldsteinauthor=F.+Rojoauthor=L.+Salmenaauthor=A.+Alimontiauthor=A.+Egiaauthor=A.+T.+Sasakiauthor=G.+Thomasauthor=S.+C.+Kozmaauthor=A.+Papaauthor=C.+Nardellaauthor=L.+C.+Cantleyauthor=J.+Baselgaauthor=P.+P.+Pandolfi&title=Inhibition+of+mTORC1+leads+to+MAPK+pathway+activation+through+a+PI3K-dependent+feedback+loop+in+human+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarracedo%26aufirst%3DA.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DTeruya-Feldstein%26aufirst%3DJ.%26aulast%3DRojo%26aufirst%3DF.%26aulast%3DSalmena%26aufirst%3DL.%26aulast%3DAlimonti%26aufirst%3DA.%26aulast%3DEgia%26aufirst%3DA.%26aulast%3DSasaki%26aufirst%3DA.%2BT.%26aulast%3DThomas%26aufirst%3DG.%26aulast%3DKozma%26aufirst%3DS.%2BC.%26aulast%3DPapa%26aufirst%3DA.%26aulast%3DNardella%26aufirst%3DC.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DPandolfi%26aufirst%3DP.%2BP.%26atitle%3DInhibition%2520of%2520mTORC1%2520leads%2520to%2520MAPK%2520pathway%2520activation%2520through%2520a%2520PI3K-dependent%2520feedback%2520loop%2520in%2520human%2520cancer%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2008%26volume%3D118%26spage%3D3065%26epage%3D3074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Sauveur-Michel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brueggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fritsch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brachmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chene, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Pover, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoemaker, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Echeverria, C.</span><span> </span><span class="NLM_article-title">Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1851</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm9012642&amp;key=10.1158%2F1535-7163.MCT-08-0017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm9012642&amp;key=18606717" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=1851-1863&author=M.+Sauveur-Michelauthor=F.+Staufferauthor=J.+Brueggenauthor=P.+Furetauthor=C.+Schnellauthor=C.+Fritschauthor=S.+Brachmannauthor=P.+Cheneauthor=A.+De+Poverauthor=K.+Schoemakerauthor=D.+Fabbroauthor=D.+Gabrielauthor=M.+Simonenauthor=L.+Murphyauthor=P.+Finanauthor=W.+Sellersauthor=C.+Garcia-Echeverria&title=Identification+and+characterization+of+NVP-BEZ235%2C+a+new+orally+available+dual+phosphatidylinositol+3-kinase%2Fmammalian+target+of+rapamycin+inhibitor+with+potent+in+vivo+antitumor+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0017%26sid%3Dliteratum%253Aachs%26aulast%3DSauveur-Michel%26aufirst%3DM.%26aulast%3DStauffer%26aufirst%3DF.%26aulast%3DBrueggen%26aufirst%3DJ.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DFritsch%26aufirst%3DC.%26aulast%3DBrachmann%26aufirst%3DS.%26aulast%3DChene%26aufirst%3DP.%26aulast%3DDe%2BPover%26aufirst%3DA.%26aulast%3DSchoemaker%26aufirst%3DK.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DGabriel%26aufirst%3DD.%26aulast%3DSimonen%26aufirst%3DM.%26aulast%3DMurphy%26aufirst%3DL.%26aulast%3DFinan%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%26aulast%3DGarcia-Echeverria%26aufirst%3DC.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520NVP-BEZ235%252C%2520a%2520new%2520orally%2520available%2520dual%2520phosphatidylinositol%25203-kinase%252Fmammalian%2520target%2520of%2520rapamycin%2520inhibitor%2520with%2520potent%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D1851%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angela, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernard, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sonia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di-Stefano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjerke, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelland, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patterson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Haven Brandon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koizumi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghir, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waterfield, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span> </span><span class="NLM_article-title">Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">5840</span><span class="NLM_x">–</span> <span class="NLM_lpage">5850</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=5840-5850&author=F.+I.+Raynaudauthor=S.+Ecclesauthor=P.+A.+Clarkeauthor=H.+Angelaauthor=N.+Bernardauthor=A.+Soniaauthor=A.+Henleyauthor=F.+Di-Stefanoauthor=Z.+Ahmadauthor=S.+Guillardauthor=L.+M.+Bjerkeauthor=L.+Kellandauthor=M.+Valentiauthor=L.+Pattersonauthor=S.+Gowanauthor=A.+De+Haven+Brandonauthor=M.+Hayakawaauthor=H.+Kaizawaauthor=T.+Koizumiauthor=T.+Ohishiauthor=S.+Patelauthor=N.+Saghirauthor=P.+Parkerauthor=M.+Waterfieldauthor=P.+Workman&title=Pharmacologic+characterization+of+a+potent+inhibitor+of+class+I+phosphatidylinositide+3-kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DEccles%26aufirst%3DS.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DAngela%26aufirst%3DH.%26aulast%3DBernard%26aufirst%3DN.%26aulast%3DSonia%26aufirst%3DA.%26aulast%3DHenley%26aufirst%3DA.%26aulast%3DDi-Stefano%26aufirst%3DF.%26aulast%3DAhmad%26aufirst%3DZ.%26aulast%3DGuillard%26aufirst%3DS.%26aulast%3DBjerke%26aufirst%3DL.%2BM.%26aulast%3DKelland%26aufirst%3DL.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DPatterson%26aufirst%3DL.%26aulast%3DGowan%26aufirst%3DS.%26aulast%3DDe%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DHayakawa%26aufirst%3DM.%26aulast%3DKaizawa%26aufirst%3DH.%26aulast%3DKoizumi%26aufirst%3DT.%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DParker%26aufirst%3DP.%26aulast%3DWaterfield%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DPharmacologic%2520characterization%2520of%2520a%2520potent%2520inhibitor%2520of%2520class%2520I%2520phosphatidylinositide%25203-kinases%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D5840%26epage%3D5850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Folkes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alderton, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alix, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chuckowree, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depledge, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancox, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kugendradas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lensun, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivero, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergl-Wilson, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saghir, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salphati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhyvoloup, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvelebil, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuttleworth, S. J.</span><span> </span><span class="NLM_article-title">The identification of 2-(1<i>H</i>-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-<i>d</i>]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5532</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800295d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm9012642&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5522-5532&author=A.+J.+Folkesauthor=K.+Ahmadiauthor=W.+K.+Aldertonauthor=S.+Alixauthor=S.+J.+Bakerauthor=G.+Boxauthor=I.+S.+Chuckowreeauthor=P.+A.+Clarkeauthor=P.+Depledgeauthor=S.+A.+Ecclesauthor=L.+S.+Friedmanauthor=A.+Hayesauthor=T.+C.+Hancoxauthor=A.+Kugendradasauthor=L.+Lensunauthor=P.+Mooreauthor=A.+G.+Oliveroauthor=J.+Pangauthor=S.+Patelauthor=G.+H.+Pergl-Wilsonauthor=F.+I.+Raynaudauthor=A.+Robsonauthor=N.+Saghirauthor=L.+Salphatiauthor=S.+Sohalauthor=M.+H.+Ultschauthor=M.+Valentiauthor=H.+J.+A.+Wallweberauthor=N.+C.+Wanauthor=C.+Wiesmannauthor=P.+Workmanauthor=A.+Zhyvoloupauthor=M.+J.+Zvelebilauthor=S.+J.+Shuttleworth&title=The+identification+of+2-%281H-indazol-4-yl%29-6-%284-methanesulfonyl-piperazin-1-ylmethyl%29-4-morpholin-4-yl-thieno%5B3%2C2-d%5Dpyrimidine+%28GDC-0941%29+as+a+potent%2C+selective%2C+orally+bioavailable+inhibitor+of+class+I+PI3+kinase+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer</span></div><div class="casAuthors">Folkes, Adrian J.; Ahmadi, Khatereh; Alderton, Wendy K.; Alix, Sonia; Baker, Stewart J.; Box, Gary; Chuckowree, Irina S.; Clarke, Paul A.; Depledge, Paul; Eccles, Suzanne A.; Friedman, Lori S.; Hayes, Angela; Hancox, Timothy C.; Kugendradas, Arumugam; Lensun, Letitia; Moore, Pauline; Olivero, Alan G.; Pang, Jodie; Patel, Sonal; Pergl-Wilson, Giles H.; Raynaud, Florence I.; Robson, Anthony; Saghir, Nahid; Salphati, Laurent; Sohal, Sukhjit; Ultsch, Mark H.; Valenti, Melanie; Wallweber, Heidi J. A.; Wan, Nan Chi; Wiesmann, Christian; Workman, Paul; Zhyvoloup, Alexander; Zvelebil, Marketa J.; Shuttleworth, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5522-5532</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphatidylinositol-3-kinase (PI3K) is an important target in cancer due to the deregulation of the PI3K/Akt signaling pathway in a wide variety of tumors.  A series of thieno[3,2-d]pyrimidine derivs. were prepd. and evaluated as inhibitors of PI3 kinase p110α.  The synthesis, biol. activity, and further profiling of these compds. are described.  This work resulted in the discovery of GDC-0941 (I) which is a potent, selective, orally bioavailable inhibitor of PI3K and is currently being evaluated in human clin. trials for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojkFv29FXqO7Vg90H21EOLACvtfcHk0lh84wqfV5vU1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVCmsr7E&md5=742084954685353ceaf18660ab3a0703</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm800295d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800295d%26sid%3Dliteratum%253Aachs%26aulast%3DFolkes%26aufirst%3DA.%2BJ.%26aulast%3DAhmadi%26aufirst%3DK.%26aulast%3DAlderton%26aufirst%3DW.%2BK.%26aulast%3DAlix%26aufirst%3DS.%26aulast%3DBaker%26aufirst%3DS.%2BJ.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DChuckowree%26aufirst%3DI.%2BS.%26aulast%3DClarke%26aufirst%3DP.%2BA.%26aulast%3DDepledge%26aufirst%3DP.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DFriedman%26aufirst%3DL.%2BS.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DHancox%26aufirst%3DT.%2BC.%26aulast%3DKugendradas%26aufirst%3DA.%26aulast%3DLensun%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DP.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DPergl-Wilson%26aufirst%3DG.%2BH.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DRobson%26aufirst%3DA.%26aulast%3DSaghir%26aufirst%3DN.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSohal%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%2BH.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DWan%26aufirst%3DN.%2BC.%26aulast%3DWiesmann%26aufirst%3DC.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DZhyvoloup%26aufirst%3DA.%26aulast%3DZvelebil%26aufirst%3DM.%2BJ.%26aulast%3DShuttleworth%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520identification%2520of%25202-%25281H-indazol-4-yl%2529-6-%25284-methanesulfonyl-piperazin-1-ylmethyl%2529-4-morpholin-4-yl-thieno%255B3%252C2-d%255Dpyrimidine%2520%2528GDC-0941%2529%2520as%2520a%2520potent%252C%2520selective%252C%2520orally%2520bioavailable%2520inhibitor%2520of%2520class%2520I%2520PI3%2520kinase%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5522%26epage%3D5532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Yu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shor, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verheijen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malwitz, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingboe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayral-Kaloustian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nowak, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zask, A.</span><span> </span><span class="NLM_article-title">Biochemical, cellular and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">6232</span><span class="NLM_x">–</span> <span class="NLM_lpage">6240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=6232-6240&author=K.+Yuauthor=L.+Toral-Barzaauthor=C.+Shiauthor=W.-G.+Zhangauthor=J.+Lucasauthor=B.+Shorauthor=J.+Kimauthor=J.+Verheijenauthor=K.+Curranauthor=D.+J.+Malwitzauthor=D.+C.+Coleauthor=J.+Ellingboeauthor=S.+Ayral-Kaloustianauthor=T.+S.+Mansourauthor=J.+J.+Gibbonsauthor=R.+T.+Abrahamauthor=P.+Nowakauthor=A.+Zask&title=Biochemical%2C+cellular+and+in+vivo+activity+of+novel+ATP-competitive+and+selective+inhibitors+of+the+mammalian+target+of+rapamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DK.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.-G.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DShor%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DVerheijen%26aufirst%3DJ.%26aulast%3DCurran%26aufirst%3DK.%26aulast%3DMalwitz%26aufirst%3DD.%2BJ.%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DEllingboe%26aufirst%3DJ.%26aulast%3DAyral-Kaloustian%26aufirst%3DS.%26aulast%3DMansour%26aufirst%3DT.%2BS.%26aulast%3DGibbons%26aufirst%3DJ.%2BJ.%26aulast%3DAbraham%26aufirst%3DR.%2BT.%26aulast%3DNowak%26aufirst%3DP.%26aulast%3DZask%26aufirst%3DA.%26atitle%3DBiochemical%252C%2520cellular%2520and%2520in%2520vivo%2520activity%2520of%2520novel%2520ATP-competitive%2520and%2520selective%2520inhibitors%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D6232%26epage%3D6240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Feldman, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Apsel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uotila, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loewith, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=371-383&author=M.+E.+Feldmanauthor=B.+Apselauthor=A.+Uotilaauthor=R.+Loewithauthor=Z.+A.+Knightauthor=D.+Ruggeroauthor=K.+M.+Shokat&title=Active-site+inhibitors+of+mTOR+target+rapamycin-resistant+outputs+of+mTORC1+and+mTORC2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeldman%26aufirst%3DM.%2BE.%26aulast%3DApsel%26aufirst%3DB.%26aulast%3DUotila%26aufirst%3DA.%26aulast%3DLoewith%26aufirst%3DR.%26aulast%3DKnight%26aufirst%3DZ.%2BA.%26aulast%3DRuggero%26aufirst%3DD.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DActive-site%2520inhibitors%2520of%2520mTOR%2520target%2520rapamycin-resistant%2520outputs%2520of%2520mTORC1%2520and%2520mTORC2%26jtitle%3DPLoS%2520Biol.%26date%3D2009%26volume%3D7%26spage%3D371%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">García-Martínez, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cosulich, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chresta, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span> </span><span class="NLM_article-title">Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR)</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">421</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=421&publication_year=2009&pages=29-42&author=J.+M.+Garc%C3%ADa-Mart%C3%ADnezauthor=J.+Moranauthor=R.+G.+Clarkeauthor=A.+Grayauthor=S.+C.+Cosulichauthor=C.+M.+Chrestaauthor=D.+R.+Alessi&title=Ku-0063794+is+a+specific+inhibitor+of+the+mammalian+target+of+rapamycin+%28mTOR%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa-Mart%25C3%25ADnez%26aufirst%3DJ.%2BM.%26aulast%3DMoran%26aufirst%3DJ.%26aulast%3DClarke%26aufirst%3DR.%2BG.%26aulast%3DGray%26aufirst%3DA.%26aulast%3DCosulich%26aufirst%3DS.%2BC.%26aulast%3DChresta%26aufirst%3DC.%2BM.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26atitle%3DKu-0063794%2520is%2520a%2520specific%2520inhibitor%2520of%2520the%2520mammalian%2520target%2520of%2520rapamycin%2520%2528mTOR%2529%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D421%26spage%3D29%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Thoreen, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichling, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabatini, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">8023</span><span class="NLM_x">–</span> <span class="NLM_lpage">8032</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm9012642&amp;key=10.1074%2Fjbc.M900301200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm9012642&amp;key=19150980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm9012642&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtVSmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=8023-8032&author=C.+C.+Thoreenauthor=S.+A.+Kangauthor=J.+W.+Changauthor=Q.+Liuauthor=J.+Zhangauthor=Y.+Gaoauthor=L.+J.+Reichlingauthor=T.+Simauthor=D.+M.+Sabatiniauthor=N.+S.+Gray&title=An+ATP-competitive+mammalian+target+of+rapamycin+inhibitor+reveals+rapamycin-resistant+functions+of+mTORC1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1</span></div><div class="casAuthors">Thoreen, Carson C.; Kang, Seong A.; Chang, Jae Won; Liu, Qingsong; Zhang, Jianming; Gao, Yi; Reichling, Laurie J.; Sim, Taebo; Sabatini, David M.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">8023-8032</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The mammalian target of rapamycin (mTOR) kinase is the catalytic subunit of two functionally distinct complexes, mTORC1 and mTORC2, that coordinately promote cell growth, proliferation, and survival.  Rapamycin is a potent allosteric mTORC1 inhibitor with clin. applications as an immunosuppressant and anti-cancer agent.  Here we find that Torin1, a highly potent and selective ATP-competitive mTOR inhibitor that directly inhibits both complexes, impairs cell growth and proliferation to a far greater degree than rapamycin.  Surprisingly, these effects are independent of mTORC2 inhibition and are instead because of suppression of rapamycin-resistant functions of mTORC1 that are necessary for cap-dependent translation and suppression of autophagy.  These effects are at least partly mediated by mTORC1-dependent and rapamycin-resistant phosphorylation of 4E-BP1.  Our findings challenge the assumption that rapamycin completely inhibits mTORC1 and indicate that direct inhibitors of mTORC1 kinase activity may be more successful than rapamycin at inhibiting tumors that depend on mTORC1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiRNo9IcTXArVg90H21EOLACvtfcHk0lgyqGKdrZQePw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtVSmtLY%253D&md5=ea4476b6a55a6b8964fc5c041c80039f</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M900301200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M900301200%26sid%3Dliteratum%253Aachs%26aulast%3DThoreen%26aufirst%3DC.%2BC.%26aulast%3DKang%26aufirst%3DS.%2BA.%26aulast%3DChang%26aufirst%3DJ.%2BW.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DReichling%26aufirst%3DL.%2BJ.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DSabatini%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DAn%2520ATP-competitive%2520mammalian%2520target%2520of%2520rapamycin%2520inhibitor%2520reveals%2520rapamycin-resistant%2520functions%2520of%2520mTORC1%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D8023%26epage%3D8032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Hopkins, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm9012642&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm9012642&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm9012642&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=L.+A.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eZgRdG8AKWOy7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DL.%2BA.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Keseru, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makara, G. M.</span><span> </span><span class="NLM_article-title">The influence of lead discovery strategies on the properties of drug candidates</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">203</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm9012642&amp;key=10.1038%2Fnrd2796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm9012642&amp;key=19247303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm9012642&amp;key=1%3ACAS%3A280%3ADC%252BD1M7ntV2qug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=203-212&author=G.+M.+Keseruauthor=G.+M.+Makara&title=The+influence+of+lead+discovery+strategies+on+the+properties+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of lead discovery strategies on the properties of drug candidates</span></div><div class="casAuthors">Keseru Gyorgy M; Makara Gergely M</div><div class="citationInfo"><span class="NLM_cas:title">Nature reviews. Drug discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Despite the widespread acceptance of guidelines related to desirable physicochemical properties of potential small-molecule drugs, key properties - such as lipophilicity - of recently developed clinical candidates and advanced lead compounds have been shown to differ significantly from those of historical leads and drugs.  By analysing the physicochemical properties of a large database of hits and corresponding leads identified in the past decade, we show that this undesirable phenomenon can be traced back to the nature of high-throughput screening hits and hit-to-lead optimization practices.  Conceptual and organizational adjustments may be required to enable a smooth lead-evolution process that reduces the chance of high compound-related attrition in clinical trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCjUjH8uzRfyM8MEzWGjS9fW6udTcc2eZgRdG8AKWOy7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7ntV2qug%253D%253D&md5=57f8228cf7f46bd4f3c3ff48f34da32c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnrd2796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2796%26sid%3Dliteratum%253Aachs%26aulast%3DKeseru%26aufirst%3DG.%2BM.%26aulast%3DMakara%26aufirst%3DG.%2BM.%26atitle%3DThe%2520influence%2520of%2520lead%2520discovery%2520strategies%2520on%2520the%2520properties%2520of%2520drug%2520candidates%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D203%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><a href="http://www.invitrogen.com/kinaseprofiling" class="extLink">http://www.invitrogen.com/kinaseprofiling</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.invitrogen.com%2Fkinaseprofiling."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Matsushita, K.; Hasegawa, H.; Kuribayashi, Y.; Ohashi, N.</span><span> </span><span class="NLM_article-title">Preparation of Sulfonylureidopyrazole Derivatives as Endothelin Converter Enzyme Inhibitors</span>. PCT Int. Appl. WO 9730978 A1,<span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">; </span>Sumitomo Pharmaceuticals Co., Ltd., Japan.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=K.+Matsushita&author=H.+Hasegawa&author=Y.+Kuribayashi&author=N.+Ohashi&title=Preparation+of+Sulfonylureidopyrazole+Derivatives+as+Endothelin+Converter+Enzyme+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMatsushita%26aufirst%3DK.%26atitle%3DPreparation%2520of%2520Sulfonylureidopyrazole%2520Derivatives%2520as%2520Endothelin%2520Converter%2520Enzyme%2520Inhibitors%26date%3D1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Muller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaplovsky, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woggon, W.-D.</span><span> </span><span class="NLM_article-title">Synthesis and photophysical properties of a deazaflavin-bridged porphyrinatoiron(III) that mimics the interaction of a deazaflavin inhibitor with the heme-thiolate cofactor of cytochrome P450 3A4</span> <span class="citation_source-journal">Helv. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">2987</span><span class="NLM_x">–</span> <span class="NLM_lpage">3001</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2006&pages=2987-3001&author=M.+A.+Mullerauthor=M.+Gaplovskyauthor=J.+Wirzauthor=W.-D.+Woggon&title=Synthesis+and+photophysical+properties+of+a+deazaflavin-bridged+porphyrinatoiron%28III%29+that+mimics+the+interaction+of+a+deazaflavin+inhibitor+with+the+heme-thiolate+cofactor+of+cytochrome+P450+3A4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DM.%2BA.%26aulast%3DGaplovsky%26aufirst%3DM.%26aulast%3DWirz%26aufirst%3DJ.%26aulast%3DWoggon%26aufirst%3DW.-D.%26atitle%3DSynthesis%2520and%2520photophysical%2520properties%2520of%2520a%2520deazaflavin-bridged%2520porphyrinatoiron%2528III%2529%2520that%2520mimics%2520the%2520interaction%2520of%2520a%2520deazaflavin%2520inhibitor%2520with%2520the%2520heme-thiolate%2520cofactor%2520of%2520cytochrome%2520P450%25203A4%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D2006%26volume%3D89%26spage%3D2987%26epage%3D3001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamison, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaRocque, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">Characterization of the cloned full-length and a truncated human target of rapamycin: activity, specificity, and enzyme inhibition as studied by a high capacity assay</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">332</span><span class="NLM_x">, </span> <span class="NLM_fpage">304</span><span class="NLM_x">–</span> <span class="NLM_lpage">310</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2005&pages=304-310&author=L.+Toral-Barzaauthor=W.+G.+Zhangauthor=C.+Lamisonauthor=J.+LaRocqueauthor=J.+Gibbonsauthor=K.+Yu&title=Characterization+of+the+cloned+full-length+and+a+truncated+human+target+of+rapamycin%3A+activity%2C+specificity%2C+and+enzyme+inhibition+as+studied+by+a+high+capacity+assay"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%2BG.%26aulast%3DLamison%26aufirst%3DC.%26aulast%3DLaRocque%26aufirst%3DJ.%26aulast%3DGibbons%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DCharacterization%2520of%2520the%2520cloned%2520full-length%2520and%2520a%2520truncated%2520human%2520target%2520of%2520rapamycin%253A%2520activity%252C%2520specificity%252C%2520and%2520enzyme%2520inhibition%2520as%2520studied%2520by%2520a%2520high%2520capacity%2520assay%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D332%26spage%3D304%26epage%3D310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Zask, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toral-Barza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tischler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaydos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cinque, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, K.</span><span> </span><span class="NLM_article-title">Synthesis and structure−activity relationship of ring-opened 17-hydroxywortmannins: potent phosphoinositide 3-kinase inhibitors with improved properties and anticancer efficacy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1319</span><span class="NLM_x">–</span> <span class="NLM_lpage">1323</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7012858" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1319-1323&author=A.+Zaskauthor=J.+Kaplanauthor=L.+Toral-Barzaauthor=I.+Hollanderauthor=M.+Youngauthor=M.+Tischlerauthor=C.+Gaydosauthor=M.+Cinqueauthor=J.+Lucasauthor=K.+Yu&title=Synthesis+and+structure%E2%88%92activity+relationship+of+ring-opened+17-hydroxywortmannins%3A+potent+phosphoinositide+3-kinase+inhibitors+with+improved+properties+and+anticancer+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm7012858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7012858%26sid%3Dliteratum%253Aachs%26aulast%3DZask%26aufirst%3DA.%26aulast%3DKaplan%26aufirst%3DJ.%26aulast%3DToral-Barza%26aufirst%3DL.%26aulast%3DHollander%26aufirst%3DI.%26aulast%3DYoung%26aufirst%3DM.%26aulast%3DTischler%26aufirst%3DM.%26aulast%3DGaydos%26aufirst%3DC.%26aulast%3DCinque%26aufirst%3DM.%26aulast%3DLucas%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520structure%25E2%2588%2592activity%2520relationship%2520of%2520ring-opened%252017-hydroxywortmannins%253A%2520potent%2520phosphoinositide%25203-kinase%2520inhibitors%2520with%2520improved%2520properties%2520and%2520anticancer%2520efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1319%26epage%3D1323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3IBE','PDB','3IBE'); return false;">PDB: 3IBE</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm9012642&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm9012642%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2009.52.issue-22%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm9012642" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679977b16e85d932","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
